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I. INTRODUCTION 
Milk protein yield has become the major economic output of the dairy industry. In 2010, 47.5% of 
collected milk was devoted to protein dependent production of cheese, including cream, curd and pulled 
curd cheese (Bundesministerium für Ernaehrung, 2011). This demand is reflected by the paying system 
of dairy industry: in 2011, the dairy industry paid for one kg milk (4.2% milk fat and 3.4% milk protein) 
34.5 ± 1.2 €-cent, corrected by 2.70 €-cent for percentage fat and 4.10 €-cent for percentage protein 
(dairy factory Weihenstephan, Freising; Topagrar, 2011). 
Milk protein yield is mainly depending on milk yield (correlation 0.92), but also on milk protein content 
(correlation 0.10; Teepker and Swalve, 1988). After focussing on efforts to increase milk yield during 
the last decades, special emphasis of genetic selection is nowadays also devoted to other traits including 
milk protein content (Lipkin et al., 2008). 
Regardless of the economic value of milk protein yield, cows with elevated protein content could have 
metabolic advantages in comparison to their herd mates with equal protein yield as a result of lower 
protein content but higher milk yield. The amount of produced milk correlates positively to the lactose 
yield (0.96; Shahbazkia et al., 2010). Regarding cows with similar milk yield, the energy demand for 
milk synthesis depends on milk fat and protein content (Kamphues et al., 2004): 
𝑚𝑖𝑙𝑘 𝑒𝑛𝑒𝑟𝑔𝑦 �𝑀𝐽
𝑘𝑔
� = 0.38 × 𝑓𝑎𝑡% + 0.21 × 𝑝𝑟𝑜𝑡𝑒𝑖𝑛% + 1.05. 
Consequently, energy demand for synthesis of milk protein is nearly half of the energy demand for the 
same amount of milk fat. Regarding the critical situation of high yielding dairy cows during the first 
weeks of lactation, when feed intake regularly lags behind energy demand for milk synthesis, it is 
worthwhile to select cows with high economic and concurrently low energetic output to decrease risks 
of typical diseases during early lactation like ketosis, hepatic steatosis, dislocation of abomasum and 
following events (impaired immune function, metritis, mastitis, lameness). However, selecting cows 
with low milk fat content is not desirable due to concomitant decrease of milk protein concentration 
(correlation 0.47), as well as selecting for low milk fat yields which would reduce milk yield 
(correlation 0.77) and protein yield (correlation 0.82; Teepker and Swalve, 1988). 
Consequently an increase of the economically valuable milk protein yield should be achieved by the 
less energy demanding increase of milk protein content with constant or lower milk and fat yields. 
In this study, dairy cows were classified into four groups according to milk yield and milk protein 
content. The aim was to evaluate metabolism, milk productivity and metabolic situation of these four 
groups during early and mid-lactation. Therefore, cows were submitted to short-term feed restrictions in 
early (wk 4 pp) and mid-lactation (wk 21 pp) and to intravenous glucose tolerance tests (ivGTTs) two 
weeks before parturition (d 14 ap), in early (d 20 pp) and mid-lactation (d 127 pp). Furthermore, blood 
and milk as well as hepatic and muscular tissue samples were collected throughout the trial to 
investigate the influence of productivity on metabolic adaptations. 
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II. LITERATURE 
1. Milk composition 
Producing a nutritive excretion for the nourishment of the offspring is the evolutional advantage of 
many mammalian species. However, in the following sections the term milk refers to cow’s milk. 
Milk is a very complex emulsion, containing approximately 3.0 to 5.0% fat mainly organised in fat 
globules and around 5% carbohydrates, mainly lactose, but also galactose and glucose in the 
aqueous phase (Schultz, 1974; Cerbulis and Farrell, 1975). Another nutritive ingredient are the 
milk proteins (around 3.2 to 3.8%), consisting of 20% whey proteins with the major components 
α-lactalbumin (α-LA) and β-lactoglobulin (β-LG) and of 80% caseins, divided into major 
subclasses α-, β- and κ-casein (-CN), arranged in micelles (Swaisgood, 1982; Rodriquez et al., 
1985). Further constituents are proteolysed fragments (γ1-3-CN and proteose peptone, plasmin 
derived from β-CN), cells (mammary epithelial cells or immune cells like leucocytes), but also 
urea, amino acids, immunoglobulins, lactoferrin, vitamins, minerals and hormones along with 
electrolytes and other components (Ng-Kwai-Hang et al., 1984; Shutt and Fell, 1985; Palmano and 
Elgar, 2002). Hereafter, only the major milk components lactose, fat and protein are further 
described in detail. 
1.1. Lactose 
Concentration of lactose is the volume limiting factor for milk synthesis, due to its osmotic activity 
and its disability to cross the membrane of mammary epithelial cells (MEC; Larson, 1969; Bleck 
et al., 2009).  
The disaccharide lactose consists of glucose and galactose, which is metabolised in MEC from 
glucose. Lactose is synthesised in the Golgi apparatus of MEC by lactose synthase, which is a 
complex of α-LA and ubiquitous galactosyltransferase (Larson, 1969; Kuhn et al., 1980). With 
increasing milk protein content, concentration of lactose synthase increases and concentrations of 
galactosyltransferase also increase with days of lactation (Bleck et al., 2009). After synthesis, 
lactose is secreted by exocytose into the mammary alveoli lumen (Shennan and Peaker, 2000). 
Lactose content in milk of different breeds ranges from 4.66 ± 0.34% in Guernsey, 4.93 ± 0.61% 
in Holstein to 5.15 ± 0.46% in Brown Swiss cows, but is equally distributed within breeds 
(Cerbulis and Farrell, 1975). 
1.2. Fat 
Milk fat provides the main energy source of milk, whereas milk protein and lactose accounts for 
half the energy density of milk fat (Emery, 1973). Moreover, lipid droplets contain lipohilic 
vitamins and other biological active substances (Parodi, 1997; Molkentin, 1999). 
Fat in milk comprises mainly of triacylglycerols which are synthesised in MEC either de novo or 
from fatty acids extracted from blood (Linzell and Peaker, 1971; Shennan and Peaker, 2000). 
About 40% of fat mass consists of short-chain and medium-chain fatty acids (4 to 14 carbon 
atoms) which are mainly synthesised from blood derived precursors acetate and β-hydroxybutyric 
acid (BHBA) and the remaining long-chain fatty acids are synthesised from blood non-esterified 
fatty acids (NEFA) and blood triacylglycerol (Linzell and Peaker, 1971). Esterification of fatty 
acids takes place in the rough endoplasmatic reticulum. Afterwards, lipid droplets migrate to the 
apex of MEC, where they buckle out the surface of the cell and then are snapped off with an intact 
membrane of phospholipids around them (Linzell and Peaker, 1971). The proteins of milk fat 
globule membrane (MFGM) represent 1-4% of total milk protein concentration and have low 
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nutritional value, but since proteomic studies give new insights, it is obvious, that MFGM proteins 
are important for cellular processes and defence mechanisms in newborns (Cavaletto et al., 2008). 
Concentration of milk fat averages 4.34 ± 0.71%, ranging from Jersey (5.42 ± 0.53%), Holstein 
(3.73 ± 0.32%) to Milking Shorthorn cows (3.58 ± 0.26%; Cerbulis and Farrell, 1975), whereas in 
Holstein herds mean fat content is 3.684 ± 0.003% (Ng-Kwai-Hang et al., 1984). 
1.3. Protein 
Synthesis of milk protein 
Precursors for mammary protein synthesis are amino acids extracted from blood or synthesised in 
MEC. Milk protein synthesis follows the same principles as in other cells: transcription of DNA, 
translation at the ribosomes of rough endoplasmatic reticulum and posttranslational modifications 
(Larson, 1969; Shennan and Peaker, 2000). The genes for the caseins are clustered in close 
proximity on bovine chromosome 6 and are conserved throughout evolution with αS1-, αS2- and β-
CN having a common ancestor whereas κ-CN was derived from the fibrinogen gene family 
(Mercier and Vilotte, 1993). Furthermore, encoding genes for α-LA can be found on chromosome 
5 and for β-LG on chromosome 11 (Mercier and Vilotte, 1993). 
Some proteins derive from blood and are secreted unchanged into milk by vesicular transport 
across MECs or by paracellular migration (e.g. BSA, immunoglobulins; Larson and Gillespie, 
1957; Shennan and Peaker, 2000). During lactation in healthy cows, the transcellular path 
predominates whereas in cows suffering inflammation of mammary gland, tight junctions between 
MEC are becoming leaky and the paracellular way gains importance (Shennan and Peaker, 2000; 
Hogarth et al., 2004). 
1.3.1. Composition of milk protein 
Depending on their solubility at pH 4.6 and 20°C, milk proteins are divided into indissoluble 
caseins and soluble whey proteins (Swaisgood, 1982).  
Casein 
According to De Marchi et al. (2009), the casein fraction of milk mainly comprises of αS1-, αS2-, β- 
and κ-CN in concentrations of 31.3, 10.8, 36.9 and 9.3% of total protein. Morris (2002) observed 
42.8, 19.4 and 11.7% of total protein for αS-, β- and κ-CN. All of the caseins bind calcium and this 
binding capacity is proportional to the phosphate content (Swaisgood, 1992). During migration 
through the cytoplasm, caseins cluster with calcium and phosphate to micelles (Walstra, 1999). 
Individual caseins exhibit varying structures: αS1-CN bears 199 amino acids (23.0 kM), two 
hydrophobic and one polar group and assembles with itself stepwise. Furthermore αS2-CN consists 
of 207 amino acids (25.0 kM), can contain a disulfide bond, is the most hydrophilic of the caseins 
and assembles also stepwise to build polymers (Morris, 2002). Moreover, β-CN consists of 209 
amino acids (24.0 kM) and acts as a detergent due to its amphiphilic character because of the 
highly charged polar N-terminal region and the hydrophobic C-terminal region. Self-assembly of 
β-CN produces large spherical aggregates (Morris, 2002). 
Although it is the least abundant casein, κ-CN has importance in stabilisation of caseins and 
micelles. After protein synthesis, caseins associate with themselves and also with other caseins to 
form sub-micelles (diameter around 14 nm). Those sub-micelles bind calcium phosphate during 
migration in Golgi vesicles through the cytoplasm of MEC, therefore loosing partly their negative 
charge, hence decreasing their size and, due to stronger interaction with other micelles, rearrange 
in micelles (Walstra, 1999). Distribution of κ-CN shows different patterns: it can be found as 
'hairy' layer at the periphery of micelles, with the hydrophilic portion pointing outside, therefore 
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providing solubility of micelles in aqueous media and it can also be uniformly distributed within 
micelles. The higher the κ-CN content at the periphery of micelles, the bigger they grow           
(92 - 142 nm; Carroll and Farrell, 1983). Composited of 169 amino acids (19.0 kM), it is cleaved 
by rennet into its hydrophobic portion para-kappa-casein and the hydrophilic portion 
caseinomacropeptide, therefore causing the micelles to agglutinate (Hallen et al., 2010). Moreover, 
during heat-induced coagulation, κ-CN interacts with β-LG (Morris, 2002).  
Whey protein 
Already in ancient times, healthy aspects of whey were known. Nowadays the underlying proteins 
and bioactive peptides are revealed, which account for effects on satiety and therefore obesity 
management or influence blood pressure (Barth and Behnke, 1997; Clare and Swaisgood, 2000; 
D'Amato et al., 2009). Apart from minor constituents like BSA, immunoglobulins and lactoferrin, 
whey consist mainly of proteins α-LA and β-LG. De Marchi et al. (2009) reported 3.2 and 9.3% of 
total protein for α-LA and β-LG and according to Morris (2002) α-LA, β-LG, immunoglobulin G 
and BSA account for 3.1, 13.3, 2.5 and 1.4% of total protein. 
The more abundant whey protein β-LG comprises of 178 amino acids (18.3 kM) and binds 
hydrophobic and amphiphilic molecules like hexane, palmitic acid, vitamin D or retinol (Sawyer, 
2003; Farrell Jr et al., 2004). As mentioned before the 123 amino acid containing globular protein 
α-LA is part of the complex for synthesis of lactose (Kuhn et al., 1980). Furthermore α-LA binds 
calcium, zinc and other metals due to its classification as calcium metalloprotein (Farrell Jr et al., 
2004). 
1.3.2. Quantification of milk protein fractions 
For separation and quantification of milk protein fractions and for analysis of genetic varieties, 
methods often apply high performance liquid chromatography (HPLC). In HPLC, protein 
solutions together with solvents are pumped through a column filled with specific materials like 
silica beads with or without carbon chains. Proteins attach according to size, ionisation or other 
properties to these fillings and duration of migration varies for different proteins (Bordin et al., 
2001; Bonfatti et al., 2008; Bonizzi et al., 2009). Moreover, HPLC coupled to mass spectrometry 
(MS) has also been used. Principle of MS is based on a separation by the ratio of mass to charge: 
samples are vaporized, ionised (e.g. by laser or electrospray), the ions are guided through an 
electromagnetic field, where a separation according to ratio of mass to charge occurs and ions are 
detected by an electron multiplier (Galvani et al., 2001; Fröhlich and Arnold, 2006; Boehmer et 
al., 2010). To obtain single peptides for analysis in MS, protein solutions are subjected to a two-
dimensional polyacrylamide gel electrophoresis (2D-PAGE) followed by trypsin digestion. In 2D-
PAGE, proteins are first separated according to their isoelectric point by isoelectric focussing and 
then according to their molecular weight by sodium dodecyl sulphate electrophoresis (SDS; 
O'Farrell, 1975). Despite of the high power of resolution and separation, 2D-PAGE and also SDS-
PAGE are very time consuming and have low throughput rates. Goetz et al. (2004) and Wu et al. 
(2008) showed that miniature electrophoresis on microfluidic chips offers a fast and reliable 
alternative for conventional SDS-PAGE. On these chips, all steps of traditional gel electrophoresis 
can be performed: gel preparation, sample loading, separation (reducing or non reducing 
conditions), staining and destaining and detection. Integration is done automatically with the 
possibility of manual integration (Agilent 2100 Expert Software). 
1.4. Effects on milk and protein composition 
Milk is not only a complex secretion, also regulation of lactation and composition of individual 
components is complex (Svennersten-Sjaunja and Olsson, 2005). Hereafter, some of the 
possibilities to influence milk and milk protein composition are discussed. 
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Genetics 
From the middle of the 20th century, dairy cows have been selected for milk and fat yield (Schultz, 
1974). Since then, new developments in molecularbiology have altered traditional breeding 
programs. Rolleri et al. (1956) have shown, that different breeds vary in milk protein composition: 
On the one hand, Holstein cows show lowest total casein, α- and β-CN, on the other hand, cows of 
the Ayrshire breed have less milk α-CN compared to Brown Swiss, Guernsey and Jersey cows. 
Nowadays breeders have a deeper understanding of the mechanisms underlying these variations 
due to comprehension of most of the impacts of genetic polymorphisms on milk protein 
composition or the detection of quantitative trait loci for protein composition (Martin et al., 2002; 
Schopen et al., 2009). All these factors together represent a new breeding system according not 
only to conventional breeding values (e.g. performance of offspring) but also to the genomic 
breeding value (Hayes et al., 2009). After decades of selecting for milk yield and fat yield, 
emphasis today shifts towards milk protein yield and concentration (Lipkin et al., 2008). 
Lactation 
Independent of the genetic equipment, milk composition alters with progressing lactation. During 
the first days, secretion of mammary gland provides immune components for the newborn. 
Concentrations of fat, protein, immunoglobulins and lactoferrin are higher in colostrum and 
several low abundance proteins appear in colostrum which are not found in mature milk (Kehoe et 
al., 2007; Stelwagen et al., 2009). With ongoing lactation, milk fat, protein and immunoglobulin 
concentrations decrease and reach levels of mature milk. Protein concentration in Brown Swiss 
cows shows a nadir at 3.0% around week (wk) 4 postpartum (pp) and increases from wk 8 pp until 
wk 44 pp (to 4.0%; Schlamberger et al., 2010). Especially in high yielding cows, milk fat 
concentration is comparative high in early lactation due to the metabolic imbalance caused by 
enormous acceleration of produced milk yield, concurrent insufficient energy intake and resulting 
mobilisation of body fat tissue (Grummer et al., 2004; Ingvartsen, 2006). 
Additionally with increasing numbers of lactation, dairy cows produce more milk (maximum in 4th 
or 5th lactation), but concentrations of main components remain relatively constant (Waite et al., 
1956; Ng-Kwai-Hang et al., 1984; Ray et al., 1992). 
Feeding  
Besides genetic and lactational effect, feeding has also a high but complex influence on milk and 
milk protein composition: adequate amounts of rumen-undegradable protein and energy intake, 
suitable roughage supply and improved peri-parturient feeding regime avoiding over-conditioning 
of dry cows optimise milk protein concentration (Sutton, 1989; Jouany, 1994; Santos et al., 1998; 
Pop et al., 2001; Brun-Lafleur et al., 2010). Moreover, energy-insufficient rations especially in 
early lactation provoke body fat mobilisation and therefore increasing milk fat concentration and 
milk fat to milk protein ratios (FPR). 
The composition of dietary fat may influence the ratio of short to long fatty acids in milk fat 
(Palmquist et al., 1993; Sigl et al., 2010). Moreover during restricted pasture allowance, Auldist et 
al. (2000) found 4% increase of caseins and 9% decrease of whey proteins as well as declining 
milk yield and fat concentration. Elevation of available protein in small intestine by infusion of 
proteins resulted only in decrease of β-LG (-4.7%; Mackle et al., 1999). 
Management and environment  
Moreover, milk composition varies through course of milk removal: fat concentration increases 
throughout the removal, protein concentration decreases only in residual milk and lactose 
concentration first increases and decreases again in residual milk (Ontsouka et al., 2003). Length 
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of dry period and milking frequency also affect milk composition. Madsen et al. and Schlamberger 
et al. found 0.4% increase of protein concentration at wk 5 pp or respectively throughout 305 day 
(d) performance in continuously milked cows without drying off at wk 8 ante partum (ap; Madsen 
et al., 2008; Schlamberger et al., 2010). Furthermore milking frequency in Holstein cows 
correlates positively to milk yield (0.40) and negatively to milk fat (-0.13) and protein 
concentration (-0.20; Løvendahl and Chagunda, 2011).  
Moreover decreasing temperatures increase protein and casein concentrations in milk and 
concentrations of all milk proteins increase after a nadir in the 2nd lactation month until end of 
lactation (Ng-Kwai-Hang et al., 1982; Rodriquez et al., 1985). 
Disease 
Besides physiological effects, also pathological mechanisms alter milk and protein composition. 
During infection of mammary gland, milk yield declines resulting in higher concentrations of 
components and the protein composition is altered towards more whey proteins (especially the 
blood derived proteins) and less caseins (Munro et al., 1984; Hogarth et al., 2004). These changes 
are complex and results of studies often contradictory as Seegers et al. (2003) reviewed. 
2. Characterisation of metabolic situation in dairy cows 
Due to selection programs over the last decades and favouring of high milk output, high yielding 
dairy cows have to face enormous changes through the gestation-lactation cycles in their 
productive life. Prior to parturition, metabolism of dairy cows undergoes tremendous alterations, 
which involve complex feedback and control mechanisms of reproductive hormones (e.g. increase 
in estrogens, decrease in progesterone), insulin (increase in blood levels, decrease in tissue 
sensitivity) as well as diminished anabolic with concurrent increased catabolic situation in adipose 
and muscle tissue (Ingvartsen and Andersen, 2000). 
Moreover, during last weeks before parturition, dry matter intake (DMI) decreases, resulting in 
increasing nutrient and energy deficit (Drackley, 1999; Ingvartsen and Andersen, 2000; Grummer 
et al., 2004). Onset of lactation enhances this deficit by direction of glucose to mammary gland 
due to up-regulation of messenger ribonucleic acid (mRNA) encoding for insulin independent 
glucose transporters (Bell and Bauman, 1997; Komatsu et al., 2005). To cope with this metabolic 
imbalance, dairy cows show sophisticated regulation mechanisms: increase of body fat 
mobilisation and hepatic oxidation of fatty acids, increasing gluconeogenesis and ketogenesis in 
liver as well as diminished utilisation of glucose by muscle and adipose tissue (Trenkle, 1981; 
Loor et al., 2005; Nafikov and Beitz, 2007; McCarthy et al., 2010). As a sign of this catabolic 
situation, specific alterations can be found in blood parameters of cows. Blood glucose decreases 
and stays on low levels and NEFA increase due to enhanced mobilisation of body fat tissue. The 
product of hepatic fatty acid oxidation acetyl-CoA is not metabolised in the citric acid cycle 
because of glucose deficiency and therefore induces ketogenesis (Zammit, 1983).  
As a function of body fat mobilisation and β-oxidation of fatty acids, blood levels of cholesterol 
increase from wk 4 ap until wk 13 pp (Graber et al., 2010). Loor et al. (2007) show that during 
restricted feeding and ketosis, mRNA encoding for enzymes of cholesterol synthesis are 
decreased. Only 20% of milk cholesterol concentrations are produced in mammary gland, the 
greater part is produced in liver and transported via blood lipoproteins to mammary gland (Long et 
al., 1980). Furthermore total bilirubin (tBR) is a hepatic marker for function and integrity of liver 
cells with extent of hyperbilirubinaemia depending on location of impaired cell function and 
integrity of cell membranes (Gopinath and Ford, 1972).  
Nevertheless, milk yield is increasing steeply with maximum around 5th week pp, whereas DMI 
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intake has its maximum later on, around 10th week pp (Schröder and Staufenbiel, 2006). During 
this critical timeframe of lactation in cows, several production diseases can occur: ketosis, 
displacement of abomasum, infections of uterus or mammary gland, hepatic steatosis and 
reproductive disorders like delayed ovulation, acyclic oestrus or ovarian cysts (Ingvartsen, 2006; 
LeBlanc, 2010). 
Later on in lactation, during mid and late lactation, energy output (for maintenance, milk 
production, if pregnant for growth of embryo) is covered or exceeded through DMI and energy 
intake so that body storages can be refilled. Nevertheless, excessive gain of body fat reserves has 
to be avoided due to the higher risk of obese cows to develop severe problems during parturition or 
to develop fatty liver syndrome after parturition (Ingvartsen, 2006; Roche et al., 2009).  
Feed restriction (FR) is an appropriate tool for enhancing energy deficit in early lactation. 
Furthermore milk and blood parameters are altered by FR during early or mid-lactation. Diverging 
results can be found in studies: a 49% FR for three weeks in mid-lactation resulted in declining 
milk yield (by -10%) and milk protein content (-5%; Gross et al., 2011), whereas 25% FR reduced 
milk yield by 12% and milk protein concentration from 3.36% to 3.09% (Guinard-Flament et al., 
2007). A 51% FR over 5 days during mid-lactation provoked 22% reduction in milk yield and had 
no effect on milk composition (Velez and Donkin, 2005). 
3. Hepatic gene expression 
Several enzymes play important roles in liver metabolism of cows. Hereafter functions of those 
individual proteins, of which abundances of encoding mRNA were measured, are discussed. 
Lipid metabolism 
Glycerol-3-phosphate acyltransferase (encoding gene GPAM) catalyses the initial step of 
triacylglycerol synthesis from acyl-CoA (Roy et al., 2006) and acetyl-CoA carboxylase α 
(encoding gene ACACA) is the rate limiting enzyme for de novo synthesis of long chain fatty acids 
in liver and adipose tissue (Mao et al., 2001).  
In β-oxidation of fatty acids, carnitine palmitoyltransferase 1A (encoding gene CPT1A) is involved 
as transport enzyme for long chain fatty acids across the mitochondrial membrane by binding to 
carnitine (van der Leij et al., 2000). Furthermore, acyl-CoA dehydrogenase very long chain 
(encoding gene ACADVL) catalyses the first step of β-oxidation of long chain fatty acids in liver 
(van Dorland et al., 2009) and enoyl CoA hydratase 1 (encoding gene ECHS1) reversibly hydrates 
unsaturated fatty acyl-CoA derivatives to hydroxy-acyl-CoA compounds (Furuta et al., 1980). 
Furthermore, several transcription factors are involved in regulation of fatty acid metabolism in 
liver: sterol regulatory element binding transcription factor 1 (encoding gene SREBF1) up 
regulates GPAM transcription, peroxisome proliferator activated receptor α (PPARA) promotes 
overall fatty acid oxidation and hepatocyte nuclear factor 4A (HNF4A) enhances fatty acid 
oxidation as well as gluconeogenesis (Loor et al., 2005). Eukaryotic translation initiation factor 4B 
(EIF4B) is involved in lipid oxidation due to diminished nutrient availability (Gingras et al., 
2001). 
During transition period, hepatic mRNAs encoding for these enzymes show higher (CPT1A, 
ACADVL, ECHS1, PPARA, HNF4A, EIF4B) or lower (GPAM, ACACA, SREBF1) abundances 
respective to function in lipid catabolism or anabolism (Loor et al., 2005; 2006; 2007). 
Protein metabolism 
In protein catabolism, tyrosine aminotransferase (TAT) catalyses the first step of tyrosine depletion 
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(Johnson et al., 1973; Dietrich, 1992) and cathepsin L (CTSL) being a lysosomal cysteine 
proteinase is also involved (Stearns et al., 1990; Becker et al., 2010). 
Carbohydrate metabolism 
During gluconeogenesis, the enzyme pyruvate carboxylase (PC) catalyses the irreversible 
carboxylation of pyruvate to oxaloacetate and cytosolic phosphoenolpyruvate carboxykinase 
(PCK1) as well as mitochondrial form (PCK2) metabolise oxaloacetate further to 
phosphoenolpyruvate and carbon dioxide (Aschenbach et al., 2010). Increased activity of these 
enzymes could be observed by Greenfield et al. (2000) during early lactation, whereas FR induces 
only PC (Stangassinger and Sallmann, 2004; Velez and Donkin, 2005). 
Furthermore, the facilitated glucose transporter member 2 (GLUT2 or solute carrier family 2, 
member 2; encoding gene SLC2A2) enables passive glucose transport into hepatic cytoplasm and 
can also be found in kidney and small intestine (Zhao et al., 1993; Zhao and Keating, 2007). 
Insulin receptor (INSR), part of tyrosine kinase receptor family, is a glycoprotein in cell 
membranes that binds insulin, which is essential for promoting glucose utilisation, glycogen and 
fat synthesis and for diminishing catabolism of fat. After three weeks of 49% FR, abundance of 
INSR mRNA is increased in restricted compared to control cows and in hepatic tissue of cows with 
fatty liver compared to healthy cows, less mRNA is found (Liu et al., 2010; Gross et al., 2011).  
Acetyl-CoA from fatty acid oxidation is metabolised by 3-hydroxy-3-methylglutaryl-coenzyme A 
synthase 2 (HMGCS2) with acetoacetyl-CoA to HMG-CoA, which is an intermediate in 
cholesterol synthesis and ketogenesis. If oxaloacetate from gluconeogenesis is diminished, HMG-
CoA is further metabolised to ketones (van Dorland et al., 2009). In fasting rats, increased activity 
of hepatic HMGCS2 is found by Hegardt (1999). 
As already mentioned, transcription factor HNF4A modulates fatty acid oxidation and furthermore 
gluconeogenesis by activation of PCK1 transcription (Loor et al., 2005). 
Common hepatic metabolism 
Citrate synthase (CS) condensates acetyl-CoA and oxaloacetate to citrate, thereby representing the 
first and pace-making step in citric acid cycle (van Dorland et al., 2009) and high acyl-CoA 
concentrations from fatty acid oxidation lead to inhibited activity resulting redirection to ketone 
body synthesis (Ballard et al., 1968). 
The cytokine tumour necrosis factor α is involved in systemic inflammation, stimulates the acute 
phase reaction and TNFA mRNA is up regulated by ad libitum feeding before parturition (Loor et 
al., 2006). Furthermore, hepatic mRNA of TNFA is up regulated after parturition and is positively 
correlated with mobilisation of body fat (Loor et al., 2005). 
Moreover, mRNA encoding for insulin-like growth factor I (IGF1) produces a protein similar to 
insulin in molecular structure and function. In humans, it exerts its main function in growth and 
development of different tissues (Bonefeld and Møller, 2011). During lactation in cows, 
concentrations of IGF1 are lower compared to dry period and lower in cows compared to bulls or 
calves (Ronge and Blum, 1989). 
4. Intravenous glucose tolerance test 
4.1. Principles of glucose metabolism in ruminants 
In lactating cows, 72 g of glucose are needed to synthesise 1 L milk (Davis and Collier, 1985). 
Contrary to monogastric animals, in ruminants the ingested carbohydrates are mainly metabolised 
by ruminal microbes and provided as short chain fatty acids (propionic, butyric and acetic acid). 
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These are immediately absorbed and metabolised in the liver, whereas only 10% of carbohydrates 
can be absorbed as glucose in small intestine (Sutton, 1971; Baird et al., 1980). Already during 
absorption by epithelium, butyrate is metabolised to BHBA (Stangassinger and Giesecke, 1986; 
Bell and Bauman, 1997). Feeding influences proportions of occurring volatile fatty acids, e.g. 
feeding less roughage decreases acetic acid and increases the others (Sutton, 1971). 
Gluconeogenesis provides almost all required glucose in cows and is regulated by insulin, growth 
hormone and glucagon (Aschenbach et al., 2010). Substrates are propionic acid as major substrate, 
lactate, glycerol and amino acids (Stangassinger and Sallmann, 2004; Nafikov and Beitz, 2007). In 
contrast to monogastric animals, rate of gluconeogenesis is higher after feeding (Young, 1977). 
Furthermore, gluconeogenesis prevents excess of volatile fatty acids in blood with its negative 
effects on appetite or acid-base balance (Aschenbach et al., 2010; Stangassinger, 2010). 
Glucose derived from gluconeogenesis is distributed to heart and further on to cells of the body. 
Transport of glucose into body cells is mediated by facilitated transport systems, called solute 
carrier family 2 (genes SLC2A and proteins GLUT), by sodium-dependent transporter systems, the 
sodium/glucose cotransporters (SGLT) and by the myoinositol transporter 1 (HMIT1; Zhao and 
Keating, 2007). According to sequence similarities, GLUT1 to GLUT13 are divided in three 
classes: class 1 containing GLUT1-4, class 2 with the fructose transporter GLUT5, GLUT7, 9 and 
11, and class 3 (GLUT6, 8, 10, 12 and HMIT1; Joost and Thorens, 2001).  
The glucose transporters have different tissue specificities: GLUT1 appears in human placenta, 
brain, blood-tissue barriers, in bovine mammary gland and at low levels in bovine erythrocytes, 
adipose and muscle tissue, GLUT2 in liver, pancreatic β-cells, renal tubular cells and at basolateral 
membrane of small intestine, GLUT3 in human brain and neurons and at low levels in bovine 
mammary gland, skeletal muscle and duodenum, GLUT4 in all insulin-sensitive tissues like 
muscle, heart and adipose tissue, GLUT5 at apical membranes of small intestine, in muscle and 
adipose tissue, in liver and kidney of lactating cows and at low levels in mammary gland and 
GLUT7 in liver as microsomal glucose transporter (Gould and Holman, 1993; Zhao et al., 1993; 
Hocquette and Abe, 2000). Furthermore, regarding their controllability by insulin, GLUT4 is 
called insulin-sensitive and GLUT1, 2, 3 as well as GLUT5 are insulin-insensitive, ensuring the 
basal requirements of cells (Hocquette and Abe, 2000). In lactation, high levels of insulin-
insensitive transporters can be found in mammary gland whereas during dry period, they are 
observed mainly in adipose and muscle tissue (Komatsu et al., 2005; Zhao and Keating, 2007). 
4.2. Hormonal regulation of glucose homeostasis 
In cows, blood glucose is lower (2.5 to 3.3 mmol/L) compared to monogastric animals or calves 
(3.9 to 6.6 mmol/l; Klinik für Wiederkäuer, 2012). The level of circulating glucose is complex 
regulated, assuring homeostasis and homeorhesis (Bauman and Currie, 1980; Stangassinger, 
2010). 
Insulin 
Synthesis of insulin occurs in β-islets of pancreas by formation of preproinsulin with acidic A 
chain, basic B chain and connecting (C-) peptide. After cleavage of amino acids and formation of 
disulphide bond between A and B chain, proinsulin emerges. Insulin consists after removing of C-
peptide of the A chain with 21 amino acids and B chain with 30 amino acids, conjugated by two 
disulfide bonds between 7th amino acid of A and B chain and between 20th amino acid of A chain 
and 19th amino acid of B chain. It is stored in granules and very similar amongst mammalians, 
human insulin differs in only three amino acids from the bovine one (Hsu and Crump, 1989; 
Hayirli, 2006).  
Intracellular calcium increases after glucose or in ruminants volatile fatty acid stimulation and 
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leads to increased production of ATP. Afterwards ATP-sensitive potassium channel closes and 
following cellular depolarisation is the final signal for fusion of insulin granules with plasma 
membrane (Mineo et al., 1990; Hou et al., 2009). Release of insulin is enhanced by nutrient 
availability (e.g. glucose, arginine, lysine, long chain fatty acids, calcium), gastrointestinal 
hormones like glucagon or parasympathetic stimuli and diminished by fasting or exercise, 
gastrointestinal hormones like somatostatin, sympathetic stimuli and prostaglandin F2α (Hayirli, 
2006). Insulin secretion after infusion of glucose is biphasic: storages in pancreatic β-cells are 
cleared within 10 to 20 minutes and if glucose stimulation lasts, synthesis of insulin is started and 
immediately secreted (60 - 120 minutes; Hove, 1978). Furthermore in dairy cows, insulin levels in 
blood are lowest in early lactation (Stangassinger, 2006) and increase with progression of lactation 
(peak lactation 18.5 µU/ml, mid-lactation 19.9 µU/ml; Bonczek et al., 1988) and is lower in high 
yielding cows (4.96 µU/ml in high yielding cows during first 50 days after parturition and 
7.44 µU/ml in low yielding cows; Gong et al., 2002). 
Insulin enhances glucose uptake in peripheral tissues, resulting in enhanced lipogenesis and 
protein anabolism, stimulates synthesis of glycogen in liver and muscle and inhibits hepatic 
gluconeogenesis (McDowell, 1983; Hayirli, 2006). After acting on receptors, insulin is released 
from receptors or depleted by cells of liver and kidney. Degradation of insulin involves 
endocytosis of the insulin-receptor complex, cleavage by insulin-degrading enzyme (proteolysis), 
protein disulfide isomerase (formerly glutathione insulin transhydrogenase, cleavage of disulfide 
bonds) and acidic proteinases in lysosomes (Duckworth et al., 1998).  
Glucagon 
The 29 amino acids containing peptide hormone glucagon is synthesised in α-cells of Langerhans-
islets in pancreas via preglucagon and preproglucagon (Hsu and Crump, 1989; Hayirli, 2006). 
Release of glucagon is stimulated by low blood glucose levels, but also by postprandial high levels 
of propionate and butyrate, mainly to avoid insulin-induced hypoglycaemia (Brockman, 1978). 
Glucagon stimulates glycogenolysis in liver and gluconeogenesis from proprionate, amino acids 
and lactate (McDowell, 1983; Donkin and Armentano, 1995; Hayirli, 2006) and shows weak 
positive influence on lipolysis (Brockman, 1979). Furthermore, glucagon decreases milk protein 
concentration and yield and alters milk protein composition towards more glycosylated κ- and αS2-
CN and less αS2-CN and α-LA without altering milk yield and other components (Bobe et al., 
2003; 2009). Rather than absolute concentration, the ratio of insulin to glucagon influences 
glucose homoeostasis (McDowell, 1983). After a nadir around d 50 pp, ratio of insulin to glucagon 
increases with progressing lactation and absolute concentrations of glucagon are higher in early 
lactation compared to later stages (Herbein et al., 1985; Stangassinger, 2011). 
When glucagon binds to its hepatic receptor, it is degraded partly by membrane-associated 
proteinases and partly after endocytosis in endosomes or lysosomes (Authier and Desbuquois, 
1991). 
Growth hormone (somatotropin) 
The peptide hormone somatotropin is synthesised, stored and pulsatile secreted by somatotrophic 
cells of anterior pituitary gland, stimulated by growth hormone-releasing factor and inhibited by 
somatostatin. In contrast to insulin, the 191 amino acid containing hormone shows similarity 
amongst cows and pigs (90%), but not amongst these animals and humans (35%), even though 
their receptors are similar to human ones (pig 89%, cow 76% receptor similarity; Buonomo and 
Baile, 1990; Etherton and Bauman, 1998).  
Somatotropin exerts various effects during growth and lactation: enhanced protein synthesis in 
muscles, enhanced blood flow and secretory activity of mammary gland and its cells, diminished 
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glucose uptake, lipogenesis and translocation of GLUT4 in adipose tissue and increased hepatic 
gluconeogenesis. By elevating glucose levels, somatotropin increases milk quantity after peak 
yield without altering composition (McDowell, 1983; Etherton and Bauman, 1998). Therefore, one 
molecule of somatotropin dimerises two of its receptors and induces a signalling cascade. 
Subsequently, somatotropin is degraded by endocytosis and cleaved by proteinases (Etherton and 
Bauman, 1998; van Kerkhof et al., 2000). 
If ruminants are not fed continuously, somatotropin level decreases with every feeding, stays low 
for several hours and then increases again until next feeding due to stretch receptors in cranial 
rumen (McDowell, 1983). With proceeding lactation, somatotropin concentration increases but its 
ratio to insulin decreases during early lactation, directing amino acids to hepatic gluconeogenesis 
(Stangassinger, 2006). In feed deprivation, levels of growth hormone increase from 2 ng/mL in fed 
cows to 4 ng/mL at the second day of feed deprivation (Samuelsson et al., 1996). 
Somatostatin  
The peptide hormone somatostatin is synthesised in δ-islets of pancreas and in posterior pituitary 
and is highly conserved within vertebrates (Buonomo and Baile, 1990; Hayirli, 2006). 
Somatostatin occurs in two forms, one with 14 and the other with 28 amino acids, and is found in 
central nervous system, pancreas and intestine (Buonomo and Baile, 1990). It inhibits secretion of 
somatotropin, insulin and glucagon and is secreted with increasing blood levels of glucose, amino 
and fatty acids (Brockman and Greer, 1980; Brockman and Halvorson, 1981). Elevation of 
somatostatin levels in blood with concurrent insulin infusions increases insulin effects on tissues 
and therefore glucose clearance (Rose et al., 1997).  
Glucocorticoids 
The corticosteroids are produced in the cortex of adrenal glands. In the Zona fasciculata 
glucocorticoids such as hydrocortisone are produced, in the Zona glomerulosa mineralocorticoids 
like aldosterone and in the Zona reticularis androgens. Synthesis is under control of 
neuroendocrine hormones of hypothalamus and pituitary gland.  
As a response to decreased blood glucose levels, hydrocortisone stimulates insulin secretion, 
protein catabolism, decreases milk yield and therefore increases gluconeogenesis (Baird, 1981; 
McDowell, 1983). Furthermore, Exton (1979) showed that glucocorticoids regulate substrate 
supply to and modulate pathways of hepatic gluconeogenesis (increase of PCK activity) and exert 
permissive effects on lipolytic and glycogenolytic action of catecholamines and on stimulation of 
gluconeogenesis by glucagon and epinephrine.  
Levels of glucocorticoids increase during starvation, exercise (Exton, 1979; McDowell, 1983) or 
after temperature or behavioural stress (Trenkle, 1978; McDowell, 1983) and are involved in long 
term regulation of energy supply (Trenkle, 1981). 
Glucocorticoid administration in supraphysiological doses induces hyperglycaemia, 
hyperinsulinaemia and increases NEFA levels, concurrently decreases insulin-stimulated glucose 
uptake in muscle cells (insulin resistance, IR) and diminishes hepatic glycogen synthesis 
(Guillaume-Gentil et al., 1993). This IR is mediated by reduced translocation of GLUT4 in muscle 
cells (Weinstein et al., 1995). Furthermore, dexamethasone activates a posttranslational 
degradation mechanism, resulting in decreased GLUT2 abundance with no effect on SLC2A2 
mRNA abundance and reduced half live of the glucose transporter, leading to inhibition of 
glucose-induced insulin secretion and elevated insulin levels in pancreatic β-cells (Gremlich et al., 
1997). 
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Catecholamines 
In adrenal medulla synthesised catecholamines adrenaline and noradrenaline are produced from 
tyrosine which is converted to dopamine, further to noradrenaline and finally to adrenaline which 
is stored in chromaffin granules. After release into blood, half time is short and the molecules are 
degraded by methylation or deamination (Molinoff and Axelrod, 1971). Synthesis and release are 
regulated by acetylcholine from sympathetic nervous system and glucocorticoids (Edwards and 
Jones, 1993). Due to various receptors (α1, α2, β1, β2, β3) in different tissues, catecholamines exert 
different effects. Adrenaline shows far higher influence on glucose homeostasis than 
noradrenaline, it inhibits insulin secretion, promotes glycogenolysis and lipolysis, stimulates 
glucagon secretion and increases gluconeogenesis leading to increasing blood glucose levels 
(McDowell, 1983). Under normal conditions, catecholamines are more effective at nerve endings 
as compared with effects on glucose homeostasis (Exton, 1979). However in stress situations 
(fight or flight), which can be simulated by infusions of adrenaline, catecholamines show 
glycogenolytic and lipolytic effects resulting in suppressed insulin secretion or lowering of its 
effect. Moreover, they promote gluconeogenesis directly and by enhanced glucagon secretion and 
after end of infusion, insulin levels and glucose utilisation increase steeply (McDowell, 1983). 
Furthermore, adrenaline distributes glucogenic precursors such as alanin, glycerol and lactate from 
peripheral tissues to liver and antagonises effect of insulin (Stevenson et al., 1991; Capaldo et al., 
1992). 
4.3. Insulin resistance 
According to Kahn (1978) IR describes the situation of normal levels of insulin producing only a 
diminished biological response based on either diminished insulin sensitivity or diminished 
maximal effect of insulin (insulin responsiveness of tissue) or based on both mechanisms. During 
diminished insulin responsiveness, no biological response can be achieved even with high insulin 
levels due to alterations at receptor or post-receptor levels, whereas during decreased insulin 
sensitivity, only dose-response curve is shifted to the right.  
Therefore, IR can have various reasons: at pre-receptor level diminished insulin production and/or 
increased depletion, at receptor level decreased number of INSR and binding affinity and at post-
receptor level impaired signalling pathways and translocation of GLUT (Hayirli, 2006). 
During late pregnancy and early lactation in dairy cows, glucose is distributed to foetus or 
mammary gland (Baird, 1981; Bell, 1995; Bell and Bauman, 1997). In this time period dairy cows 
experience a more or less severe but physiological IR (Stangassinger, 2006). 
Nevertheless, no differences can be observed in expression of insulin responsive glucose 
transporter mRNA (SLC2A4) in adipose tissue of lactating and dry cows. Furthermore resistin, an 
inhibitor of adipocyte differentiation, glucose tolerance and promoter of IR, shows higher levels in 
adipose tissue and lower levels in mammary gland tissue of lactating cows than in dry cows, 
suggesting a contribution to inhibition of GLUT4 translocation during lactation (Komatsu et al., 
2003). 
4.4. Methods for determination of insulin response 
For determination of insulin response and IR, various tests derived from human medicine are also 
conducted in cows: intravenous (and in humans also oral) glucose tolerance tests (ivGTT; McCann 
and Reimers, 1985b; Bickhardt et al., 1989; Bigner et al., 1996; Chagas et al., 2009), insulin 
tolerance tests (McCann and Reimers, 1985a; Ohtsuka et al., 2006; Oikawa and Oetzel, 2006; 
Kerestes et al., 2009), hyperglycaemic (HGC; Sano et al., 1993; Blum et al., 1999; Holtenius et al., 
2000) or hyperinsulinaemic euglycaemic clamp (HEC; Dunshea et al., 1995; Andersen et al., 
2002). 
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Furthermore, model estimations can be applied such as the homeostatic model assessment of 
insulin resistance (HOMA-IR) or the quantitative insulin sensitivity check index (QUICKI) in 
humans (Radziuk, 2000; Muniyappa et al., 2008), as well as the revised QUICKI, which can also 
be applied in cows (Holtenius and Holtenius, 2007; Kerestes et al., 2009; Stengarde et al., 2010). 
Clamp techniques 
The clamp techniques are the gold standard procedures for determination of insulin sensitivity in 
vivo (Katz et al., 2000; Wallace and Matthews, 2002). However they demand more technical 
equipment and are more time consuming compared to tolerance tests. 
During hyperglycaemic clamps (HGCs), blood glucose levels are elevated by adjusting 
intravenous glucose infusion rates until blood glucose levels are clamped on a hyperglycaemic 
plateau (steady state) within 60 minutes (2.78 mmol/l above preinfusion values; Sano et al., 1993). 
Because of the constant blood glucose, infusion rate reflects endogenous insulin secretion whereas 
infused glucose is metabolised. Therefore function of pancreatic β-cells can be determined by 
HGC (Sano et al., 1991; Holtenius et al., 2000). 
During hyperinsulinaemic euglycaemic clamp (HEC), two infusions are administered: one with 
insulin, elevating blood level and clamping it on a hyperinsulinaemic level. Infusion of 1 µg 
insulin per kg BW per hour resulted in fourfold increase of blood insulin levels (Griinari et al., 
1997; Mackle et al., 1999). The second infusion provides glucose to avoid hypoglycaemia and 
maintain normoglycaemic glucose levels. At the time point when steady state is achieved, glucose 
infusion rates equals glucose uptake by body cells and therefore reflects insulin responsiveness of 
tissues. For measurement of peripheral IR (at receptor or post-receptor level), HEC is the most 
appropriate test in human and veterinary medicine (Holtenius et al., 2000; Muniyappa et al., 2008).  
Glucose and insulin tolerance test 
During ivGTT, insulin sensitivity is indirectly measured (Stangassinger, 2006). A bolus injection 
of glucose (100 mg per kg BW; Cummins and Sartin, 1987; Roche et al., 2008; 300 mg per kg 
BW; Grünberg et al., 2011) provokes insulin release from pancreas. Repeated measurements of 
glucose and insulin levels are done before the injection for basal values and in short intervals for 
around 120 minutes after injection. These values give information on maximum increase of 
insulin, half-live and turnover rate of glucose and area under the curve (AUC) of insulin and 
glucose (Palmquist and Moser, 1981; Opsomer et al., 1999; Murphy et al., 2000; Roche et al., 
2008). Glucose tolerance defines the efficiency of homeostatic mechanisms (e.g. cellular uptake, 
gluconeogenesis, excretion) to restore basal glucose levels (Radziuk, 2000). 
Due to lactation and insulin independent partitioning of glucose to mammary gland (Bell and 
Bauman, 1997), this method provides only marginal insight into insulin responsiveness of 
peripheral tissue in lactating cows. Nevertheless, advantage of ivGTT is the easy implementation 
and its non-invasive character, especially in studies with large test numbers.  
Instead of glucose a bolus injection of insulin is administered during insulin tolerance tests and 
decrease of blood glucose levels is measured (Muniyappa et al., 2008). Insulin tolerance tests 
consume less time compared to ivGTT, blood samples are taken for 15 minutes after injection 
every 2 minutes. Afterwards, glucose is injected intravenously to avoid hypoglycaemia. Insulin 
resistance is calculated by logarithmic glucose concentrations (Wallace and Matthews, 2002). 
Model estimations 
To avoid the time and material consuming clamps and tolerance tests, various calculation models 
can be applied based on blood levels of glucose, insulin and NEFA. According to Kusenda (2010), 
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the correlations of HEC to various indices range from 0.44 for HOMA-IR to 0.61 for RQUICKI in 
lactating cows. 
According to Radziuk (2000), HOMA-IR is calculated with fasted basal blood glucose levels and 
mean of thrice sampled basal insulin concentrations: 
𝐻𝑂𝑀𝐴 − 𝐼𝑅 =  𝑏𝑎𝑠𝑎𝑙 𝑔𝑙𝑢𝑐𝑜𝑠𝑒 �𝑚𝑚𝑜𝑙𝐿 � × 𝑏𝑎𝑠𝑎𝑙 𝑖𝑛𝑠𝑢𝑙𝑖𝑛  �µ𝑈𝑚𝐿�22.5  × 0.5 
The higher HOMA-IR, the higher is IR and the lower is insulin sensitivity. The denominator of 
22.5 derives from the product of normal fasting blood glucose (4.5 mmol/L) and insulin 
(5 µU/mL) in healthy humans (Muniyappa et al., 2008). For using this index in other subjects, 
basal levels of the respective animal have to be considered. Furthermore in evaluation of IR, the 
decal logarithm of HOMA-IR provides better correlations compared to HOMA-IR in humans 
(Muniyappa et al., 2008). 
Holtenius and Holtenius (2007) modified the QUICKI according to Katz et al. (2000) with levels 
of blood NEFA and evaluated its validity in lactating dairy cows: 
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The lower this index, the lower is insulin sensitivity and the higher IR. The RQUICKI is not 
influenced by week of lactation and shows good correlation to insulin sensitivity during the first 
15 weeks of lactation (Hayirli, 2006; Holtenius and Holtenius, 2007). 
5. Hydrocortisone and β-hydroxybutyric acid in milk 
Hydrocortisone 
As shown before, hydrocortisone is involved in gluconeogenesis by directing amino acids to liver 
and blood levels increase during fasting or stress, controlled by pituitary adrenocorticotropic 
hormone and corticotrophin-releasing hormone from hypothalamus. 
Measurements of blood levels are inappropriate due to pulsatile secretion of hydrocortisone and 
elevation during blood sampling procedure (Bitman et al., 1990; Lefcourt et al., 1993). In milk, the 
situation of hydrocortisone levels in blood is reflected (Bremel and Gangwer, 1978). Milk 
hydrocortisone is associated with aqueous phase, not with milk fat like other steroid hormones 
(Butler and Des Bordes, 1980; van der Kolk, 1990). Acute stress situations can only be detected in 
milk via elevated hydrocortisone levels, if the acute stressor happens within four hours prior to 
milking (Gwazdauskas et al., 1977; Fox et al., 1981; Verkerk et al., 1998).  
Therefore, measurement of hydrocortisone in milk of dairy cows is an appropriate method to 
determine extent of chronic stress due to automatic milking systems (Abeni et al., 2005), restricted 
lying behaviour (Fisher et al., 2002) or postpartal hypocalcaemia with downer-cow syndrome 
(Horst and Jorgensen, 1982; Waage et al., 1984; Forslund et al., 2010). 
According to Breves et al. (1980), blood glucose levels are positively (0.18) and blood ketone 
body levels are negatively (-0.31) correlated to blood hydrocortisone levels. In ketotic cows, 
hydrocortisone blood levels are lower (9.6 nmol/L) compared to cows with mastitis (23.3 nmol/L) 
or recumbent animals (96.7 nmol/l; Forslund et al., 2010) and milk levels are higher in early 
lactation (1.63 nmol/L) compared to later stages (0.69 nmol/l; Schwalm and Tucker, 1978). 
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Especially in high yielding cows, increased pituitary activity with increased reactivity to 
corticotrophin-releasing hormone as well as reduced adrenocortical reactivity to 
adrenocorticotropic hormone is observed (Beerda et al., 2004). Furthermore, milk hydrocortisone 
levels are negatively correlated to milk protein content (Fukasawa et al., 2008) and milk fat 
concentration (Schwalm and Tucker, 1978). 
β-hydroxybutyric acid 
In milk, BHBA is secreted if levels in blood exceed metabolising capacity of cells due to enhanced 
ketogenesis in liver during metabolic imbalance and excessive mobilisation of body fat. Besides 
loss of appetite, decreasing milk yield, loss of body condition and excitation in the nervous form of 
ketosis, ketolactia is one of the signs for clinical and without other signs for subclinical ketosis. 
This disease occurs in early lactation and risk for ketosis increases with number of lactation. 
Furthermore, cows with ketosis show hyperketonaemia, hypoglycaemia, increased levels of NEFA 
as well as fatty liver and loss of liver glycogen (Baird, 1982). 
In fasted cows, alimentary ketogenesis (production of BHBA in rumen epithelium) decreases until 
cessation at 3rd day and hepatic ketogenesis increases (Heitmann et al., 1987). Moreover, milk 
levels of BHBA are influenced by milking interval and sampling time point during milking 
(Nielsen et al., 2005b). Due to correlation of blood and milk levels of BHBA (0.66; Enjalbert et 
al., 2001), threshold values for detecting ketosis in cows can be evaluated with BHBA tests in milk 
(over 0.6 mmol/l; Nielsen et al., 2005a). 
Most of tests are provided as semi quantitative tests in form of strips or powder, most relying on 
the principle of Rothera test, a reaction of nitroprussid with acetone derived from acetoacetate 
from BHBA metabolism. Positive Rothera test results in different shades of violet, the more 
acetone, the darker violet appears.  
For quantitative measurements, flow injection analysis (Marstorp et al., 1983) or enzymatic test 
systems are necessary (Stein and Bässler, 1968). According to Bergmeyer and Bernt (1965), 
BHBA is metabolised by 3-hydroxybutyrate-dehydrogenase to acetoacetate: 
ℎ𝑦𝑑𝑟𝑜𝑥𝑦𝑏𝑢𝑡𝑦𝑟𝑖𝑐 𝑎𝑐𝑖𝑑 + 𝑁𝐴𝐷+ 3−𝐻𝐵𝐷𝐻�⎯⎯⎯⎯� 𝑎𝑐𝑒𝑡𝑜𝑎𝑐𝑒𝑡𝑎𝑡𝑒 + 𝑁𝐴𝐷𝐻 + 𝐻+ 
𝑁𝐴𝐷𝐻 +  𝐻+ +  𝐼𝑁𝑇 𝑁𝐴𝐷−𝑑𝑒ℎ𝑦𝑑𝑟𝑜𝑔𝑒𝑛𝑎𝑠𝑒�⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯� 𝑁𝐴𝐷+ + 𝑡𝑒𝑡𝑟𝑎𝑧𝑜𝑙𝑖𝑢𝑚 𝑐ℎ𝑙𝑜𝑟𝑖𝑑𝑒 
(3-HBDH: 3-hydroxybutyrate-dehydrogenase, INT: iodonitrotetrazoliumchlorid) 
Afterwards, tetrazolium chloride can be photometrical determined at 492 nm (Willibald, 2011).  
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III. MATERIALS AND METHODS 
1. Animal experiment 
1.1. Experimental design and experimental animals 
The animal welfare committee of the government of Upper Bavaria, Germany approved this study 
(AZ 55.2-1-54-2531-110-09) and federal guidelines were followed throughout the experimental 
period. From August 2009 to January 2011, the animal trial was conducted at the research farm 
Veitshof of the Technische Universitaet Muenchen in Freising, Germany. Multiparous Holstein-
Friesian cows (n = 26), which had been raised at a saxonian dairy farm (AgroProdukt Leubsdorf 
GmbH, Leubsdorf, Germany), were transported in groups of 4 to 6 animals each to the research 
farm approximately 4 weeks prior to expected parturition. Cows were selected according to their 
milk yield and milk protein concentration during lactation in Saxony. According to performance in 
early lactation (d 23 to 25 pp) at Veitshof, cows were then assigned to four groups: high FCM 
yield and high milk protein concentration (MP-cows), low FCM yield and low milk protein 
concentration (mp-cows), high FCM yield and low milk protein concentration (Mp-cows) and low 
FCM yield and high milk protein concentration (mP-cows). Health status was determined daily 
and disease was defined as necessary veterinary intervention. In this study retained placenta, 
ketosis, lameness and mastitis occurred. 
The cows were housed at the research farm Veitshof, together with its dairy herd (70 Brown Swiss 
cows) in a freestall barn with rubber-coated slatted floors and cubicles bedded with straw powder. 
Prior to parturition, they were moved to a single calving box bedded with barley straw. One day pp 
they were reintegrated into the herd. From arrival on, cows conceived lactation diet (LD), 
containing 60% corn silage, 23% grass silage, 4% hay, 12% concentrates and 1% mineral mix 
(Ingredients: 14% calcium, 10% sodium, 5% phosphor, 5% magnesium; Josera, Kleinheubach, 
Germany; table 1). The partly mixed ration, calculated for a basis milk yield of 22 kg/d, was 
delivered once daily at 0700 h and intended to offer ad libitum intake (residual feed >5%). 
Additional concentrates, composited of 18.4% corn gluten, 13.8% turnips molasses chips, 
10.0% wheat, 10.0% triticale, 10.0% rape cake, 8.8% maize, 6.0% malt germ, 5% grain distillation 
residual (ProtiGrain), 5% rape extraction grist, 5% rumen protected rape extraction grist, 3.3% 
palm corn cake, 2.8% soy extraction grist, 1.0% sodium bicarbonate, 0.99% calcium bicarbonate 
and 0.40% plant oil (palm coconut) and containing 7 mega joule netto energy lactation 
(MJ NEL/kg; Raiffeisen Kraftfutterwerke Sued, Wuerzburg, Germany) were fed in automated 
feeding stations. Cows received 2 kg of concentrates after parturition and amounts increased by 
0.3 kg daily. From d 14 to 100 pp, 6 kg of concentrates were fed, thereafter amounts declined by 
0.03 kg per day until end of experiment (d 155 pp). Additional concentrates were fed depending on 
day of lactation to eliminate effects of performance-related feeding. Nutritional values and 
composition of the partial-mixed ration were determined by enhanced Weender-analysis 
performed at the Bavarian State Institute of Agriculture (Landesanstalt fuer Landwirtschaft, LfL), 
Zentrallabor Grub (Poing, Germany). Cows had free access to fresh drinking water at all times. 
Milking was conducted in a 2 × 2 tandem milking parlour (GEA WestfaliaSurge GmbH, Boenen, 
Germany) twice daily at 0420 and 1540 h. 
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Table 1: Components and nutritional values of lactation diet (LD). 
Components, 
% 
LD 
Nutritional values,             
% of dry matter 
LD 
energetic value,      
MJ/kg dry matter 
LD 
corn silage 60.0 crude ash 6.3 
metabolisable  
energy 
11.2 
grass silage 23.0 crude protein 16.7 NEL 6.8 
hay 4.0 crude fibre 17.2   
concentrates 12.0 crude fat 3.4   
mineral mix 1.0 non-fibre carbohydrates 56.4   
straw 0.0 neutral detergent fibre 37.4   
dry matter 45.2 acid detergent fibre 22.4   
  available crude protein 15.7   
  
ruminal nitrogen 
balance 
0.1   
 
1.2. Body weight, body condition and back-fat-thickness 
Every two weeks body weight (BW), body condition score (BCS) and back-fat-thickness (BFT) 
were measured (figure 1). Weighing was conducted using weighing elements underneath the claw 
stand (FX1, Texas Trading, Windach, Germany). Estimation of BCS was performed according to a 
five point scale (1 = meagre, 5 = obese) subdivided in quarter points (Edmonson et al., 1989). 
Thickness of subcutaneous fat was measured via ultrasound with a 7.5 megahertz probe (Universal 
Ultrasound, Sonovet 2000, Kretztechnik AG, Tiefenbach, Austria) in an area one handbreadth 
cranial of ischial tuberosity (Schröder and Staufenbiel, 2006), including skin thickness of 6 mm. 
The same persons conducted measurements of BCS and BFT at all times. 
 
 
Figure 1: experimental design 
Coloured arrows show sampling time points during study. Numbers on pale yellow arrow 
indicate weeks, numbers above coloured arrows indicate days relative to parturition. 
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1.3. Collection of milk samples and measurement of milk composition 
Milk yield was recorded with electronic milk meters (Metatron P21, GEA WestfaliaSurge GmbH, 
Boenen, Germany). Approximately 500 mL of milk were obtained as proportional subsamples of 
total milk during each morning and evening milking depending on total amount of milk and milk 
flow rate. Milk yield data were stored electronically (DairyPlan C21, GEA WestfaliaSurge GmbH, 
Boenen, Germany). Milk samples for analysis of milk components and protein fractions were 
taken on d 1 to 10, 12, 15, 17, 20 to 22, 32, 36, 43, 50, 57, 64, 71, 78, 85, 92, 99, 106, 113, 120, 
127, 134, 137 and 155 pp. To obtain a representative sample, aliquots of morning and evening 
milk were composited according to the morning and evening milk yield and 5 aliquots (one with 
50 mL and four with 11 mL) were stored at -20°C until analysis of progesterone, hydrocortisone, 
BHBA and protein fractions. From d 39 pp on, additional milk samples (11 mL) for analysis of 
progesterone were taken three days after weekly milk sample, resulting in two milk samples per 
week for progesterone monitoring. These additional milk samples were also stored at -20°C until 
analysis. For analysis of milk fat, protein, lactose and urea concentration as well as somatic cell 
count (SCC) and pH, milk samples were stored with acidiol as preserving agent at 4°C until 
analysis (maximum seven days) in the laboratories of Milchpruefring Bayern e.V. (Wolnzach, 
Germany). Analysis of total protein, fat, lactose, urea and pH were done by infrared-
spectrophotometry (MilkoScan-FT-6000, VOSS GmbH, Rellingen, Germany). Measurement of 
SCC was conducted by fluorescence-optical counting (Fossomatic-FC, FOSS GmbH, Rellingen, 
Germany). 
1.4. 100 day performance in previous and current lactation 
Performances of milk yield, milk protein yield and milk fat yield in Leubsdorf during previous 
lactation were estimated from at least three milk yield recordings and calculated at LKV Sachsen 
(Lichtenwalde, Germany). At Veitshof, milk yield, milk fat yield as well as milk protein yield 
were summarised from weekly means multiplied by number of days, meaning by 7. Afterwards, 
milk fat yield and protein yield were divided by milk yield, to achieve milk fat and protein 
concentrations. 
1.5. Collection of blood samples and measurement of metabolites 
Blood samples were taken one and two weeks before expected parturition (d 7 and 14 ap) and on 
first day of wk 1, 2, 3, 4, 7, 9, 17 and 23 (d 1, 8, 15, 22, 43, 57, 113 and 155 pp; figure 1). Jugular 
veins were punctured after milking and before feeding (0645 h). Two vacuum tubes (9 mL, 
Vacuette, Greiner Bio-One, Kremsmuenster, Austria) were used for collection of blood per 
sampling time, one with anticoagulation factor ethylenediamine-tetraacetic acid (EDTA) for blood 
plasma and the other with clotting assistance for blood serum. Plasma tubes were directly cooled, 
serum tubes allowed to coagulate at room temperature (RT; maximum 1 h). Afterwards, plasma 
and serum were separated by centrifugation (2,000 × g, 15 min, 4°C) and three aliquots each 
(1.5 mL) were stored at -20°C until analysis. Measurement of serum parameters was conducted at 
Tieraerztliche Hochschule (Hannover, Germany) with an automated clinical chemistry analyzer 
(ABX Pentra 400, Horiba, Montpellier, France), including daily calibrations and quality controls. 
Glucose concentrations were determined by hexokinase method (coefficient of variation, 
CV = 2.3%) and NEFA concentrations by colorimetric enzymatic reactions (CV = 6.2%; both 
Hoffmann La-Roche, Basel, Switzerland). Measurement of BHBA concentrations was done by 
spectrophotometric enzymatic analysis (CV = 7.1%; Sigma-Aldrich Diagnostics, Munich, 
Germany). Serum tBR concentrations were determined with the reaction of Jendrassik and Grof 
(1938) and serum cholesterol concentrations with an enzymatic colorimetric test (Sigma-Aldrich, 
Munich, Germany). 
III. Materials and methods     19 
1.6. Tissue collection  
Hepatic tissue 
Liver biopsies were obtained after milking and before feeding (0650 h). Hepatic tissue was 
sampled at day of parturition within 24 hours after calving (d 1 pp) and at d 15 and 57 pp. On the 
right side of the cow, an area of 15 cm × 15 cm was shaved, washed and degreased with 70% 
ethanol prior to disinfection with iodine solution (Vet-Sept®, Albrecht GmbH, Aulendorf, 
Germany). Skin, subcutaneous and intercostal muscle tissue was desensitized with local 
anaesthetic (7 mL procaine hydrochloride, Procasel®, Selectavet, Weyarn, Germany). At the 
intersection of the 11th intercostal space with an imaginary line running from the tuber coxae to 
the shoulder joint (Pearson and Craig, 1980), a small incision was made through the skin to admit 
the trocar (12 Gauge, 2.7 mm) for the blind percutaneous needle biopsy (Bard®MagnumTM, 
Covington, USA). Approximately 200 mg of liver tissue were obtained and subdivided. One part 
was deep-frozen in liquid nitrogen and afterwards stored at -80°C. The other aliquot was 
transferred into RNA stabilisation solution (1 mL RNAlater®, Applied Biosystems, Darmstadt, 
Germany), incubated over-night at 4°C and stored at -80°C until mRNA extraction. 
Muscle tissue 
Muscle biopsies were performed after milking and before feeding (0650 h) at day of parturition 
within 24 hours after calving (d 1 pp) and at d 43 and 113 pp. An area above the intervertebral 
space of 3rd and 4th caudal vertebra and an area of 20 cm × 20 cm on the caudal upper distal ischial 
tuberosity, alternating with every biopsy on the right or the left, were washed, shaved and 
degreased with 70% ethanol prior to disinfection with iodine solution (Vet-Sept®, Albrecht 
GmbH, Aulendorf, Germany). An epidural anaesthesia (5 mL) was applied between 3rd and 4th 
caudal vertebra and subsequently skin of upper leg was desensitized (7 mL, both procaine 
hydrochloride, Procasel®, Selectavet, Weyarn, Germany). To obtain best possible sterile 
conditions, hands of surgeon were thoroughly washed, disinfected with ethanol and sterile gloves 
(Vasco OP Protect®, B. Braun Melsungen AG, Melsungen, Germany) worn throughout surgery. 
An incision of 2-3 cm through the skin was made one handbreadth distal of ischial tuberosity. 
Subcutaneous tissue was cut until semitendinous muscle became visible. Two pea-sized samples 
(approximately 600 mg) of semitendinous muscle were removed using surgical scissors. Samples 
were cut free of visible connective tissue. One aliquot was immediately deep-frozen in liquid 
nitrogen and stored at -80°C, another aliquot was transferred into RNA stabilization solution 
(1 mL RNAlater®, Applied Biosystems, Darmstadt, Germany), incubated over-night at 4°C and 
stored at -80°C. Muscle tissue was sutured continuously with absorbable multifilamentous suture 
(Surgicryl® PGA, USP 0/EP 3.5, SMI, St. Vith, Belgium) with a hemicyclic circular needle. 
Subcutaneous tissue and skin were adapted with single sutures, using non-absorbable 
multifilamentous suture (Dermafil® Green, USP 5/EP 7, SMI, St. Vith, Belgium) and three-
eighths outward cutting needle. A sterile bandage was applied to the biopsied area and was 
renewed every three days. Furthermore, to prevent bacterial inflammations, cows subcutaneously 
received 1 mg ceftiofur per kg body weight (Excenel RTU®, Pfizer GmbH, Berlin, Germany) at 
day of biopsy and at the following day. After 10 days, the skin stitches were removed. 
1.7. Feed restrictions in early and mid-lactation 
Cows were subjected to a metabolic challenge in early lactation (d 26 to 28 pp) and in mid-
lactation (d 141 to 143 pp). From d 23 until d 31 pp and from d 138 until d 146 pp, cows were 
moved to a tie-stall with eye contact to the herd. They had free access to water. In the first three 
days (d 23 to 25 pp and d 138 to 140 pp), cows were fed ad libitum with LD and additional 
concentrates (6 kg in FR1 and 4.5 kg in FR2) in separated feeding troughs. From d 26 to d 28 pp 
(FR1) and d 141 to d 143 pp (FR2) cows received a restriction diet (RD) containing 56.4% corn 
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silage, 21.6% grass silage, 3.8% hay, 11.3% concentrates, 0.9% mineral mix and 6.0% straw 
(table 2) and received no additional concentrates. Fresh feed was mixed daily and cows were fed 
half of their daily allotment of RD at 0700 h and at 1700 h, respectively. The following three days 
(d 29 to 31 pp and d 144 to 146 pp, respectively) they were fed again with LD ad libitum and 6 or 
4.5 kg of additional concentrates. The amount of feed offered and refused was weighed and 
recorded daily for calculation of DMI.  
Table 2: Components and nutritional values of restriction diet (RD). 
Components, 
% 
RD 
Nutritional values,               
% of dry matter 
RD 
energetic value, 
MJ/kg dry matter 
RD 
corn silage 56.4 crude ash 6.3 
metabolisable  
energy 
11.0 
grass silage 21.6 crude protein 15.9 NEL 6.6 
hay 3.8 crude fibre 18.7   
concentrates 11.3 crude fat 3.2   
mineral mix 0.9 non-fibre carbohydrates 55.7   
straw 6.0 neutral detergent fibre 39.9   
dry matter 47.6 acid detergent fibre 23.8   
  available crude protein 15.2   
  
ruminal nitrogen 
balance 
-0.2   
 
Milk samples were collected every day according to the procedure as described before. Blood 
samples were collected before FR1 at d 26 pp, each day from d 27 to 29 pp (FR1) and after FR at 
d 32 pp. In FR2, blood samples were collected in the morning before FR at d 141 pp, each day 
from d 142 to 144 pp and after FR at d 147 pp. Biopsies of hepatic tissue were taken as described 
before after morning milking at d 29 (FR1) and 144 pp (FR2). 
1.8. Intravenous glucose tolerance tests 
All cows were subjected to an ivGTT 14 days before expected parturition and at d 20 and 127 pp. 
Cows were moved to a tie-stall with eye contact to the herd at the day prior to ivGTT after evening 
milking (1800 h). Thereafter they received only hay and drinking water to avoid effects of 
concentrate feeding on blood glucose levels. After morning milking on test-day, cows were 
weighed and clinically examined. Only healthy animals were allowed to enter the test. 
A 10 cm × 10 cm area in the central right jugular sulcus was washed, shaved, degreased with 70% 
ethanol and disinfected with iodine solution (Vet-Sept®, Albrecht GmbH, Aulendorf, Germany). 
Afterwards, animals were catheterised into the right jugular vein, using a 12 G (2.7 mm) 
Braunuele® (length 80 mm, B. Braun Melsungen AG, Melsungen, Germany). The intravenous 
catheter was fixed with a non-absorbable multifilamentous suture (Dermafil® Green, USP 5/EP 7, 
SMI, St. Vith, Belgium) stitched singly through the skin. A 50 cm elongation (internal diameter 
2.5 mm, volume 2.5 mL, Ho-Med GmbH, Vienna, Austria) with a three-way cock (Discofix®, 
B. Braun Melsungen AG, Melsungen, Germany) was filled with 0.9% saline solution (B. Braun 
Melsungen AG, Melsungen, Germany) and applied to the catheter. After assurance of patency, an 
elastic protective bandage (Bellissimo, Dachau, Germany) provided support to the elongation 
(Figure 2).  
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Figure 2: Cow with elastic bandage during ivGTT. 
 
After 30 minutes without handling, blood glucose was measured and blood samples were taken for 
serum and plasma preparation at 20, 15 and 10 minutes and immediately before infusion of 
glucose solution. Cows received 1 g D-Glucose per kg metabolic body weight (BW0.75) over 
4 minutes as 40% D-Glucose solution (B. Braun Melsungen AG, Melsungen, Germany). 
Afterwards, 50 mL of saline were infused to prevent contamination of blood samples by glucose 
solution. Each blood sampling procedure began with removal of 5 mL saline and blood and ended 
with administration of 10 mL saline to maintain patency. Blood samples (1 mL) for glucose 
measurements were obtained 2, 4, 6, 8, 10, 12, 14, 20, 25, 30, 40, 45, 50, 60, 75, 90, 105 and 
120 min after infusion (figure 3).  
 
Figure 3: sampling time points during ivGTT 
Time is given in minutes relative to glucose infusion. Duration of glucose infusion was 4 
minutes. Red arrows show sampling for blood serum and plasma, green arrows show 
glucose determination. 
 
Blood glucose was determined without delay applying the glucose-dehydrogenase-method with 
glucometer Contour® (Bayer Vital GmbH, Leverkusen, Germany): 
𝒈𝒍𝒖𝒄𝒐𝒔𝒆 + 𝑵𝑨𝑫 𝒈𝒍𝒖𝒄𝒐𝒔𝒆−𝒅𝒆𝒉𝒚𝒅𝒓𝒐𝒈𝒆𝒏𝒂𝒔𝒆�⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯�  𝒈𝒍𝒖𝒄𝒐𝒏𝒐𝒍𝒂𝒄𝒕𝒐𝒏𝒆 + 𝑵𝑨𝑫𝑯𝟐 
 
At time points 6, 10, 14, 20, 25, 30, 45, 60, 90 and 120 minutes post infusion, additional samples 
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for blood plasma and serum separation were collected in two 10 mL tubes (Sarstedt, Nuembrecht, 
Germany). Tubes contained anticoagulation factor (200 µL EDTA) or beads and clotting 
assistance to obtain blood plasma or serum, respectively. Plasma tubes were immediately placed 
on ice, serum tubes were stored at RT for coagulation (maximum 1 h) and then stored at 4°C. 
Afterwards, plasma and serum were separated by centrifugation (2,000 × g, 15 min, 4°C) and three 
aliquots (1.5 mL) of each were stored at -20°C until analysis. After end of measurements and 
blood collection, stitch and catheter were removed and the cow was released into the herd. 
Analysis of insulin in blood plasma was conducted at the endocrinological laboratory of 
Tieraerztliche Hochschule Hannover (Hannover, Germany), using an insulin radioimmunoassay 
(IM3210, Immunotech, Beckman Coulter, Brea, USA). The intra-assay CV was 7.6% and the 
inter-assay CV 10.7%. Values below 3.2 µU/mL were not clearly distinguished, so for further 
calculations, they were defined as 2.0 µU/mL. 
Model estimations of insulin resistance were calculated as follows: 
𝐻𝑂𝑀𝐴 − 𝐼𝑅 =  𝑏𝑎𝑠𝑎𝑙 𝑔𝑙𝑢𝑐𝑜𝑠𝑒 �𝑚𝑚𝑜𝑙𝐿 � × 𝑏𝑎𝑠𝑎𝑙 𝑖𝑛𝑠𝑢𝑙𝑖𝑛  �µ𝑈𝑚𝐿�22.5  × 0.5 
𝑄𝑈𝐼𝐶𝐾𝐼 =  �log �𝑏𝑎𝑠𝑎𝑙 𝑖𝑛𝑠𝑢𝑙𝑖𝑛 µ𝑈
𝑚𝐿
� + log �𝑏𝑎𝑠𝑎𝑙 𝑔𝑙𝑢𝑐𝑜𝑠𝑒 𝑚𝑔
𝑑𝐿
��
−1
 
1.9. Slaughter and tissue collection 
Cows were slaughtered around d 155 pp and at ovarian cycle d 12. All cows were synchronised by 
implanting the intravaginal progesterone device CIDR® (Pfizer GmbH, Berlin, Germany) three 
weeks prior to slaughtering. Progesterone device was removed two weeks before slaughtering, and 
2 mL sodium-cloprostenol were applied intramuscularly (Estrumate®, Intervet Deutschland 
GmbH, Unterschleißheim, Germany). At d 155 pp, cows were brought to the slaughterhouse of 
LfL in Grub, Germany (veterinary control number BY-ES 101). According to animal welfare 
guidelines, animals were numbed with a captive bolt stunner and afterwards exsanguinated. 
Approximately 5 g of each of the following tissues were obtained: skin, mammary gland, tongue, 
lungs, heart, liver, spleen, kidney, adrenal gland, muscle, fatty tissue, rumen, abomasum, small 
intestine, caecum, colon, mesenteric lymph node, cerebrum and pituitary. Tissues were divided in 
four parts, three were deep-frozen in liquid nitrogen and stored at -80°C and the fourth one was 
incubated over-night in 1 mL RNA stabilization solution (RNAlater®, Applied Biosystems, 
Darmstadt, Germany) and afterwards stored at -80°C until mRNA extraction. 
2. Analytical methods 
2.1. Extraction, transcription and real time qPCR of hepatic mRNA 
Liver tissue (50 mg) stored in RNAlater was added to tubes containing ceramic beads (400 mg, 
Matrix-Green, MP Biomedicals Europe, Illkirch, France). Messenger RNA was extracted using 
peqGOLD TriFast® (Peqlab, Erlangen, Germany) in a one-step liquid-phase extraction according 
to the manufacturer`s protocol. TriFast (1 mL) containing phenol and guanidine thiocyanate was 
added to liver tissue and beads. The mixture was homogenised two times for 20 seconds 
(FastPrep®-24, 4 m/s, MP Biomedicals Europe, Illkirch, France). Between the homogenisation 
steps, sample tubes were placed on ice for 30 seconds. Incubation at RT (5 min) allowed the 
dissociation of nucleotide-complexes. Chloroform (200 µL, Carl Roth GmbH & Co KG, 
Karlsruhe, Germany) was added and tubes were shaken thoroughly (Vortex mixer classic, Velp 
scientifica srl, Usmate, Italy), followed by another incubation (10 min) at RT. Afterwards, tubes 
were centrifugated (15 min, 4°C, 12,000 × g, Centrifuge 5415 R, Eppendorf AG, Hamburg, 
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Germany), resulting in different phases within the tube: at the ground tissue rests and ceramic 
beads, in the middle DNA in red phenol-chloroform-phase, a small white interphase with proteins 
and DNA and on top RNA in achromatic aqueous solution. To precipitate the RNA, only the upper 
phase was transferred into new tubes and 2-propanol (500 µL, Scharlau, Barcelona, Spain) was 
added. Subsequently, tubes were mixed and incubated on ice (15 min). After centrifugation 
(10 min, 4°C, 12,000 × g) the precipitated RNA was attached to the bottom of the tube. Tubes 
were placed on ice, the supernatant was removed and the pellet was washed twice in 1 mL of 75% 
ethanol (Merck KGaA, Darmstadt, Germany). Afterwards, the RNA pellet was dried and then 
dissolved in sterile RNase-free water (50 µL, Quiagen, Hilden, Germany). RNA quality and 
quantity were determined by spectrophotometry (BioPhotometer, Eppendorf, Hamburg). Reverse 
transcription to complementary desoxyribonucleic acid (cDNA) was conducted with constant 
amounts of 1 µg RNA and with the following reverse transcription master mix: 12 μL 5 × Buffer 
(Promega, Mannheim, Germany), 3 μL Random Hexamer Primers (50 mM; Invitrogen, Carlsbad, 
USA), 3 μL dNTP Mix (10 mM; Fermentas, St. Leon-Rot, Germany) and 200U of MMLV-H-
reverse transcriptase (Moloney Murine Leukemia Virus Reverse Transcriptase, RNAse H Minus, 
Promega, Regensburg, Germany). According to the manufacturer, reaction was carried out in a   
60-µL volume using a polymerase chain reaction (PCR) thermocycler (Biometra, Goettingen, 
Germany). Successive incubations at 21°C for 10 min and 48°C for 50 min, finishing with enzyme 
inactivation at 90°C for 2 min were performed. Reverse transcription products were stored at         
-20°C. 
Prior to real time quantitative PCR (RT-qPCR), gene sequences of candidate genes were obtained 
from the gene bank of the National Centre for Biotechnology Information (NCBI) for primer 
design. Exon-spanning primer sequences were designed using NCBI primer tool except for those 
previously published for HNF4A (Loor et al., 2005), PPARA and PPARG (Sigl et al., 2010), and 
SREBF1 (van Dorland et al., 2009). Synthesis of primers was done at Eurofins MWG (Ebersberg, 
Germany). Primer sequences, accession numbers and product lengths for each gene are listed in 
Table 3. 
Table 3: Primer sequences, accession numbers and product lengths. 
Function Gene Sequence 5‘-3‘ 
GenBank accession 
no. 
Length [bp] 
Reference 
genes 
ACTB for AACTCCATCATGAAG
TGTGAC 
AY141970 202 
 ACTB rev GATCCACATCTGCTG
GAAGG 
  
 GAPD for GTCTTCACTACCATG
GAGAAGG 
U85042 197 
 GAPD rev TCATGGATGACCTTG
GCCAG 
  
 H3F3A for ACTTGCTACAAAAGC
CGCTC 
BT025472 183 
 H3F3A rev ACTTGCCTCCTGCAA
AGCAC 
  
Protein 
metabolism 
CTSL for CACTGGTGCTCTTGA
AGGACA 
BC102312 177 
 CTSL rev TAAGATTCCTCTGAG
TCCAGGC 
  
 TAT for ACCCTTGTGGGTCAG
TGTTC 
BT021798 165 
 TAT rev ACAGGATGGGGACTT
TGCTG 
  
               Carbo-
hydrate 
metabolism 
PC for ATCTCCTACACGGGT
GACGT 
NM_177 946 214 
PC rev TGTCGTGGGTGTGGA   
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Function Gene Sequence 5‘-3‘ 
GenBank accession 
no. 
Length [bp] 
TGTGCA 
 PCK1 for TTTGGCGTCGCTCCG
GGAAC 
AY 145503 244 
 PCK1 rev GGCACTGGCTGGCTG
GAGTG 
  
 PCK2 for TACGAGGCCTTCAAC
TGGCGT 
XM_58 3200 365 
 PCK2 rev AGATCCAAGGCGCCT
TCCTTA 
  
Glucose 
transport 
SLC2A2 for GGACCTTGGTTTTGG
CTGTC 
BC149324 275 
 SLC2A2 rev CACAGACAGGGACCA
GAACA 
  
Hormone 
receptor 
INSR for CCAACTGCTCAGTCA
TCGAA 
XM_002688832 164 
 INSR rev GTTGGGGAACAAGTC
CTTCA 
  
Keto-
genesis 
HMGCS2 for CGCCCGGCGTCCCGT
TTAAA 
NM_001045883 294 
 HMGCS2 rev GGACCCGCCACACTT
TCGGTC 
  
Translation EIF4B for CCACGCCGGGACATG
GATCG 
NM_001035028 164 
 EIF4B rev TCATAGCGGTCCCCG
CCTCC 
  
Trans-
cription 
regulation 
HNF4A for GCATGGCCAAGATCG
ACAA 
AY318752 73 
HNF4A rev TGGGCATGAGGTGCT
TCAC 
  
 PPARA for GGATGTCCCATAACG
CGATTCG  
BT020756 235 
 PPARA rev TCGTGGATGACGAAA
GGCGG  
  
 SREBF1 for CCAGCTGACAGCTCC
ATTGA 
NM_001113302 67 
 SREBF1 rev TGCGCGCCACAAGGA   
 PPARG for CTCCAAGAGTACCAA
AGTGCAATC  
NM_181024 198 
 PPARG rev CCGGAAGAAACCCTT
GCATC  
  Final 
metabolism 
CS for TGGACATGATGTATG
GTGG 
BC114138 217 
 CS rev AGCCAAGATACCTGT
TCCTC 
  
Anabolism IGF1 for CATCCTCCTCGCATCT
CTTC 
NM_001077828 239 
  IGF1 rev CTCCAGCCTCCTCAG
ATCAC 
    
ACACA = acetyl-CoA carboxylase α; ACADVL = acetyl-CoA dehydrogenase, very long 
chain; ACTB = actin beta; CPT1A = carnitinepalmitoyltransferase; CS = citrate synthase; 
CTSL = cathepsin L; ECHS1 = enoyl CoA hydratase 1; EIF4B = eukaryotic translation 
initiation factor 4B; GAPD = glyceraldehyde-3-phosphate dehydrogenase; GPAM = 
glycerol-3-phosphate acyltransferase; H3F3A = H3 histone family 3A; HMGCS2 = 3-
hydroxy-3-methylglutary-coenzyme A synthase 2; HNF4A = hepatocyte nuclear factor-4A; 
IGF1 = insulin-like growth factor 1; INSR = insulin receptor; PC = pyruvate carboxylase; 
PCK1 = phosphoenolpyruvate carboxylase, cytosolic; PCK2 = phosphoenolpyruvate 
carboxylase, mitochondrial; PPARA = peroxisome proliferator activated receptor-α; 
PPARG = peroxisome proliferator activated receptor-γ; SLC2A2 = facilitated glucose 
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transporter, member 2; SREBF1 = sterol regulatory element binding transcription factor 1; 
TAT = tyrosine aminotransferase 
MESA Green qPCR MasterMix plus for SYBR® Assay w/fluorescein (Eurogentec, Cologne, 
Germany) was used and a standard protocol recommended by the manufacturer was followed to 
perform RT-qPCR. All components were mixed in the reaction wells of semi-skirted twin.tec PCR 
plate 96 (Eppendorf, Hamburg, Germany). The mastermix contained 7.5 µL 2 × MESA Green 
qPCR MasterMix, 1.5 µL forward primer (10 pmol/µL), 1.5 µL reverse primer (10 pmol/µL), and 
3.0 µL RNase free water. Per well, 13.5 µL mastermix and 1.5 µL cDNA were added. The plate 
was sealed, placed in the iQ5 Cycler (Bio-Rad, Munich, Germany), and the following PCR 
protocol was started: denaturating step (95°C, 5 min), cycling program (95°C, 3 s; primer specific 
annealing temperature, 60 s) and melting curve analysis. 
Genes were selected as reference genes using GenEx Pro Software Version 5.2.7.44 (MultiD 
Analyses, Gothenburg, Sweden). The mean of the three selected housekeeping genes actin beta 
(ACTB), glyceraldehyde-3-phosphate acyltransferase (GAPD) and H3 histone family 3A (H3F3A) 
was calculated for the reference gene index and used for normalisation. Quantitative cycles (Cq) 
were calculated by Bio-Rad iQ5 Optical System Software Version 2.1 with the analysis mode 
‘PCR base line substracted curve fit’.  
The ΔCq-values were calculated as ΔCq = Cqtarget gene – mean Cqrefence genes and subtracted from the 
arbitrary value of 15 (15 - ΔCq) to avoid negative digits and to allow a relative comparison 
between two time points. High ΔCq-values show high transcript abundance and increase of one 
ΔCq represents two-fold increase of mRNA transcripts (Livak and Schmittgen, 2001). 
Data of genes from all animals and at all time points were excluded from statistical analysis, if 
more than 5 amplifications in one of the groups failed. Furthermore, data of animals at one time 
point were excluded, if more than 5 RT-qPCR runs of different genes did not work. 
2.2. Analysis of major proteins in skim milk samples  
Protein fractions in skim milk were analysed at first day of wk 2, 3, 4, 6, 7, 8, 9, 10, 12, 14, 16, 17, 
18, 20 and 22 pp, during FR at d 25, 28, 31, 140, 143 and 146 pp and at days of ivGTT (d 20 and 
127 pp; figure 4).  
Figure 4: sampling time points for protein fractions 
Arrows indicate day of sampling relative to parturition. Dotted arrows show days of ivGTT, 
dashed arrows the last day before FR, last day of FR and three days after FR. 
 
Analyses of α-LA, β-LG, α-, β-, and κ-CN were conducted using a microfluidic electrophoresis 
(Agilent 2100 Bioanalyzer system, Agilent Technologies, Waldbronn, Germany). The provided 
Protein 80 kit (Agilent Technologies, Waldbronn, Germany) contained chips and all reagents. For 
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measurement necessary reagents were gel matrix, dye concentrate, sample buffer with upper 
(95 kDa) and lower (1.6 kDa) marker and molecular mass ladder. According to the manufacturer’s 
protocol, gel-dye mix was prepared by spin filtration (2,500 × g, 15 minutes) of 650 µL gel matrix 
and addition of 25 µL dye concentrate. Destaining solution was obtained by solely spin filtration 
of gel matrix (650 µL). A reducing denaturing solution was prepared by addition of 1 mol 
dithiothreitol solution (7 µL, 3.5%) to 200 µL sample buffer. After thawing of milk samples 
(37°C, 20 min), skim milk was obtained by centrifugation (3,000 × g, 4°C, 15 minutes) and 
diluted in deionised water (1:20). Protein mix (200 µg/mL of each α-LA, β-LG, α-, β-, κ-CN; all 
Sigma-Aldrich Chemie GmbH, Munich, Germany), milk samples and ladder were prepared 
according to the manual: ladder (6 µL) or sample with denaturing solution (4 µL and 2 µL, 
respectively) were placed in a 0.5 mL tube and heated (95°C, 5 minutes). After cooling, tubes were 
shortly centrifuged and 84 µL of deionised water were added to receive total volume of 90 µL. For 
purposes of variance calculation and to ensure comparability between chips, the protein mix was 
measured on every chip. 
 
 
Figure 5: Layout of wells and channels of typical microfluidic chip in upper part (adopted 
from Anema and Lloyd, 1999) and electropherogram of standard proteins in lower part. 
G1-G4 denotes wells to be filled with 12 µL gel-dye mix, DS well with 12 µL destaining 
solution, L well with 6 µL of prepared ladder, S1-S9 wells for 6 µL of prepared samples 
and S10 well for 6 µL of prepared protein mix. Arrows highlight the points of separation 
(A), destaining (B) and detection (C). 
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Figure 5 (Anema and Lloyd, 1999) shows the layout of a microfluidic chip and the 
electropherogram of the standard proteins. The chip was primed by pushing 12 µL gel-dye mix 
from well G1 into the channels of the chip with air pressure produced by a syringe. Afterwards the 
wells were filled with either gel-dye mix (12 µL, G2 – G4), destaining solution (12 µL, DS), 
prepared ladder (6 µL, L) or prepared samples (6 µL, S1 – S9) respectively prepared protein mix 
(S10). The points of separation (A), destaining (B) and detection (C) are highlighted with arrows. 
After the chip was loaded into the Bioanalyzer and the electrodes were inserted into each well by 
closing the lid, measurement was started immediately. Electrophoresis and simultaneous automatic 
integration took approximately 30 minutes. For standardisation of peak area and migration time, 
the upper and lower markers were used as internal standards. For standardisation of molecular 
mass the molecular mass of ladder proteins were used. If required, automatic integration could be 
corrected manually by using Agilent 2100 Expert software. The chips were discarded after 
completed runs and electrodes were cleaned after every run with the provided cleaning chip and 
fresh deionised water. 
2.3. Enzyme immuno assay of progesterone in skim milk 
Beginning d 8 pp, ovarian activity was monitored by twice weekly measurements of progesterone 
in skim milk with a competitive enzyme immuno assay (EIA) described by Meyer et al. (1986) 
with modifications. Day of first ovulation was defined as three days before progesterone 
concentrations were for the first time greater or equal 0.5 ng/mL. 
Microtiterplates (F96 MikroWell Plates Maxisorb, Nunc, Thermo Fisher Scientific, 
Langenselbold, Germany) were coated with 1 µg/well affinity purified antibody against rat IgG 
raised in goats (Physiology Weihenstephan, Freising, Germany) and residual binding sites blocked 
with 200 µL/well 0.1% BSA in PBST (phosphate buffered saline with Tween-20), containing 
7.12 g/L Na2HPO4 × 2 H2O, 8.5 g/L NaCl (both Merck KGaA, Darmstadt, Germany), 1 g/L BSA 
(Serva GmbH, Heidelberg, Germany), deionised water and HCl until pH 7.5 (Merck KGaA, 
Darmstadt, Germany). Microtiterplates were stored at -20°C until day of measurement. 
Monoclonal anti-progesterone antibodies produced in rat (Sigma-Aldrich Chemie GmbH, Munich, 
Germany) were used as second antibodies, diluted 1:3000 in PBST. Horseradish peroxidase 
(Roche Applied Science, Mannheim, Germany) was coupled to Progesterone-3CMO (Steraloids, 
Newport, USA) and diluted 1:3000 in PBST. Standard samples (0.2, 0.4, 0.8, 1.6, 3.2, 6.3 and 
12.5 ng/mL) and control samples (0.5, 1.0 and 2.0 ng/mL) were obtained by spiking progesterone-
free (around d 10 pp) skim milk with considered concentrations of progesterone (Sigma-Aldrich 
Chemie GmbH, Munich, Germany). 
Milk samples were thawed (37°C, 20 min) and skimmed by centrifugation (3,000 × g, 4°C, 
15 minutes). Competitive binding reaction was performed with duplicate 20 µL skim milk 
samples, standard or control samples and 100 µL of each enzyme-bound progesterone and anti-
progesterone-antibody per well during 2 hours at RT and darkness. Afterwards, plates were 
washed and 20 minutes at RT in darkness incubated with 150 µL/well substrate, containing 
equally substrate A (1 g/L CH6N2O3, 18 g/L Na2HPO4 × 2 H2O, 10.3 g/L C6H8O7 ×  H2O, pH 5) 
and substrate B (500 mg/L tetramethylbenzidine (TMB), 40 mL/L DMSO, 10.3 g/L C6H8O7 × 
H2O, pH 2.4). TMB and DMSO were provided from Sigma-Aldrich Chemie GmbH, Munich, 
Germany and all other chemicals from Merck KGaA, Darmstadt, Germany. Horseradish 
peroxidase cleaves hydrogen peroxide in OH-radicals, which react with amino-group of TMB, 
resulting in blue TMB-cations. Enzymatic reaction was stopped with 50 µL/well 2 M H2SO4, 
followed by protonation of TMP-radical and therefore colour change to yellow. Extinction was 
photometric measured at 450 nm (Sunrise microplate reader) and standard curves as well as 
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concentrations of progesterone in skim milk were calculated with Magellan data analysis software 
(both Tecan Group Ltd, Maennedorf, Switzerland). Variance between assays was 13.5%, within 
the assays 5.7%. Values within the physiological range of 0.2 to 3.0 ng/mL were distinguishly 
quantified. 
 
 
Figure 6: competitive EIA with second antibody-technique. 
 
2.4. Enzyme immuno assay of hydrocortisone in skim milk 
Measurement of hydrocortisone in skim milk was performed by a competitive EIA (Sauerwein et 
al., 1991) with additional modifications of Physiology Weihenstephan. Coating antibody was 
raised in goats against rabbit IgG (Sigma-Aldrich GmbH, Munich, Germany) and second antibody 
(C1Pool2 Weihenstephan) in rabbits against hydrocortisone-21-hemisuccinate-BSA (Sigma-
Aldrich GmbH, Munich, Germany). After affinity purification, antibodies were solved in 
ammonium sulphate. Like described before, 96-well-microtiterplates were activated with 1 µg/well 
of polyclonal antibody against rabbit IgG and residual binding sites were blocked with BSA in 
PBST. Microtiterplates were stored at -20°C until use. Competitive agent was hydrocortisone-21-
glucuronide (Steraloids, Newport, USA) labelled with horseradish peroxidase (1:12000, Roche 
Applied Science, Mannheim, Germany). 
Skim milk obtained by centrifugation (3,000 × g, 4°C, 15 minutes) of bulk tank milk was used to 
create hydrocortisone standards and control samples. Endogenous hydrocortisone was removed by 
treatment with activated charcoal. Therefore 0.7 mg charcoal per 100 mL skim milk were added 
and shaken horizontally (30 min, 1500 min-1). After centrifugation (3,000 × g, 4°C, 15 min), 
desired amounts of hydrocortisone (0.1 to 34.5 nmol/L and 1.0, 2.0, 5.0 nmol/L; Sigma-Aldrich 
Chemie GmbH, Munich, Germany) were added to skim milk. 
Experimental milk samples were thawed (37°C, 20 min) and skimmed by centrifugation 
(3,000 × g, 4°C, 15 min). Duplicate skim milk samples or standards (10 µL each) were pipetted to 
respective coated EIA wells and enzyme-conjugated hydrocortisone (100 µL, diluted 1:12,000) 
and specific antibody C1Pool2 (100 µL, diluted 1:90,000) were added. After over-night incubation 
(4°C), microtiterplates were washed with PBST. Above described substrate solution (150 µL) was 
added. After incubation in the dark (RT, 40 min), reaction was stopped by addition of sulphuric 
acid (50 µL). Extinction was determined photometrically at 450 nm (Sunrise microplate reader) 
and standard curves as well as concentrations of hydrocortisone in skim milk samples were 
TMB  TMB+ 
 
 
enzyme-bound metabolite 
 
 
 
metabolite 
 
specific antibody against metabolite 
 
 
coating antibody 
III. Materials and methods     29 
calculated with Magellan data analysis software (both Tecan Group Ltd, Maennedorf, 
Switzerland).  
Interassay variance was 12.6% and intraassay variance 6.7%. Values within the range of 1.0 to 
10.0 nmol/L were well distinguished and quantified. 
2.5. Analysis of β-hydroxybutyrate in skim milk 
BHBA was measured in skim milk samples at the day before, the last day of and three days after 
FRs: d 25, 28, 31, 140, 143 and 146 pp (Willibald, 2011) using a BHBA test kit (R-Biopharm AG, 
Darmstadt, Germany). To create a standard curve, skim milk was treated with activated charcoal 
and BHBA (R-Biopharm AG, Darmstadt, Germany) added in concentrations of 0.0, 6.5, 13.0, 
19.5, 26.0, 39.0, 52.0 and 78.0 mg/L. By addition of 39.0, 52.0 and 78.0 mg/L BHBA control 
samples for purposes of variance calculation were created. Frozen experimental milk samples were 
thawed in a water bath (37°C, 20 min) and skimmed by centrifugation (3,000 × g, 4°C, 15 min). 
To eliminate protein-derived adulterations of measurements, Carrez-precipitation of proteins was 
carried out with 250 µL each of Carrez-solution I (zinc sulphate, Sigma Aldrich Chemie GmbH, 
Munich, Germany) and II (potassium ferrocyanide, Merck KGaA, Darmstadt, Germany) to skim 
milk (2 mL). Sodium hydroxide was added until pH 7.5 to 8.5 was reached. After filtration, BHBA 
was measured with a photometric test system on 96-well microtiterplates. Chemicals were 
provided with BHBA test kit. In every well were pipetted: 60 µL solution 1 (potassium 
phosphate/triethanolamine buffer, Triton X-100), 20 µL solution 2 (diaphorase and nicotinamide 
adenine dinucleotide, NAD), 20 µL solution 3 (iodnitrotetrazolium chloride), 10 µL sample and 
190 µL water. Reaction was initiated when 5 µL of 3-hydroxybutyrate-dehydrogenase (solution 4) 
were added. After incubation (RT, 20 min), extinction was measured at 492 nm (Sunrise 
microplate reader) and BHBA concentration in standard samples as well as in experimental 
samples were calculated with Magellan data analysis software (both Tecan Group Ltd, Männedorf, 
Switzerland). Variance within the assay was 12.2% and between assays 36.6%.  
Therefore, all samples were multiplied with a correction factor (CF) derived from measured 
concentrations and known concentrations of control samples: 
𝐶𝐹 = �𝑚𝑒𝑎𝑠.  𝐵𝐻𝐵𝐴 (𝑐𝑜𝑛𝑡𝑟𝑜𝑙 39)39 +  𝑚𝑒𝑎𝑠.  𝐵𝐻𝐵𝐴 (𝑐𝑜𝑛𝑡𝑟𝑜𝑙 52)52+ 𝑚𝑒𝑎𝑠.  𝐵𝐻𝐵𝐴 (𝑐𝑜𝑛𝑡𝑟𝑜𝑙 78)78 � ×  13 
 
3. Statistical analysis 
Statistical analysis was conducted using REML in the MIXED procedure in SAS 
(SAS SAS, 2002). Standard model for a repeated measurements experiment is: 
𝑌𝑖𝑗𝑘 = µ +  𝑔𝑟𝑜𝑢𝑝𝑖+ 𝑑𝑘 + cow𝑗(𝑔𝑟𝑜𝑢𝑝𝑖) + (𝑔𝑟𝑜𝑢𝑝𝑖 ×  𝑑𝑘) + 𝑒𝑖𝑗𝑘 
 Yijk:  parameter of cow j in group i at time k. 
 µ:  overall mean 
 groupi:  fixed effect of group i 
 dk:   fixed effect of day in lactation k 
 cowj(groupi):  random effect of cow j in group i 
 groupi × dk:  fixed interaction effect of group i with time k 
 eijk:   random error at time k on cow j in group i 
As measurements of different animals were independent, covariance structure referred to variances 
at different time points and to correlation between measurements of the same animal. This 
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correlation consists firstly of the fact that two measurements of the same animal are correlated just 
because it is the same animal (variation between animals, RANDOM statement) and secondly it 
consists of covariation within the same animal (measurements close in time tend to be more highly 
correlated than those far apart, REPEATED statement). For every parameter, three covariance 
structures were evaluated: unstructured, compound symmetry or autoregressive order one. Used 
was the covariance structure that was closest to zero in the Akaike information criterion or Sawa's 
Bayesian information criterion (Littell et al., 1998). Day of lactation and group as well as their 
interaction (day × group) were used as fixed effects, whereas cow within treatment was the 
random effect. Furthermore, cow was the repeated subject. PDIFF function was used to determine 
the differences between treatments. Data was considered to differ significantly at P < 0.05. 
Specific calculations or statistic calculations differing from above mentioned approach are 
explained below. 
3.1. Milk parameters during experimental period 
Energy balance (EB) was calculated using the formula 𝐸𝐵 = (𝐷𝑀𝐼 𝑑𝑖𝑒𝑡 × 𝑁𝐸𝐿  𝑑𝑖𝑒𝑡) + (𝐷𝑀𝐼 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑒𝑠 ×  𝑁𝐸𝐿𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑒𝑠) −  (0.293 × 𝑏𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡0.75 −  [(0.38 ×
𝑚𝑖𝑙𝑘 𝑓𝑎𝑡 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛) − (0.21 × 𝑚𝑖𝑙𝑘 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛) +  0.95]  × 𝑚𝑖𝑙𝑘 𝑦𝑖𝑒𝑙𝑑 as 
described by Kamphues et al. (2004). ECM was calculated with the formula 
𝐸𝐶𝑀 = (𝑚𝑖𝑙𝑘 𝑦𝑖𝑒𝑙𝑑 × 0.327) + (𝑓𝑎𝑡 𝑦𝑖𝑒𝑙𝑑 × 12.86) + (𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑦𝑖𝑒𝑙𝑑 × 7.65) and FCM with 
𝐹𝐶𝑀 = (𝑚𝑖𝑙𝑘 𝑦𝑖𝑒𝑙𝑑 × 0.4) + (𝑓𝑎𝑡 𝑦𝑖𝑒𝑙𝑑 × 15). 
Prior to statistical analysis, repeated end point measurements (daily milk yield, milk composition 
and hydrocortisone) were pooled to weekly means. Days 21, 23 to 31, 127 and 138 to 146 pp were 
excluded from calculation of weekly means because FR and ivGTT were conducted at these days. 
For better illustration, milk parameters were subsumed to 6 time periods: d 1 to 22 pp (period 1), 
d 33 to 56 pp (period 2), d 57 to 84 pp (period 3), d 85 to 112 pp (period 4), d 113 to 134 pp 
(period 5) and d 148 to 155 pp (period 6). Calculation of statistical differences were performed 
using REML in the MIXED procedure in SAS. To conserve the effect of different intervals 
between measurements, SAS received the first day of each period as day of interest (e.g. 1 for 
period 1 or 85 for period 4). 
3.2. Feed restrictions in early and mid-lactation 
Repeated end point measurements of the last day before, the last day during and the last day after 
restricted feeding were compared within groups for milk parameters including hydrocortisone and 
β-hydroxybutyrate (d 25, 28 and 31 pp as well as d 140, 143 and 146 pp), blood parameters (d 26, 
29 and 32 pp as well as d 141, 144 and 147 pp) and for feed intake and EB (d 25, 28 and 31 pp as 
well as d 140, 143 and 146 pp) using REML in the mixed procedure in SAS, like mentioned 
above. Differences between groups within each FR and differences between similar days of early 
and mid-lactation FR were evaluated correspondingly. 
3.3. Intravenous glucose tolerance tests 
Area under the curve for insulin (AUCI) and glucose (AUCG) from -20 to 120 minutes after 
infusion were calculated with the trapezoid-rule: 
𝐴𝑈𝐶 ≈  � �𝑡𝑖2 − 𝑡𝑖1� × (𝐶𝑖1 + 𝐶𝑖2) × 12𝑖𝑛 = 120
𝑖1 = −20  
t: minute of sampling 
C: concentration of glucose [mmol/L] or insulin [µU/mL] 
i: sampling time point 
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Values for basal insulin and basal glucose were obtained by calculating arithmetic means of the 
four measurements before glucose infusion (-20, -15, -10 and immediately before infusion). 
Afterwards, basal AUCI and AUCG (bAUCI and bAUCG) were calculated as 𝑏𝐴𝑈𝐶 ≈
𝑏𝑎𝑠𝑎𝑙 𝑖𝑛𝑠𝑢𝑙𝑖𝑛 or 𝑔𝑙𝑢𝑐𝑜𝑠𝑒 × 140, assuming that the base is a rectangle with height of basal 
insulin or glucose concentrations and length of 140 minutes. Then net AUCI and AUCG (nAUCI 
and nAUCG) were calculated by subtraction of bAUCI from AUCI and bAUCG from AUCG, 
respectively. 
According to Kerestes et al. (2009), clearance of glucose was calculated using the formula 
𝐶𝑅 =  ln 𝑔𝑙𝑢𝑐𝑜𝑠𝑒𝑖5−ln 𝑔𝑙𝑢𝑐𝑜𝑠𝑒𝑖60
60−5
× 100. Consistent with Radziuk (2000), homeostatic model 
assessment of insulin was calculated as 𝐻𝑂𝑀𝐴 − 𝐼𝑅 =  𝑏𝑎𝑠𝑎𝑙 𝑔𝑙𝑢𝑐𝑜𝑠𝑒 ×𝑏𝑎𝑠𝑎𝑙 𝑖𝑛𝑠𝑢𝑙𝑖𝑛
22.5 . 
Statistical differences were calculated using REML in the MIXED procedure in SAS, like 
mentioned before.  
3.4. Major milk proteins in skim milk 
Data was provided by the software as percentage amount of total protein concentration. Due to 
technical reasons, the absolute amount of individual proteins were constantly over- or 
underestimated, so all following calculations were conducted with the percentage amount of 
protein concentration in the sample. To obtain comparable results between chips, every protein 
fraction was corrected by multiplication with a correction factor on the basis of the results of the 
respective proteins in the protein mix sample. Correction factor (CF) was calculated as            
𝐶𝐹 =  20%% 𝑜𝑓 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑖𝑛 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑚𝑖𝑥. After correction, percentage amount of each protein 
fraction within the sum of all protein fractions was determined. Results were subsumed to six time 
periods like done before with milk parameters. Differences between groups and time points were 
estimated with the above described model in SAS. 
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IV. RESULTS  
1. Animal experiment  
1.1. Cows and classification 
Approximately four weeks before parturition 26 cows were transported from a farm in Saxony to 
the research farm Veitshof. One cow died during the course of parturition due to severe calving 
difficulties caused by an oversized calf. Another cow had to be euthanized shortly after parturition 
due to downer-cow-syndrome and slipping injuries. Additionally, all data of one animal had to be 
omitted because of recurring inflammations which were caused by a perforating foreign body in 
the reticulum. 
Classification of remaining 23 cows was done based on mean FCM yield and mean milk protein 
content during d 23, 24 and 25 pp and resulted in four groups: 6 cows with high FCM 
(52.66 ± 2.91 kg/d) and high protein content (3.28 ± 0.07%; MP-cows), 5 cows showing low FCM 
(40.49 ± 1.15 kg/d) and low protein content (2.84 ± 0.06%; mp-cows), 7 cows with high FCM 
(48.98 ± 2.12 kg/d) and low protein content (2.90 ± 0.06%; Mp-cows) and 5 cows showing low 
FCM (39.08 ± 0.60 kg/d) and high protein content (3.40 ± 0.05%; mP-cows; table 4). Furthermore 
MP- and Mp-cows showed higher FCM compared to mp- and mP-cows (P < 0.01), whereas mp- 
and Mp-cows showed lower milk protein content compared to MP- and mP-cows (P < 0.001). 
Parity amongst all groups was comparable (MP-cows 2.8 ± 0.3, mp-cows 2.4 ± 0.2, Mp-cows 
2.3 ± 0.3, and mP-cows 2.8 ± 0.4; P = 0.35). 
Table 4: Parameters of classification (mean FCM yield, kg/d and mean milk protein 
content, %) of 23 cows during d 23, 24 and 25 pp. 
cow parity group 
milk 
FCM, 
kg/d 
mean 
FCM, 
kg/d 
milk protein 
content, % 
mean protein 
content, % 
14024 57758 4 MP 58.73 
52.66 
± 2.91a 
3.07 
3.28 ± 0.07a 
14027 34346 3 MP 51.04 3.06 
14027 34439 3 MP 60.16 3.50 
14030 03463 3 MP 55.78 3.42 
14030 03870 2 MP 40.97 3.29 
14031 15582 2 MP 49.25 3.33 
14026 25564 3 mp 44.25 
40.49 
± 1.15b 
3.02 
2.84 ± 0.06b 
14027 34303 3 mp 37.70 2.70 
14031 15366 2 mp 38.64 2.86 
14032 20073 2 mp 41.59 2.73 
14032 20330 2 mp 40.24 2.89 
14026 25242 4 Mp 54.13 
48.98 
± 2.12a 
3.00 
2.90 ± 0.06b 
14028 63689 2 Mp 46.72 3.00 
14030 03642 2 Mp 55.40 2.71 
14030 03827 2 Mp 41.13 2.95 
14030 03863 2 Mp 44.10 3.02 
14031 15265 2 Mp 54.23 2.95 
14031 15625 2 Mp 47.17 2.67 
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cow parity group 
milk 
FCM, 
kg/d 
mean 
FCM, 
kg/d 
milk protein 
content, % 
mean protein 
content, % 
14027 34230 4 mP 40.32 
39.08 
± 0.60b 
3.28 
3.40 ± 0.05a 
14027 34311 3 mP 40.47 3.51 
14027 34460 3 mP 38.70 3.36 
14031 15263 2 mP 38.74 3.53 
14031 15662 2 mP 37.19 3.31 
abcdMeans with alphabetic superscripts indicate differences between groups (P < 0.05) 
1.2. Mean milk and blood parameters during 22 weeks of lactation 
Data of mean milk parameters during 22 weeks of lactation and mean blood serum parameters 
during 2 weeks before until 22 weeks after parturition of the four groups can be found in table 5.  
Table 5: Mean milk and blood serum parameters of the four groups during 155 days of 
lactation. 
 MP mp Mp mP 
milk parameters, mean wk 1 to 22 pp 
yield, kg/d 37.2 ± 0.55a 34.7 ± 0.62b 41.7 ± 0.52c 30.4 ± 0.44d 
FCM, kg/d 41.7 ± 0.74a 35.6 ± 0.74b 42.8 ± 0.56a 34.0 ± 0.50b 
ECM, kg/d 44.7 ± 0.73a 38.4 ± 0.76b 45.9 ± 0.54a 37.2 ± 0.49b 
protein content, % 3.46 ± 0.06a 3.22 ± 0.05b 3.15 ± 0.04b 3.75 ± 0.05c 
protein yield, g/d 1,256 ± 15a 1,101 ± 22b 1,295 ± 14a 1,124 ± 13b 
fat content, % 4.89 ± 0.10a 4.19 ± 0.10b 4.22 ± 0.08b 4.79 ± 0.09a 
fat yield, g/d 1,799 ± 36a 1,445 ± 38b 1,741 ± 31a 1,452 ± 26b 
lactose content, % 4.74 ± 0.02 4.69 ± 0.02 4.77 ± 0.01 4.81 ± 0.02 
lactose yield, g/d 1,774 ± 31a 1,637 ± 35ab 1,993 ± 27c 1,469 ± 23b 
FPR 1.43 ± 0.03a 1.32 ± 0.02b 1.36 ± 0.02ab 1.29 ± 0.02b 
SCC,  × 1,000/mL 64.9 ± 9.6ab 148.7 ± 53.4ab 64.5 ± 13.3a 482.8 ± 96.4b 
pH 6.63 ± 0.01a 6.58 ± 0.01b 6.61 ± 0.01ab 6.63 ± 0.01a 
urea, mg/L 201.1 ± 3.8 197.8 ± 5.1 201.5 ± 4.6 202.4 ± 4.4 
hydrocortisone, nmol/L 3.80 ± 0.13 3.32 ± 0.14 3.71 ± 0.12 3.66 ± 0.20 
blood serum parameters, mean wk -2 to 22 pp 
glucose, mmol/L 3.99 ± 0.07 3.91 ± 0.16 3.74 ± 0.07 3.98 ± 0.06 
NEFA, µmol/L 562 ± 54 478 ± 60 525 ± 60 470 ± 74 
BHBA, mmol/L 0.54 ± 0.04 0.65 ± 0.06 0.53 ± 0.04 0.49 ± 0.04 
cholesterol, mmol/L 3.49 ± 0.23 3.18 ± 0.17 3.80 ± 0.22 3.19 ± 0.18 
tBR, µmol/L 5.15 ± 0.40 4.77 ± 0.43 4.69 ± 0.35 4.61 ± 0.40 
abcdMeans with alphabetic superscripts indicate differences between groups (P < 0.05) 
Mean ECM and FCM were higher in cows grouped for high FCM (MP- and Mp-cows) than in 
those with low (mp- and mP-cows; P < 0.05, table 5).  
Mean milk fat content was highest in MP- (4.89 ± 0.10%) and mP-cows (4.79 ± 0.09%) compared 
to mp- (4.19 ± 0.10%; P < 0.01) and Mp-cows (4.22 ± 0.08%; P < 0.01, table 5).  
Milk protein yield and milk fat yield were higher in cows with high milk yield (MP- and Mp-
cows) than in those with low milk yield (mp- and mP-cows; P < 0.05, table 5).  
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In milk lactose content, there was no difference observed between groups (table 5). Highest milk 
lactose yield was shown by Mp-cows (1,993 ± 27 g/d; P < 0.05). Furthermore, milk lactose yield 
of MP-cows (1,774 ± 31 g/d) was similar to mp-cows (1,637 ± 35 g/d; P = 0.19) but higher than in 
mP-cows (1,469 ± 23 g/d; P < 0.01). No difference could be found in milk lactose yield of mp- and 
mP-cows (P = 0.16). 
FPR was highest in MP-cows (1.43 ± 0.03) compared to mp- (1.32 ± 0.02; P < 0.05) and mP-cows 
(1.29 ± 0.02; P < 0.01, table 5). Moreover, Mp-cows (1.36 ± 0.02) had similar FPR compared to 
mp- (P = 0.45) and mP-cows (P = 0.21). SCC was highest in mP-cows (482.8 ± 96.4 × 1,000/mL) 
compared to Mp-cows (64.5 ± 13.3 × 1,000/mL; P < 0.05, table 5), whereas no difference could be 
observed between those two groups and MP- (64.9 ± 9.6 × 1,000/mL) or mp-cows 
(148.7 ± 53.4 × 1,000/mL).  
Milk pH was lower in mp-cows (6.58 ± 0.01) than in MP- (6.63 ± 0.01; P < 0.05) and mP-cows 
(6.63 ± 0.01; P < 0.05, table 5). Mp-cows were similar in milk pH to MP- and mP-cows (P > 0.30).  
No differences could be observed in milk urea, milk hydrocortisone contents and concentrations of 
blood serum glucose, NEFA, BHBA, cholesterol and tBR (table 5). 
1.3. Course of milk parameters during 22 weeks of lactation 
Milk yield 
Milk yield increased during period 1 and decreased slowly from period 2 to period 5 (figure 7). 
During period 1, Mp-cows (39.4 ± 1.38 kg/d) had highest milk yield compared to MP- 
(33.1 ± 1.66 kg/d; P < 0.01), mp- (32.3 ± 1.73 kg/d; P < 0.01) and mP-cows (28.4 ± 1.43 kg/d; 
P < 0.001; table 6). Furthermore during period 2, Mp-cows (46.1 ± 0.82 kg/d) showed higher milk 
yield compared to mp- (38.0 ± 1.08 kg/d; P < 0.01) and mP-cows (34.3 ± 0.68 kg/d; P < 0.001). 
Moreover, MP-cows (42.1 ± 0.65 kg/d) had higher milk yield than mP-cows (34.3 ± 0.68 kg/d; 
P < 0.01). Milk yield in period 3 was still highest in Mp-cows (45.3 ± 0.79 kg/d) compared to MP- 
(40.7 ± 0.70 kg/d; P < 0.05), mp- (37.5 ± 1.09 kg/d; P < 0.01) and mP-cows (32.7 ± 0.49 kg/d; 
P < 0.001). Moreover, MP-cows showed higher milk yield than mP-cows (P < 0.01). 
Throughout period 4, 5 and 6, mP-cows showed lowest milk yields (30.3 ± 0.46, 27.8 ± 0.71 and 
22.9 ± 3.00 kg/d) compared to MP- (37.9 ± 0.79, 32.8 ± 1.06 and 32.6 ± 1.47 kg/d; P < 0.05) and 
Mp-cows (42.2 ± 0.72, 37.8 ± 1.17 and 36.7 ± 1.56 kg/d; P < 0.001). Furthermore, milk yield of 
Mp-cows was higher compared to mp-cows (34.5 ± 1.08, 32.5 ± 1.25 and 28.4 ± 3.45 kg/d in 
period 4, 5, and 6; P < 0.01). Additionally in period 5, milk yield of Mp-cows was higher 
compared to MP-cows (P < 0.05).  
In all cows, highest milk yield was obtained in period 2 (42.1 ± 0.65, 38.0 ± 1.08, 46.1 ± 0.82 and 
34.3 ± 0.68 kg/d for MP-, mp-, Mp- and mP-cows; P < 0.001). Furthermore, milk yield decreased 
from period 3 to 5 in MP-cows by 7.9 kg (to 32.8 ± 1.06 kg/d; P < 0.01) and in Mp-cows from 
period 3 to 6 by 8.6 kg (to 36.7 ± 1.56 kg/d; P < 0.01). Additionally, declines were found from 
period 3 to 4 by 3 kg in mp-cows (P < 0.01) and by 2.4 kg in mP-cows (P < 0.05) to 34.5 ± 1.08 
and 30.3 ± 0.46 kg/d. From period 5 to 6, milk yield decreased further in mp-cows by 4.1 kg 
(to 28.4 ± 3.45; P < 0.01) and by 4.9 kg in mP-cows (to 22.9 ± 3.00 kg/d; P < 0.01). 
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Figure 7: Milk yield (kg/d) during first 22 weeks of lactation 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model: 
time P < 0.001, group P < 0.001 and time × group P = 0.41. Differences between periods 
and between groups can be found in table 6. 
 
FCM 
After increase of FCM in period 1, cows showed slowly decreasing yields in periods 2 until 5. 
During this time, high yielding cows (MP- and Mp-cows) were clearly distinguishable from low 
yielding cows (mp- and mP-cows, figure 8). 
During period 1, Mp-cows showed highest FCM (47.0 ± 1.19 kg/d) compared to mp- 
(38.7 ± 1.94 kg/d; P < 0.01) and mP-cows (35.5 ± 1.78 kg/d; P < 0.001; table 6). Moreover, higher 
FCM was observed in MP- (43.5 ± 1.61 kg/d) compared to mP-cows (P < 0.01). During periods 2, 
3 and 4, MP- (48.7 ± 1.58, 44.2 ± 0.90 and 40.9 ± 0.70 kg/d) and Mp-cows (47.5 ± 1.28, 
45.1 ± 0.83 and 40.2 ± 0.90 kg/d) showed higher FCM yields compared to mp- (40.1 ± 1.61, 
36.3 ± 1.47 and 33.0 ± 1.38 kg/d; P < 0.01, only in period 3 P < 0.05) and mP-cows (36.8 ± 1.06, 
35.0 ± 0.69 and 33.0 ± 0.56 kg/d; P < 0.01). In period 5, FCM was higher in Mp- 
(37.7 ± 1.07 kg/d) compared to mP-cows (P < 0.05). During period 6, MP- (34.1 ± 1.53 kg/d) and 
Mp-cows (36.9 ± 1.61 kg/d) showed higher FCM compared to mP-cows (25.6 ± 3.42 kg/d; 
P < 0.05) and higher FCM was observed in Mp- compared to mp-cows (29.4 ± 3.65 kg/d; 
P < 0.05). 
In MP-cows, FCM increased from period 1 to period 2 by 5.2 kg (P < 0.001) and decreased 
afterwards to period 3 by 4.5 kg (P < 0.001) and from period 4 to period 5 by 5.0 kg (P < 0.001). 
Furthermore, declining FCM was observed in mp-cows from period 2 through period 4 by total 
7.1 kg (P < 0.05). In Mp-cows, FCM decreased from period 2 until period 5 (-9.8 kg; P < 0.05) and 
solely decrease in mP-cows was observed between period 5 and 6 (-6.0 kg; P < 0.01). 
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Figure 8: FCM (kg/d) during first 22 weeks of lactation 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model: 
time P < 0.001, group P < 0.01 and time × group P = 0.07. Differences between periods 
and between groups can be found in table 6. 
 
ECM 
Course of ECM was similar to FCM, during period 1 yield increased and afterwards declined until 
period 5. High and low yielding cows were clearly distinguishable. During period 1, ECM of Mp-
cows (50.3 ± 1.07 kg/d) was higher than ECM of low yielding cows (P < 0.01; table 6, figure 9). 
Furthermore MP-cows (46.5 ± 1.53 kg/d) showed higher ECM compared to mP-cows 
(38.6 ± 1.73 kg/d; P < 0.01). ECM of high yielding cows was higher during period 2 to 4 
compared to that of low yielding cows (P < 0.05). In period 5, Mp-cows (40.8 ± 1.12 kg/d) showed 
higher ECM compared to mP-cows (34.9 ± 0.90 kg/d; P < 0.05). Moreover, mP-cows 
(28.7 ± 3.67 kg/d) showed in period 6 lower ECM than MP- (37.1 ± 1.33 kg/d; P < 0.05) and Mp-
cows (40.0 ± 1.71 kg/d; P < 0.01). Additionally, ECM of mp-cows (32.0 ± 4.07 kg/d) was lower 
than in Mp-cows (P < 0.05). 
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Figure 9: Energy-corrected milk yield (kg/d) during first 22 weeks of lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model: 
time P < 0.001, group P < 0.01 and time × group P = 0.08. Differences between periods 
and between groups can be found in table 6. 
Milk protein content 
Milk protein content showed highest levels during wk 1 pp, decreased until wk 3 pp and increased 
slowly from wk 6 on. Throughout all periods milk protein content in Mp-cows was lower 
compared to MP- (P < 0.05) and mP-cows (P < 0.01; table 6, figure 10). Furthermore, mp-cows 
had lower milk protein contents compared to MP- (P < 0.01) and mP-cows (P < 0.01). In period 2, 
milk protein concentration of mP-cows was higher in comparison to mp-cows (3.38 ± 0.05 and 
2.86 ± 0.05% for mP- and mp-cows; P < 0.001). Throughout periods 3 to 6, mP-cows showed 
higher milk protein concentrations than MP- (P < 0.05) and mp-cows (P < 0.001). In all cows, 
milk protein concentration was lower in period 2 than in period 1 (3.13 ± 0.06, 2.86 ± 0.05, 
2.85 ± 0.02 and 3.38 ± 0.05% for  MP-, mp-, Mp- and mP-cows; P < 0.001). Afterwards, milk 
protein content increased with only significant difference in MP-cows between period 3 and 4 
(increase by 0.19% to 3.40 ± 0.05%). 
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Figure 10: Milk protein content (%) during first 22 weeks of lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model: 
time P < 0.001, group P < 0.001 and time × group P = 0.24. Differences between periods 
and between groups can be found in table 6. 
Milk protein yield 
Milk protein yield stabilised on a higher level in high yielding cows and a lower level in low 
yielding cows. During period 1, milk protein yield was higher in Mp-cows (1,394 ± 34 g/d) 
compared to mP- (1,127 ± 48 g/d; P < 0.01) and mp-cows (1,129 ± 44 g/d; P < 0.01; table 6; figure 
11). In period 2, mp-cows (1,093 ± 46 g/d) showed lower milk protein yield than MP- 
(1,318 ± 33 g/d; P < 0.01) and Mp-cows (1,313 ± 24 g/d; P = 0.01). Throughout period 3 and 6 
milk protein yield was higher in Mp-cows (1,338 ± 32 and 1,170 ± 55 g/d) than in mp- (1,148 ± 58 
and 943 ± 132 g/d; P < 0.05) and mP-cows (1,157 ± 18 and 924 ± 103 g/d; P < 0.05). Furthermore, 
mp-cows (1,094 ± 41 g/d) showed lower milk protein yield during period 4 than MP- 
(1,279 ± 21 g/d; P < 0.05) and Mp-cows (1,292 ± 18 g/d; P < 0.05). 
Milk protein yield decreased in Mp-cows until period 2 by 81 g (P < 0.05) and from period 4 to 6 
by 122 g (P < 0.05) to 1,313 ± 24 and 1,170 ± 55 g/d, respectively. MP-cows showed single 
decrease from period 4 to 5 by 148 g to 1,131 ± 27 g/d (P < 0.01). From period 5 to 6, milk protein 
yield declined in mp-cows by 119 g to 943 ± 132 g/d (P < 0.01) and in mP-cows by 152 g 
to 924 ± 103 g/d (P < 0.01). 
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Figure 11: Milk protein yield (g/d) during first 22 weeks of lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model: 
time P < 0.001, group P < 0.05 and time × group P = 0.43. Differences between periods 
and between groups can be found in table 6. 
Milk fat content 
Milk fat content was highest in wk 1 pp, decreased throughout period 2 and levelled higher in high 
protein cows than in low protein cows. During period 1, milk fat content was higher in MP-cows 
(6.23 ± 0.26%) than in mp- (5.42 ± 0.30%; P < 0.05) and Mp-cows (5.42 ± 0.22%; P < 0.05; 
table 6, figure 12). Further on in period 2, MP-cows (5.03 ± 0.18%) showed higher fat content than 
Mp-cows (4.21 ± 0.15; P < 0.05). High protein cows showed during period 4 higher contents of 
milk fat compared to low protein cows (4.57 ± 0.10, 4.62 ± 0.10, 3.67 ± 0.10 and 3.70 ± 0.12% for 
MP-, mP-, mp- and Mp-cows; P < 0.05). In period 5, Mp-cows (3.94 ± 0.12%) had lower milk fat 
content compared to MP- (4.68 ± 0.12%; P < 0.05) and mP-cows (4.84 ± 0.18%; P < 0.01). 
Furthermore, milk fat concentration was lower in mp-cows (3.95 ± 0.11%) in comparison to mP-
cows (P < 0.05). 
Moreover, all cows had lower milk fat concentrations in period 2 compared to period 1 
(P < 0.001). Subsequently, MP- and mp-cows showed further decrease by 0.66 and 0.55% 
to 4.37 ± 0.09 and 3.79 ± 0.16% in period 3. Thereafter, milk fat content stabilized at a similar 
level throughout the remaining study period. 
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Figure 12: Milk fat content (%) during first 22 weeks of lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model: 
time P < 0.001, group P < 0.05 and time × group P = 0.53. Differences between periods 
and between groups can be found in table 6. 
Milk fat yield 
Milk fat yield showed highest amounts during period 1 and 2 and declined afterwards. All cows 
showed similar milk fat yields. During period 1 to 3, milk fat yield was higher in high yielding 
cows (MP- and Mp-cows) compared to low yielding cows (mp- and mP-cows; P < 0.05; table 6, 
figure 13). In period 4, MP-cows (1,720 ± 33 g/d) showed higher milk fat yield than mp- 
(1,277 ± 65 g/d; P < 0.01) and mP-cows (1,394 ± 31 g/d; P < 0.05). Furthermore, milk fat yield in 
Mp-cows (1,558 ± 51 g/d) was higher than in mp-cows (P < 0.05). No differences were observed 
between cows in period 5, whereas milk fat yield in period 6 was higher in Mp- (1,481 ± 73 g/d) 
than in mP-cows (1,096 ± 149 g/d; P < 0.05). 
In Mp-cows, milk fat yield declined from period 1 to 4 by 526 g (2,084 ± 62 to 1,558 ± 51 g/d; 
P < 0.05). Furthermore, milk fat yield decreased in MP- and mp-cows from period 2 to 3 by 265 
and 237 g (to 1,858 ± 46 g/d in MP-cows and to 1,422 ± 79 g/d in mp-cows; P < 0.01). 
Additionally in MP-cows, milk fat yield declined from period 4 to 5 by 202 g (to 1,518 ± 41 g/d; 
P < 0.01). Moreover, milk fat yield decreased in mP-cows solely from period 5 to 6 by 268 g 
(to 1,096 ± 149 g/d; P < 0.05). 
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Figure 13: Milk fat yield (g/d) during first 22 weeks of lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model: 
time P < 0.001, group P < 0.01 and time × group P = 0.07. Differences between periods 
and between groups can be found in table 6. 
Other milk parameters 
Concentrations of milk hydrocortisone (figure 14, table 6) showed no distinguishable differences. 
In wk 2 pp, milk hydrocortisone concentration in one of five mP-cows was outstanding high 
(18.69 nmol/L) and in wk 19 pp, two out of five MP-cows showed similar high levels (16.63 and 
12.50 nmol/L). This resulted in significant difference during period 5, in which MP-cows 
(4.67 ± 0.31 nmol/L) showed higher levels compared to mp-cows (3.12 ± 0.19 nmol/L; P < 0.05). 
Furthermore, milk hydrocortisone increased in MP-cows from period 4 (3.74 ± 0.20 nmol/L) to 
period 5 by 0.93 nmol/L (P < 0.05) and in mP-cows from period 5 to 6 by 1.39 nmol/L 
(to 5.00 nmol/L; P < 0.05). 
Differences between groups and between time periods in milk lactose content and yield, FPR, 
SCC, pH and milk urea can be found in table 6. 
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Figure 14: Milk hydrocortisone (nmol/L) during first 22 weeks of lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model: 
time P < 0.05, group P = 0.57 and time × group P = 0.51. Differences between periods and 
between groups can be found in table 6. 
Table 6: Mean milk parameters of 6 time periods during 155 days of lactation. 
 MP mp Mp mP 
milk yield, kg/d 
period 1 33.1 ± 1.66a 32.3 ± 1.73a 39.4 ± 1.38b 28.4 ± 1.43a 
period 2 42.1 ± 0.65ab* 38.0 ± 1.08ac* 46.1 ± 0.82b* 34.3 ± 0.68c* 
period 3 40.7 ± 0.70a 37.5 ± 1.09ac 45.3 ± 0.79b 32.7 ± 0.49c 
period 4 37.9 ± 0.79ab* 34.5 ± 1.08bc* 42.2 ± 0.72a* 30.3 ± 0.46c* 
period 5 32.8 ± 1.06a* 32.5 ± 1.25ab 37.8 ± 1.17c* 27.8 ± 0.71b 
period 6 32.6 ± 1.47ab 28.4 ± 3.45ac* 36.7 ± 1.56b* 22.9 ± 3.00c* 
FCM, kg/d 
period 1 43.5 ± 1.61ab 38.7 ± 1.94ac 47.0 ± 1.19b 35.5 ± 1.78c 
period 2 48.7 ± 1.58a* 40.1 ± 1.61b 47.5 ± 1.28a 36.8 ± 1.06b 
period 3 44.2 ± 0.90a* 36.3 ± 1.47b* 45.1 ± 0.83a* 35.0 ± 0.69b 
period 4 40.9 ± 0.70a 33.0 ± 1.38b* 40.2 ± 0.90a* 33.0 ± 0.56b 
period 5 35.9 ± 0.96ab* 32.6 ± 1.38ab 37.7 ± 1.07b* 31.6 ± 0.95a 
period 6 34.1 ± 1.53ab 29.4 ± 3.65bc 36.9 ± 1.61a 25.6 ± 3.42c* 
ECM, kg/d 
period 1 46.5 ± 1.53ab 41.3 ± 1.91ac 50.3 ± 1.07b 38.6 ± 1.73c 
period 2 51.1 ± 1.45a* 42.1 ± 1.68b 50.1 ± 1.17a 39.9 ± 1.11b 
period 3 47.3 ± 0.85a* 39.3 ± 1.50b 48.2 ± 0.81a 38.3 ± 0.66b 
period 4 44.3 ± 0.69a 36.1 ± 1.47b* 43.7 ± 0.83a* 36.5 ± 0.56b 
period 5 38.9 ± 0.96ab* 35.6 ± 1.51ab 40.8 ± 1.12a* 34.9 ± 0.90b 
period 6 37.1 ± 1.33ab 32.0 ± 4.07ac* 40.0 ± 1.71b 28.7 ± 3.67c* 
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 MP mp Mp mP 
milk protein content, % 
period 1 4.20 ± 0.28a  3.75 ± 0.22b 3.73 ± 0.18b 4.17 ± 0.26a 
period 2 3.13 ± 0.06ab* 2.86 ± 0.05ac* 2.85 ± 0.02c* 3.38 ± 0.05b* 
period 3 3.21 ± 0.05a 3.04 ± 0.07ab 2.95 ± 0.05b 3.55 ± 0.06c 
period 4 3.40 ± 0.05a* 3.16 ± 0.03ab 3.07 ± 0.03b 3.74 ± 0.05c 
period 5 3.49 ± 0.08a 3.26 ± 0.04ab 3.14 ± 0.03b 3.90 ± 0.07c 
period 6 3.37 ± 0.08a 3.30 ± 0.08ab 3.19 ± 0.04b 4.07 ± 0.11c 
milk protein yield, g/d 
period 1 1,281 ± 43ab 1,129 ± 44a 1,394 ± 34b 1,127 ± 48a 
period 2 1,318 ± 33a 1,093 ± 46b 1,313 ± 24a* 1,161 ± 31ab 
period 3 1,304 ± 29ab 1,148 ± 58a 1,338 ± 32b 1,157 ± 18a 
period 4 1,279 ± 21a 1,094 ± 41b 1,292 ± 18a 1,130 ± 18ab 
period 5 1,131 ± 27* 1,062 ± 48 1,185 ± 34* 1,076 ± 18 
period 6 1,098 ± 36ab 943 ± 132a* 1,170 ± 55b* 924 ± 103a* 
milk fat content, % 
period 1 6.23 ± 0.26a 5.42 ± 0.30b 5.42 ± 0.22b 5.61 ± 0.31ab 
period 2 5.03 ± 0.18a* 4.34 ± 0.12ab* 4.21 ± 0.15b* 4.47 ± 0.13ab* 
period 3 4.37 ± 0.09* 3.79 ± 0.16* 3.99 ± 0.12 4.48 ± 0.14 
period 4 4.57 ± 0.10a 3.67 ± 0.10b 3.70 ± 0.12b 4.62 ± 0.10a 
period 5 4.68 ± 0.12ab 3.95 ± 0.11ac 3.94 ± 0.12c 4.84 ± 0.18b 
period 6 4.48 ± 0.37 4.26 ± 0.28 4.05 ± 0.13 4.77 ± 0.15 
milk fat yield, g/d 
period 1 2,018 ± 71a 1,718 ± 94b 2,084 ± 62a 1,610 ± 93b 
period 2 2,123 ± 92a 1,659 ± 81b 1,939 ± 74a* 1,538 ± 57b 
period 3 1,858 ± 46a* 1,422 ± 79b* 1,797 ± 49a* 1,459 ± 43b 
period 4 1,720 ± 33a 1,277 ± 65b 1,558 ± 51ac* 1,394 ± 31bc 
period 5 1,518 ± 41* 1,308 ± 63 1,506 ± 49 1,364 ± 53 
period 6 1,401 ± 100ab 1,202 ± 156ab 1,481 ± 73a 1,096 ± 149b* 
milk lactose content, % 
period 1 4.50 ± 0.09 4.50 ± 0.07 4.62 ± 0.04 4.65 ± 0.09 
period 2 4.82 ± 0.03* 4.76 ± 0.04* 4.79 ± 0.02* 4.89 ± 0.03* 
period 3 4.79 ± 0.03 4.75 ± 0.05 4.82 ± 0.02 4.87 ± 0.03 
period 4 4.78 ± 0.03 4.72 ± 0.04 4.79 ± 0.02 4.82 ± 0.03 
period 5 4.75 ± 0.05 4.71 ± 0.04 4.80 ± 0.02 4.79 ± 0.04 
period 6 4.82 ± 0.04 4.61 ± 0.16 4.74 ± 0.03 4.75 ± 0.11 
milk lactose yield, g/d 
period 1 1,524 ± 95a 1,480 ± 95a 1,832 ± 77b 1,352 ± 80a 
period 2 2,028 ± 40ab* 1,812 ± 65bc* 2,211 ± 44a* 1,678 ± 31c* 
period 3 1,951 ± 42ab 1,786 ± 67bc 2,182 ± 38a 1,592 ± 24c 
period 4 1,814 ± 45ab* 1,638 ± 65ac* 2,021 ± 34b* 1,460 ± 22c* 
period 5 1,561 ± 59a* 1,532 ± 68a 1,813 ± 57b* 1,330 ± 34a 
period 6 1,571 ± 60ab 1,317 ± 201ac* 1,740 ± 68b* 1,080 ± 123c* 
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 MP mp Mp mP 
FPR 
period 1 1.58 ± 0.06 1.52 ± 0.06 1.53 ± 0.06 1.44 ± 0.11 
period 2 1.62 ± 0.08a 1.52 ± 0.05ab 1.48 ± 0.06ab 1.32 ± 0.03b 
period 3 1.42 ± 0.04* 1.27 ± 0.06* 1.37 ± 0.06 1.26 ± 0.04 
period 4 1.35 ± 0.03a 1.16 ± 0.03b 1.21 ± 0.04b* 1.24 ± 0.03ab 
period 5 1.35 ± 0.04 1.24 ± 0.03 1.28 ± 0.04 1.27 ± 0.04 
period 6 1.28 ± 0.11 1.28 ± 0.06 1.27 ± 0.05 1.18 ± 0.04 
SCC, × 1,000/mL 
period 1 153.0 ± 46.2ab 244.6 ± 100.7ab 82.6 ± 19.0a 571.4 ± 240.7b 
period 2 51.9 ± 15.7ab 54.5 ± 9.9ab 23.4 ± 3.1a 459.0 ± 279.5b 
period 3 37.3 ± 6.7 73.5 ± 18.6 19.3 ± 1.6 408.0 ± 230.1 
period 4 45.8 ± 9.8ab 59.8 ± 11.3ab 21.8 ± 2.2a 460.9 ± 184.4b 
period 5 62.2 ± 15.7 410.8 ± 236.3* 167.0 ± 59.4 601.0 ± 211.3 
period 6 34.3 ± 8.0a 50.2 ± 16.9ab 88.8 ± 42.3ab 232.8 ± 152.5b 
pH 
period 1 6.53 ± 0.05ab 6.48 ± 0.05a 6.57 ± 0.03b 6.56 ± 0.05b 
period 2 6.69 ± 0.01a* 6.61 ± 0.01b* 6.65 ± 0.01b* 6.67 ± 0.01b* 
period 3 6.65 ± 0.03 6.61 ± 0.01 6.63 ± 0.01 6.66 ± 0.01 
period 4 6.64 ± 0.02 6.59 ± 0.01 6.61 ± 0.01 6.64 ± 0.01 
period 5 6.62 ± 0.02 6.58 ± 0.01 6.61 ± 0.01 6.62 ± 0.02 
period 6 6.63 ± 0.02 6.56 ± 0.01 6.61 ± 0.02 6.62 ± 0.03 
milk urea, mg/L 
period 1 186.6 ± 9.7 173.4 ± 13.3 164.0 ± 7.9 186.6 ± 15.1 
period 2 194.9 ± 10.3 190.5 ± 10.5 182.5 ± 11.3 185.1 ± 7.7 
period 3 188.4 ± 6.7 191.9 ± 9.2 196.8 ± 10.5 201.7 ± 10.5 
period 4 211.9 ± 9.0 217.0 ± 12.2 226.6 ± 7.8* 216.1 ± 6.3 
period 5 217.3 ± 6.3 206.6 ± 11.9 218.0 ± 8.7 212.1 ± 8.3 
period 6 221.1 ± 15.7ab 175.7 ± 29.5a 240.8 ± 23.3b* 224.5 ± 37.4ab 
milk hydrocortisone, nmol/L 
period 1 3.36 ± 0.32 3.79 ± 0.66 3.60 ± 0.29 4.91 ± 2.22 
period 2 3.16 ± 0.37 3.02 ± 0.40 3.48 ± 0.48 3.15 ± 0.40 
period 3 3.58 ± 0.39 3.26 ± 0.23 3.55 ± 0.39 3.30 ± 0.24 
period 4 3.74 ± 0.20 3.20 ± 0.25 3.93 ± 0.41 3.57 ± 0.23 
period 5 4.67 ± 0.31a* 3.12 ± 0.19b 3.89 ± 0.47ab 3.61 ± 0.53ab 
period 6 4.66 ± 0.34 3.62 ± 0.91 3.81 ± 0.44 5.00 ± 0.50* 
abcdMeans with alphabetic superscripts indicate differences between groups (P < 0.05). 
*Means with asterisks indicate differences to previous period (P < 0.05). 
1.4. Course of blood serum parameters during 22 weeks of lactation 
Blood serum glucose 
Blood serum glucose (table 7, figure 15), showed only difference between groups at day of 
parturition. Glucose levels were higher in mp-cows (5.48 ± 1.28 mmol/L) compared to MP- 
(4.44 ± 0.38 mmol/L; P < 0.01), Mp- (4.18 ± 0.32 mmol/L; P < 0.001) and mP-cows 
(4.14 ± 0.14 mmol/L; P < 0.001). Two out of five mp-cows showed extraordinary high blood 
serum glucose levels at day of parturition (9.45 and 7.58 mmol/L).  
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Increase of blood serum glucose levels from d 7 ap to day of parturition was significant in mp-
cows (1.29 mmol/L; P < 0.001). Furthermore, blood serum glucose levels decreased to d 8 pp by 
0.86, 1.86 and 0.83 mmol/L in MP- (to 3.58 ± 0.17 mmol/L; P < 0.01), mp- 
(to 3.62 ± 0.26 mmol/L; P < 0.001) and Mp-cows (to 3.35 ± 0.23 mmol/L; P < 0.01), respectively. 
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Figure 15: blood serum glucose (mmol/L) during 155 days of lactation 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Shaded areas show feed restrictions. Values are 
presented as LSM ± SEM. Fixed effects in model: time P < 0.001, group P = 0.28 and 
time × group P = 0.34. Differences between time points and between groups can be found 
in table 7. 
 
Blood serum NEFA 
Blood serum NEFA levels increased before parturition until d 8 pp (table 7, figure 16). At this day, 
3 MP- (50%), 2 mp- (40%), 5 Mp- (71%) and 2 mP-cows (40%) showed blood serum NEFA 
levels above 1,000 µmol/L. Thereafter, blood serum levels of NEFA decreased throughout the 
remaining study period. 
No differences between groups at any time point could be observed in blood serum NEFA levels, 
even if higher blood serum NEFA levels of MP-cows before parturition purported this (P > 0.15). 
Blood serum NEFA levels increased from d 7 ap to day of parturition by 505, 777, 601 and 730 
µmol/L in MP- (404 ± 134 to 909 ± 157 µmol/L; P < 0.01), mp- (136 ± 137 to 913 ± 143 µmol/L; 
P = 0.01), Mp- (222 ± 116 to 823 ± 93 µmol/L; P < 0.01) and mP-cows (140 ± 150 to 
870 ± 260 µmol/L; P < 0.05), respectively. In Mp-cows blood serum NEFA levels increased 
further to 1,228 ± 116 µmol/L at d 8 pp (P < 0.01). Thereafter, decrease of NEFA levels was seen 
in mp-cows until d 15 pp (from 1,104 ± 137 to 714 ± 165 µmol/L; P < 0.05) and in mP-cows until 
d 22 pp (from 1,067 ± 238 µmol/L to 551 ± 62 µmol/L; P < 0.05). In high yielding cows, blood 
serum NEFA levels declined between d 22 and 43 pp by 322 (to 446 ± 69 µmol/L; P < 0.05) and 
487 µmol/L (to 380 ± 100 µmol/L; P < 0.001) in MP- and Mp-cows, respectively. 
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Figure 16: blood serum NEFA (µmol/L) during 155 days of lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Shaded areas show feed restrictions. Values are 
presented as LSM ± SEM. Fixed effects in model: time P < 0.001, group P = 0.59 and 
time × group P = 0.80. Differences between time points and between groups can be found 
in table 7. 
Blood serum BHBA 
Course of blood serum levels of BHBA showed similar pattern to NEFA levels. Blood serum 
levels increased until d 8 pp and showed slow decrease until end of study (table 7, figure 17). 
At d 8 pp, 5 MP- (83%), 4 mp- (80%), 6 Mp- (86%) and 3 mP-cows (60%) showed BHBA levels 
higher 0.50 mmol/L. 
At d 22 pp, three mp-cows showed extraordinary high blood serum BHBA levels (2.20, 1.36 and 
1.03 mmol/L). Consequently, mp-cows (1.07 ± 0.34 mmol/L) showed higher BHBA levels 
at d 22 pp compared to MP- (0.62 ± 0.07 mmol/L; P < 0.01), Mp- (0.74 ± 0.25 mmol/L; P < 0.01) 
and mP-cows (0.50 ± 0.06 mmol/L; P < 0.01). Furthermore at d 43 pp, blood serum BHBA levels 
of mp-cows (0.73 ± 0.10 mmol/L) were higher than those of mP-cows (0.37 ± 0.03 mmol/L; 
P < 0.05). In mp-cows, BHBA levels increased from d 1 to 8 pp (P < 0.05) and further from d 15 
to 22 pp (P < 0.05) each by 0.29 mmol/L, resulting in total increase from 0.69 ± 0.12 mmol/L at 
d 1 pp to 1.07 ± 0.34 mmol/L at d 22 pp. 
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Figure 17: blood serum BHBA (mmol/L) during 155 days of lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Shaded areas show feed restrictions. Values are 
presented as LSM ± SEM. Fixed effects in model: time P < 0.001, group P = 0.40 and 
time × group P = 0.59. Differences between time points and between groups can be found 
in table 7. 
Blood serum cholesterol 
At d 43 and 57 pp, Mp-cows (5.11 ± 0.35 and 5.82 ± 0.37 mmol/L) had higher blood serum 
cholesterol levels compared to MP- (4.59 ± 0.42 and 4.92 ± 0.53 mmol/L), mp- (4.28 ± 0.22 and 
4.50 ± 0.26 mmol/L) and mP-cows (4.09 ± 0.53 and 4.25 ± 0.51 mmol/L; P < 0.05; table 7, figure 
18). At d 113 and 155 pp, Mp-cows (6.03 ± 0.49 and 5.55 ± 0.51 mmol/L, respectively) had 
highest blood serum cholesterol levels compared to mp- (4.76 ± 0.17 and 4.06 ± 0.27 mmol/L; 
P < 0.01) and mP-cows (4.48 ± 0.36 and 4.22 ± 0.41 mmol/L; P < 0.01). Furthermore, MP-cows 
(5.74 ± 0.69 at d 113 pp and 5.17 ± 0.69 mmol/L at d 155 pp) had higher cholesterol levels than 
mp- (P < 0.01) and mP-cows (P < 0.05). 
In MP-cows, blood serum cholesterol levels increased from d 8 to 15 pp by 0.86 mmol/L 
(P < 0.05), from d 22 to 43 pp by 1.56 mmol/L (P < 0.001) and further from d 57 to 113 pp by 
0.82 mmol/L (P < 0.001) up to 2.75 ± 0.18, 4.59 ± 0.42 and 5.74 ± 0.69 mmol/L, respectively. In 
mp-cows, blood cholesterol levels increased from d 22 to 43 pp by 1.12 mmol up to 
4.28 ± 0.22 mmol/L (P < 0.001) and declined from d 113 to 155 pp by 0.7 mmol to 
4.06 ± 0.27 mmol/L (P < 0.05). Moreover, blood serum cholesterol levels in Mp-cows increased 
from d 8 to d 57 pp by 3.6 mmol up to 5.82 ± 0.37 mmol/L (P < 0.05) and decreased from d 113 to 
155 pp from 6.03 ± 0.49 to 5.55 ± 0.51 mmol/L (P < 0.05). Furthermore, mP-cows showed higher 
blood serum cholesterol levels at d 43 pp (4.09 ± 0.53 mmol/L) than at d 22 pp 
(3.16 ± 0.41 mmol/L; P < 0.05). 
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Figure 18: blood serum cholesterol (mmol/L) during 155 days of lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Shaded areas show feed restrictions. Values are 
presented as LSM ± SEM. Fixed effects in model: time P < 0.001, group P < 0.05 and 
time × group P < 0.001. Differences between time points and between groups can be found 
in table 7. 
Blood serum bilirubin 
Blood serum concentrations of tBR showed no differences between groups at any time point 
(table 7, figure 18). From d 7 ap to day of parturition, tBR levels increased by 5.11, 6.50, 5.23 and 
4.83 µmol/L in MP-, mp-, Mp- and mP-cows, respectively (P < 0.001). Furthermore, declining 
blood serum tBR levels could be observed in mp-cows from d 8 to 15 pp (by 2.08 µmol to 
5.47 ± 1.33 µmol/L; P < 0.05) and in mP-cows from d 15 to 22 pp (by 2.94 µmol to 
4.34 ± 0.38 µmol/L; P < 0.01). 
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Figure 19: blood serum total bilirubin (µmol/L) during 155 days of lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Shaded areas show feed restrictions. Values are 
presented as LSM ± SEM. Fixed effects in model: time P < 0.001, group P = 0.79 and 
time × group P = 0.86. Differences between time points and between groups can be found 
in table 7. 
 
Table 7: Mean blood serum parameters (LSM ± SE) during 155 days of lactation. 
day of 
lactation 
MP mp Mp mP 
Blood serum glucose, mmol/L 
-14 4.02 ± 0.15 3.89 ± 0.23 3.82 ± 0.14 4.05 ± 0.22 
-7 3.92 ± 0.16 4.19 ± 0.25 4.16 ± 0.17 4.00 ± 0.16 
1 4.44 ± 0.38a 5.48 ± 1.28b* 4.18 ± 0.32a 4.14 ± 0.14a 
8 3.58 ± 0.17* 3.62 ± 0.26* 3.35 ± 0.23* 3.87 ± 0.15 
15 3.67 ± 0.18 3.48 ± 0.17 3.48 ± 0.17 3.81 ± 0.19 
22 4.04 ± 0.24 3.65 ± 0.21 3.46 ± 0.22 3.99 ± 0.22 
43 3.89 ± 0.10 3.70 ± 0.37 3.73 ± 0.19 3.75 ± 0.28 
57 3.98 ± 0.13 3.77 ± 0.08 3.57 ± 0.18 4.23 ± 0.22 
113 4.02 ± 0.26 3.56 ± 0.23 3.69 ± 0.12 4.02 ± 0.12 
155 4.51 ± 0.19 3.79 ± 0.18 4.01 ± 0.15 3.94 ± 0.20 
 
IV. Results   50 
day of 
lactation 
MP mp Mp mP 
Blood serum NEFA, µmol/L 
-14 484 ± 136 185 ± 171 83 ± 123 114 ± 152 
-7 404 ± 134 136 ± 137 222 ± 116 140 ± 150 
1 909 ± 157* 913 ± 143* 823 ± 93* 870 ± 260* 
8 1,043 ± 124 1,104 ± 137 1,228 ± 116* 1,107 ± 137 
15 837 ± 121 714 ± 165* 1,025 ± 183 1,067 ± 238 
22 768 ± 138 607 ± 172 867 ± 225 551 ± 62* 
43 446 ± 69* 484 ± 63 380 ± 100* 254 ± 33 
57 381 ± 74 269 ± 69 349 ± 102 177 ± 19 
113 118 ± 15 133 ± 31 97 ± 18 111 ± 30 
155 191 ± 80 112 ± 35 105 ± 11 123 ± 44 
Blood serum BHBA, mmol/L 
-14 0.38 ± 0.07 0.37 ± 0.08 0.34 ± 0.07 0.40 ± 0.08 
-7 0.44 ± 0.11 0.44 ± 0.06 0.39 ± 0.01 0.40 ± 0.04 
1 0.68 ± 0.16 0.69 ± 0.12 0.57 ± 0.06 0.64 ± 0.09 
8 0.78 ± 0.20 0.98 ± 0.28* 0.73 ± 0.09 0.76 ± 0.15 
15 0.58 ± 0.08 0.78 ± 0.24 0.68 ± 0.12 0.77 ± 0.22 
22 0.62 ± 0.07a 1.07 ± 0.34b* 0.74 ± 0.25a 0.50 ± 0.06a 
43 0.57 ± 0.13ab 0.73 ± 0.10ab* 0.49 ± 0.06a 0.37 ± 0.03b 
57 0.50 ± 0.07 0.52 ± 0.09 0.60 ± 0.14 0.37 ± 0.03 
113 0.42 ± 0.05 0.45 ± 0.07 0.40 ± 0.06 0.34 ± 0.03 
155 0.41 ± 0.07 0.41 ± 0.04 0.34 ± 0.05 0.33 ± 0.06 
Blood serum cholesterol, mmol/L 
-14 2.52 ± 0.26 2.24 ± 0.12 2.47 ± 0.14 2.59 ± 0.28 
-7 2.07 ± 0.28 2.05 ± 0.19 2.01 ± 0.14 2.27 ± 0.22 
1 1.81 ± 0.25 1.66 ± 0.08 1.77 ± 0.17 1.67 ± 0.12 
8 1.89 ± 0.14 2.02 ± 0.06 2.22 ± 0.19 2.10 ± 0.24 
15 2.75 ± 0.18* 2.66 ± 0.10 3.14 ± 0.21* 2.74 ± 0.33 
22 3.03 ± 0.26 3.16 ± 0.13 3.70 ± 0.23* 3.16 ± 0.41 
43 4.59 ± 0.42a* 4.28 ± 0.22a* 5.11 ± 0.35b* 4.09 ± 0.53a* 
57 4.92 ± 0.53a 4.50 ± 0.26a 5.82 ± 0.37b* 4.25 ± 0.51a 
113 5.74 ± 0.69a* 4.76 ± 0.17b 6.03 ± 0.49a 4.48 ± 0.36b 
155 5.17 ± 0.69a 4.06 ± 0.27b* 5.55 ± 0.51a* 4.22 ± 0.41b 
Blood serum bilirubin, µmol/L 
-14 4.59 ± 0.92 3.21 ± 0.72 2.56 ± 0.46 3.69 ± 0.65 
-7 3.99 ± 0.93 1.83 ± 0.25 2.68 ± 0.67 2.90 ± 0.72 
1 9.10 ± 1.91* 8.33 ± 1.92* 7.91 ± 0.89* 7.73 ± 1.32* 
8 8.03 ± 1.33 7.55 ± 1.75 8.51 ± 1.04 7.29 ± 1.54 
15 6.76 ± 1.26 5.47 ± 1.33* 6.73 ± 0.91 7.28 ± 1.54 
22 5.21 ± 0.94 5.73 ± 0.99 5.65 ± 0.79 4.34 ± 0.38* 
43 4.20 ± 0.57 4.52 ± 0.51 3.15 ± 0.41 3.53 ± 0.77 
57 3.53 ± 0.57 3.80 ± 0.90 4.46 ± 1.05 2.86 ± 0.31 
113 3.42 ± 0.59 3.20 ± 0.56 2.57 ± 0.20 3.20 ± 0.69 
155 2.60 ± 0.15 3.13 ± 0.41 2.36 ± 0.26 2.72 ± 0.52 
abcdMeans with alphabetic superscripts indicate differences between groups (P < 0.05). 
*Means with asterisks indicate differences to previous sampling time point (P < 0.05). 
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1.5. Body weight, body condition score and back-fat-thickness 
Body weight 
All cows showed higher body weights prior to parturition and lost body weight during the first six 
weeks of lactation. Afterwards cows remained on low body weight levels or showed slowly 
increasing body weights. 
In all groups, body weight decreased from wk 1 ap to wk 2 pp and further to wk 4 pp (823 ± 23 to 
689 ± 21 kg for MP-cows, 774 ± 54 to 626 ± 46 kg mp-cows, 773 ± 27 to 642 ± 20 kg for Mp- and 
792 ± 28 to 677 ± 32 kg for mP-cows; P < 0.001, figure 20). Only in Mp-cows, weight increased 
from wk -3 to -1 pp (730 ± 26 to 773 ± 27 kg; P < 0.05). In mP-cows, body weight decreased 
significantly from wk 4 to 6 pp (P < 0.05). 
From wk 2 pp on, MP-cows lost 10.3% (75 kg) of their body weight until wk 12 pp, mp-cows lost 
12.9% (90 kg) until wk 10 pp, Mp-cows 10.0% (69 kg) until wk 8 pp and mP-cows lost 9.7% 
(70 kg) until wk 6 pp. 
Only mP-cows showed slowly increasing body weights after wk 6 pp. At last weighing in 
wk 22 pp, they showed higher body weight (737 ± 19 kg) compared to Mp-cows (606 ± 29 kg; 
P < 0.05). 
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Figure 20: body weight during two weeks before and 22 weeks after parturition 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Shaded areas show feed restrictions and dashed 
line parturition. Values are presented as LSM ± SEM. Fixed effects in model: time 
P < 0.001, group P = 0.42 and time × group P = 0.72. 
 
Body condition score 
From wk 3 ap on, all cows showed decreasing BCS until wk 10 pp. Only mP-cows had slowly 
increasing BCS from wk 12 pp until end of study (figure 21). 
In MP-cows, BCS decreased from wk 3 to 1 ap by 0.36 points to 4.04 ± 0.24 (P < 0.05). Further 
decrease from wk 1 ap to wk 2 pp was seen in MP-, Mp- and mP-cows. BCS decreased from 
IV. Results   52 
4.04 ± 0.24 to 3.21 ± 0.10, from 3.57 ± 0.13 to 3.04 ± 0.10 and from 3.85 ± 0.26 to 3.30 ± 0.20 in 
MP-, Mp- and mP-cows, respectively (P < 0.001). In mp- and mP-cows, BCS decreased from wk 2 
to 4 pp by 0.25 points to 3.25 ± 0.32 and 3.05 ± 0.12 (P < 0.05). Furthermore, BCS decreased in 
MP-, mp- and Mp-cows from wk 4 to 6 pp by 0.29, 0.40 and 0.21 points from 3.13 ± 0.14 to 
2.83 ± 0.15 (P < 0.01), 3.25 ± 0.32 to 2.85 ± 0.28 (P < 0.001) and from 2.89 ± 0.12 to 2.68 ± 0.12 
(P < 0.05) for MP-, mp- and Mp-cows, respectively. Moreover, BCS of mP-cows decreased from 
wk 6 to 8 pp (2.90 ± 0.23 to 2.60 ± 0.22; P < 0.01) and from wk 10 to 12 pp (2.70 ± 0.20 to 
2.45 ± 0.23; P < 0.05).  
In MP-cows, BCS decreased from wk 3 ap until wk 18 pp by 38.6% (1.65). Moreover, BCS 
decreased from wk 3 ap to wk 12 pp by 37.7% (1.48) in mp-cows, by 31.2% (1.07) in Mp-cows 
and by 36.4% (1.40) in mP-cows. 
At first estimation of BCS in wk 3 ap, Mp-cows (3.50 ± 0.08) showed lower BCS compared to 
MP-cows (4.40 ± 0.19; P < 0.01). Differences at following measurements proved not to be 
significant. 
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Figure 21: body condition score during two weeks before and 22 weeks after parturition 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Shaded areas show feed restrictions and dashed 
line parturition. Values are presented as LSM ± SEM. Fixed effects in model: time 
P < 0.001, group P = 0.49 and time × group P = 0.12. 
 
Back-fat thickness 
Similar to BCS, all cows showed declining BFT from wk 3 ap until wk 12 pp and afterwards 
remained low until end of study. 
No differences in BFT between cows could be seen during all estimations, except of one 
difference at wk 3 ap between MP- (25.0 ± 3.8 mm) and mP-cows (20.3 ± 5.1; P < 0.05; 
figure 22). In mp-cows, there was a decrease in BFT from wk 2 to 4 pp by 5.2 mm (21.0 ± 5.0 mm 
to 15.8 ± 3.3 mm; P < 0.001) and from wk 6 to 8 pp by 3.4 mm (15.2 ± 3.7 mm to 11.8 ± 2.1 mm; 
P < 0.05). Furthermore, BFT declined in Mp-cows from wk 1 ap to wk 4 pp by 7 mm 
(24.8 ± 2.6 mm to 17.8 ± 1.6 mm; P < 0.01) and from wk 6 to 8 pp by 3.8 mm (12.8 ± 1.9 mm to 
9.0 ± 1.2 mm; P < 0.05). From wk 3 to 1 before parturition, BFT of mP-cows increased by 1.9 mm 
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(20.3 ± 5.1 mm to 22.2 ± 5.6 mm; P < 0.01). Afterwards, BFT of mP-cows decreased from wk 2 
until wk 4 pp (to 15.6 ± 2.8 mm; P < 0.01). 
Before parturition until wk 12 (MP-), 20 (mp-), 18 (Mp-) and 6 pp (mP-cows), BFT declined by 
69.4% (17.7 mm) in MP-cows, by 54.9% (11.2 mm) in mp-cows, by 70.0% (14.9 mm) in Mp-
cows and by 52.3% (11.6 mm) in mP-cows. 
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Figure 22: Back-fat-thickness during two weeks before and 22 weeks after parturition 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Shaded areas show feed restrictions and dashed 
line parturition. Values are presented as LSM ± SEM. Fixed effects in model: time 
P < 0.001, group P = 0.50 and time × group P = 0.31. 
1.6. Cyclicity and health status 
Ovarial cysts occurred in one mp- and two Mp-cows. These cows had to be treated and were not 
considered for statistical analysis of cyclicity. Day of first ovulation was comparable among 
groups (24 ± 4, 24 ± 6, 31 ± 4 and 22 ± 3 d pp for MP-, mp-, Mp- and mP-cows, respectively). 
First ovulation prior to d 30 pp was found in 67% of MP-, 75% of mp-, 40% of Mp- and 100% of 
mP-cows (table 8). 
Table 8: Cyclicity 
 MP mp Mp mP 
Ovarial cysts, % 0 20 29 0 
First ovulation, d 24 ± 4 24 ± 6 31 ± 4 22 ± 3 
First ovulation before d 30 pp, % 67 75 40 100 
 
In this study, one mP-cow suffered on mastitis (fever, turgid mammary gland and strongly positive 
California Mastitis Test; Barnum and Newbould, 1961), 7 cows on retained placenta (retention > 8 
hours, veterinary intervention necessary; 3 MP-, 1 mp-, 2 Mp- and 1 mP-cow) and one Mp-cow 
had a clinical ketosis diagnosed by clinical signs (inappetence, declining milk yield) and urinary 
ketone bodies. Lameness occurred in 11 cows, thereof 3 MP-cows, 1 mp-cow, 4 Mp-, and 3 mP-
cows (table 9). 
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Table 9: Occurrence of health disorders and first day of diagnosis1. 
 MP mp Mp mP 
Mastitis    1 (32) 
Retained placenta 3 (1) 1 (1) 2 (1) 1 (1) 
Ketosis 1 (5)    
Lameness 3 (-2, 19, 50) 1 (5) 4 (-7, -2, 20, 48) 3 (7, 11, 18) 
1Data in parentheses indicate the first day of diagnosis relative to calving. 
1.7. 100 day milk performance in previous and current lactation 
Mean 100-d-performances of all animals during the previous (farm in Saxony) and the current 
(Veitshof, Bavaria) lactation are shown in table 10. 
100-d-performance of milk yield increased in Mp-cows by 715 kg (P < 0.05). Consequently, milk 
fat and protein yield increased by 43 and 26 kg (P < 0.001 and P < 0.01) in these cows. 
Furthermore, milk fat yield increased in MP-cows by 38 kg (P < 0.01). 
Table 10: 100-d-performance of cows in previous lactation (Saxony, SN) and current 
lactation (Bavaria, BY). 
Parameter Lact. MP mp Mp mP 
Milk yield, kg 
SN 3,519 ± 303 3,637 ± 270 3,711 ± 334 3,478 ± 208 
BY 4,054 ± 171a 3,448 ± 176b 4,426 ± 137a* 3,205 ± 135b 
Milk protein 
content, % 
SN 3.4 ± 0.1a 3.0 ± 0.1b 2.9 ± 0.1b 3.4 ± 0.2a 
BY 3.2 ± 0.1a 3.0 ± 0.1ab 3.0 ± 0.0b 3.5 ± 0.1c 
Milk protein 
yield, kg 
SN 118 ± 9 109 ± 11 106 ± 9 119 ± 10 
BY 131 ± 7a 103 ± 7b 132 ± 3a* 113 ± 6b 
Milk fat 
content, % 
SN 4.4 ± 0.2a 4.0 ± 0.1ab 3.8 ± 0.2b 4.4 ± 0.2a 
BY 4.8 ± 0.2a 4.0 ± 0.2b 4.1 ± 0.3ab 4.4 ± 0.3ab 
Milk fat 
yield, kg 
SN 156 ± 15 145 ± 11 138 ± 10 152 ± 6 
BY 194 ± 8a* 139 ± 14b 181 ± 8a* 142 ± 9b 
abcdMeans with alphabetic superscripts indicate differences between groups (P < 0.05). 
*Means with asterisks indicate differences to previous lactation (P < 0.05).  
Fixed effects in model milk yield: group P = 0.06, lactation P = 0.20, lactation × group 
P = 0.06. Fixed effects in model milk fat yield: group P = 0.07, lactation P < 0.05, 
lactation × group P < 0.01. Fixed effects in model milk protein yield: group P = 0.27, 
lactation P = 0.19, lactation × group P = 0.08. Fixed effects in model milk fat content: 
group P < 0.05, lactation P = 0.10, lactation × group P = 0.50. Fixed effects in model milk 
protein content: group P < 0.001, lactation P = 0.77, lactation × group P = 0.15. 
2. Hepatic mRNA expression during 22 weeks of lactation 
Abundance of hepatic mRNA during lactation was measured in 127 liver tissue samples of 23 
animals (thereof 41 after FR) and assorted to 4 groups like described before (MP-, mp-, Mp- and 
mP-cows). Results of PCK2 and PPARG were omitted, because five or more measurements failed 
in each group independent of sample day and cow. Furthermore, results of single samples were left 
unconsidered, if minimum five RT-qPCR runs with different primers did not work. Single results 
were omitted at d 1 pp (34311, mP-cow), d 29 pp (03463, MP-cow), d 57 pp (03827, Mp-cow), 
d 144 pp (03463, MP-cow) and at day of slaughtering, d 155 pp (03827, Mp-; 34303, mp- and 
15263, mP-cow). 
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Lipid metabolism 
For characterisation of hepatic lipid metabolism during 155 days of lactation, mRNA abundance of 
ACACA, ACADVL, CPT1A, ECHS1 and GPAM was measured (table 11, figure 23). In ACACA, no 
differences were observed between groups at any time point. Transcript abundance of ACACA in 
mp-cows was higher at d 57 pp (10.48 ± 0.74) compared to d 15 pp (8.68 ± 0.69; P < 0.05). In Mp-
cows, mRNA abundance was highest at d 57 pp (9.90 ± 0.24; P < 0.05) and higher at d 15 pp 
(8.49 ± 0.73) compared to day of slaughtering (6.54 ± 0.61; P < 0.05). Transcript abundance of 
ACACA in mP-cows was lowest at day of slaughtering (7.87 ± 1.85; P < 0.05). 
Moreover, mRNA encoding for ACADVL showed lowest abundance in mp-cows at d 15 pp 
(13.09 ± 0.19; P < 0.05). At d 57 pp, mRNA levels were higher in Mp-cows (13.59 ± 0.17) 
compared to mP-cows (13.00 ± 0.21; P < 0.05) and at day of slaughtering, mRNA abundance was 
higher in MP- (13.77 ± 0.21) compared to mP-cows (13.10 ± 0.21; P < 0.05). In mp-cows, 
transcript abundance of ACADVL was higher at day of parturition (13.89 ± 0.19) compared to d 15 
(P < 0.01) and 57 pp (13.27 ± 0.21; P < 0.05). Furthermore, in Mp-cows mRNA levels were lower 
at day of slaughtering (13.20 ± 0.24) compared to d 15 pp (13.85 ± 0.16; P < 0.05). In mP-cows, 
lower mRNA abundance of ACADVL was measured at d 57 and 155 pp compared to day of 
parturition (13.97 ± 0.24; P < 0.01) and d 15 pp (13.85 ± 0.21; P < 0.05). 
Transcript abundance of CPT1A was lowest in mp-cows at d 15 pp (12.71 ± 0.25; P < 0.05) 
amongst all cows and in mP-cows lowest at day of slaughtering (12.56 ± 0.27; P < 0.05). 
Moreover, at d 155 pp mRNA encoding for ECHS1 showed higher abundance in MP-cows 
(15.08 ± 0.22) compared to mp-cows (14.44 ± 0.19; P < 0.05). In MP-cows, mRNA abundance of 
ECHS1 was higher at d 57 pp (15.42 ± 0.14) compared to day of parturition (14.77 ± 0.21; 
P < 0.05) and day of slaughtering (P < 0.01). Additionally, mp-cows showed highest mRNA 
abundance at d 57 pp (15.51 ± 0.13; P < 0.05) and higher mRNA levels of ECHS1 at d 15 pp 
(15.12 ± 0.21) compared to day of slaughtering (P < 0.01). In Mp-cows, transcript abundance of 
ECHS1 was higher at d 57 pp (15.65 ± 0.11) compared to day of parturition (14.90 ± 0.22; 
P < 0.01). Moreover, mRNA levels were lower at d 155 pp (14.60 ± 0.16) compared to d 15 
(15.47 ± 0.17; P < 0.001) and 57 pp (P < 0.001). In mP-cows, mRNA transcripts of ECHS1 were 
lowest at d 155 pp (14.93 ± 0.19) compared to d 15 pp (15.52 ± 0.22; P = 0.03) and d 57 pp 
(15.51 ± 0.13; P < 0.001). 
At d 155 pp, transcript abundance of GPAM was lower in mP-cows (10.34 ± 0.31) compared to 
MP- (11.66 ± 0.31; P < 0.01) and mp-cows (11.59 ± 0.35; P < 0.01). In MP-cows, mRNA level of 
GPAM was lower at day of parturition (11.25 ± 0.28) compared to d 15 pp (12.17 ± 0.31; P < 0.01) 
and d 57 pp (12.12 ± 0.31; P < 0.05). Furthermore, mRNA abundance in mp-cows was higher at 
d 57 pp (12.48 ± 0.31) compared to day of parturition (11.37 ± 0.28; P < 0.01) and day of 
slaughtering (P < 0.05). In Mp-cows, mRNA levels of GPAM were higher at d 15 pp 
(12.14 ± 0.24; P < 0.01) and d 57 pp (12.19 ± 0.25; P < 0.001) compared to day of slaughtering 
(10.93 ± 0.30). Moreover, mP-cows showed lowest transcript abundance at day of slaughtering 
(P < 0.001). 
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Figure 23: Changes in mRNA abundance of genes related to hepatic lipid metabolism during 
155 days of lactation. 
MP-cows are shown as black boxes, mp-cows as dotted boxes, Mp-cows as grey boxes and 
mP-cows as shaded boxes. Asterisks indicate differences between groups (P < 0.05). 
Differences between time points and between groups can be found in table 11. Fixed effects 
in model ACACA: time P < 0.001, group P = 0.31 and time × group P = 0.64. Fixed effects 
in model ACADVL: time P < 0.05, group P = 0.53 and time × group P < 0.05. Fixed effects 
in model CPT1A: time P < 0.05, group P = 0.22 and time × group P = 0.23. Fixed effects in 
model ECHS1: time P < 0.001, group P = 0.29 and time × group P < 0.01. Fixed effects in 
model GPAM: time P < 0.001, group P = 0.94 and time × group P < 0.05. 
Protein metabolism 
Concerning hepatic protein metabolism, mRNA abundance of CTSL and TAT was measured 
(table 11, figure 24).  
At day of parturition and at d 15 pp, mRNA levels of CTSL were higher in mp- (15.79 ± 0.23 and 
15.94 ± 0.22) compared to MP-cows (14.95 ± 0.23 and 15.20 ± 0.25 at day of parturition and 
d 15 pp, respectively; P < 0.05). No differences between time points were observed in transcript 
abundances of CTSL in MP-cows, whereas in mp-cows mRNA level was lowest at day of 
slaughtering (14.44 ± 0.28; P < 0.001). Furthermore in Mp- and mP-cows, transcript abundance 
was higher at d 57 pp (15.77 ± 0.20 and 15.78 ± 0.25) compared to day of slaughtering 
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(14.95 ± 0.24 and 14.93 ± 0.25 for Mp- and mP-cows; P < 0.01). 
Transcript abundances of TAT showed no differences between groups during time points. In MP-, 
Mp- and mP-cows, mRNA levels of TAT were higher at day of slaughtering (16.43 ± 0.32, 
16.44 ± 0.32 and 16.59 ± 0.32, for MP-, Mp- and mP-cows) compared to d 15 pp (in MP-cows 
15.47 ± 0.32, P < 0.05; in Mp-cows 15.54 ± 0.24, P < 0.05 and in mP-cows 15.40 ± 0.32, 
P < 0.01). Furthermore, mRNA encoding for TAT showed higher abundance in Mp-cows at 
d 155 pp compared to day of parturition (15.36 ± 0.32; P < 0.05). 
Carbohydrate metabolism 
Regarding hepatic carbohydrate metabolism, mRNA levels of PC and PCK1 were determined 
(table 11, figure 24).  
MP-cows showed lower mRNA levels of PC at day of parturition (10.01 ± 0.69) compared to mP-
cows (12.32 ± 0.87; P < 0.05) and at d 57 pp (7.61 ± 0.76) compared to Mp-cows (9.96 ± 0.63; 
P < 0.05). Furthermore transcript abundances of PC were higher in MP-cows at day of parturition 
compared to d 57 pp (P < 0.01). In mp-cows, highest mRNA level was observed at day of 
parturition (11.64 ± 0.69; P < 0.05). Moreover, mRNA levels of PC in mP-cows were higher at 
day of parturition compared to d 57 pp (8.31 ± 0.77; P < 0.001) and d 155 pp (9.67 ± 0.76; 
P < 0.01). Additionally transcript abundance in mP-cows at d 15 pp (10.36 ± 0.77) was higher 
compared to d 57 pp (P < 0.05). 
At day of parturition, mRNA levels of PCK1 were higher in mP- (16.47 ± 0.72) compared to mp-
cows (14.52 ± 0.56; P < 0.05), whereas at day of slaughtering transcript abundance of PCK1 was 
higher in mp- (17.19 ± 0.72) compared to mP-cows (15.11 ± 0.62; P < 0.05). MP-cows showed 
lower mRNA levels at day of parturition (15.16 ± 0.56) compared to d 15 pp (16.95 ± 0.62; 
P < 0.05) and d 57 pp (17.40 ± 0.62; P < 0.01). Furthermore transcript abundance of PCK1 was 
higher in MP-cows at d 57 pp compared to day of slaughtering (15.69 ± 0.62; P < 0.05). In mp-
cows, mRNA levels were lowest at day of parturition compared to d 57 pp (17.17 ± 0.62; P < 0.01) 
and d 155 pp (P < 0.01). At d 57 pp, Mp-cows showed higher mRNA levels (17.12 ± 0.51) 
compared to d 155 pp (15.15 ± 0.72; P < 0.05). Moreover, mP-cows had lowest transcript 
abundances of PCK1 at d 155 pp compared to d 15 pp (17.19 ± 0.63; P < 0.05) and d 57 pp 
(16.87 ± 0.62; P < 0.05). 
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Figure 24: Changes in mRNA abundance of genes related to hepatic protein (left figures) and 
carbohydrate metabolism (right figures) during 155 days of lactation. 
MP-cows are shown as black boxes, mp-cows as dotted boxes, Mp-cows as grey boxes and 
mP-cows as shaded boxes. Asterisks indicate differences between groups (P < 0.05). 
Differences between time points and between groups can be found in table 11. Fixed effects 
in model CTSL: time P < 0.001, group P = 0.40 and time × group P = 0.29. Fixed effects in 
model TAT: time P < 0.01, group P = 0.96 and time × group P = 0.77. Fixed effects in 
model PC: time P < 0.001, group P = 0.42 and time × group P = 0.08. Fixed effects in 
model PCK1: time P < 0.01, group P = 0.95 and time × group P = 0.16. 
 
Glucose metabolism and ketogenesis 
For better description of hepatic glucose metabolism and ketogenesis, mRNA abundance of 
SLC2A2, INSR and HMGCS2 was determined (table 11, figure 25). At day of slaughtering, mRNA 
levels of SLC2A2 were lowest in Mp-cows (11.98 ± 0.40) compared to mp- (13.30 ± 0.46; 
P < 0.05) and mP-cows (13.25 ± 0.40; P < 0.05). Furthermore mp-cows showed higher mRNA 
abundance of SLC2A2 at d 57 pp (14.21 ± 0.40) compared to d 15 pp (12.90 ± 0.36; P < 0.05). 
Moreover Mp-cows had lowest transcript abundance of SLC2A2 at day of slaughtering (P < 0.05).  
At day of parturition, highest mRNA level of INSR was observed in mP-cows (12.27 ± 0.24) 
compared to MP- (11.33 ± 0.19; P < 0.01) and Mp-cows (11.58 ± 0.21; P < 0.05). Furthermore at 
d 155 pp, Mp-cows showed higher mRNA abundance compared to mP-cows (12.10 ± 0.21 and 
11.50 ± 0.21 for Mp- and mP-cows; P < 0.05). Moreover in mP-cows, mRNA encoding for INSR 
showed lowest abundance at day of slaughtering compared to day of parturition (P < 0.05) and 
d 15 pp (12.11 ± 0.21; P < 0.05). 
At d 57 pp, transcript abundance of HMGCS2 was higher in MP- (16.16 ± 0.59) compared to Mp-
cows (14.40 ± 0.49; P < 0.05). Furthermore at day of slaughtering, mRNA levels of HMGCS2 
were lower in Mp-cows (13.21 ± 0.58) compared to MP- (14.99 ± 0.59; P < 0.05) and mP-cows 
(15.33 ± 0.60; P < 0.05). In MP-cows, mRNA abundance of HMGCS2 was lower at day of 
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parturition (14.37 ± 0.54) compared to d 15 pp (16.10 ± 0.59; P < 0.01) and d 57 pp (16.16 ± 0.59; 
P < 0.01). Moreover, in mp-cows mRNA levels were lowest at d 1 pp (13.08 ± 0.55; P < 0.05). 
Transcript abundance of HMGCS2 in Mp-cows was highest at d 15 pp (15.08 ± 0.46) compared to 
d 1 pp (13.70 ± 0.58; P < 0.05) and d 155 pp (P < 0.01). 
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Figure 25: Changes in mRNA abundance of genes related to hepatic glucose metabolism and 
ketogenesis during 155 days of lactation. 
MP-cows are shown as black boxes, mp-cows as dotted boxes, Mp-cows as grey boxes and 
mP-cows as shaded boxes. Asterisks indicate differences between groups (P < 0.05). 
Differences between time points and between groups can be found in table 11. Fixed effects 
in model SLC2A2: time P < 0.01, group P = 0.09 and time × group P = 0.48. Fixed effects 
in model INSR: time P = 0.79, group P = 0.51 and time × group P = 0.07. Fixed effects in 
model HMGCS2: time P < 0.001, group P = 0.15 and time × group P = 0.36. 
 
Translation and transcription factors 
For hepatic translation factors and transcription regulating factors mRNA encoding for EIF4B, 
HNF4A, PPARA and SREBF1 was measured (table 11, figure 26). 
Hepatic transcript abundance of translation factor EIF4B showed no differences between groups at 
any time point. In Mp- and mP-cows, mRNA levels at day of parturition (13.80 ± 0.32 and 
13.68 ± 0.37 for Mp- and mP-cows) were lowest compared to d 15 pp (Mp-cows 14.57 ± 0.25, 
mP-cows 14.55 ± 0.33, P < 0.05) and d 155 pp (Mp-cows 14.95 ± 0.32, mP-cows 15.13 ± 0.33, 
P < 0.01). Furthermore mRNA abundance in mP-cows at d 155 pp was higher compared to d 57 pp 
(14.16 ± 0.33; P < 0.01). 
Moreover mRNA encoding for HNF4A showed higher abundance at d 15 pp in MP-cows 
(13.50 ± 0.34) compared to mp-cows (12.52 ± 0.32; P < 0.05). In MP-cows mRNA levels were 
higher at d 155 pp (13.85 ± 0.34) compared to d 57 pp (12.99 ± 0.34; P < 0.01). Furthermore in 
mp-cows mRNA abundance at d 15 pp was lower compared to d 57 pp (13.28 ± 0.34; P < 0.01) 
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and day of slaughtering (13.67 ± 0.37; P < 0.01). Mp-cows had highest mRNA levels at day of 
slaughtering (14.39 ± 0.33; P < 0.01). In mP-cows hepatic mRNA abundance of HNF4A was 
lower at d 57 pp (12.71 ± 0.34) compared to day of parturition (13.64 ± 0.39; P < 0.05) and day of 
slaughtering (13.91 ± 0.34; P < 0.001). 
Additionally hepatic mRNA encoding for PPARA showed no differences between groups at any 
time point. In mp-cows mRNA levels at d 1 pp (13.17 ± 0.17) and d 15 pp (13.30 ± 0.17) were 
lower compared to d 57 pp (13.90 ± 0.19; P < 0.05) and d 155 pp (13.91 ± 0.22; P < 0.05). 
Transcript abundance of PPARA in Mp-cows was higher at d 57 pp (14.05 ± 0.16) compared to 
day of parturition (13.44 ± 0.19; P < 0.05). 
Hepatic mRNA transcripts of SREBF1 showed no differences between groups at any time point, 
whereas in MP-cows mRNA levels at day of parturition were lowest (6.63 ± 0.48; P < 0.01). 
Additionally mRNA transcripts in MP-cows were lower at d 57 pp (8.09 ± 0.52) compared to 
d 155 pp (9.47 ± 0.51; P < 0.05). In mp-cows hepatic mRNA abundance of SREBF1 was lower at 
d 1 and 15 pp (7.13 ± 0.49 and 7.26 ± 0.53) compared to d 57 (8.95 ± 0.52; P < 0.01) and 155 pp 
(8.90 ± 0.58; P < 0.01). Furthermore mRNA level of SREBF1 was lowest in Mp-cows at day of 
parturition (6.52 ± 0.50; P < 0.01) and concurrently mRNA abundance at d 15 pp (8.17 ± 0.41) 
was lower compared to d 155 pp (9.24 ± 0.50; P < 0.05). 
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Figure 26: Changes in mRNA abundance of genes related to hepatic translation and 
transcription regulation during 155 days of lactation. 
MP-cows are shown as black boxes, mp-cows as dotted boxes, Mp-cows as grey boxes and 
mP-cows as shaded boxes. Asterisks indicate differences between groups (P < 0.05). 
Differences between time points and between groups can be found in table 11. Fixed effects 
in model EIF4B: time P < 0.01, group P = 0.92 and time × group P = 0.13. Fixed effects in 
model HNF4A: time P < 0.001, group P = 0.72 and time × group P = 0.07. Fixed effects in 
model PPARA: time P < 0.01, group P = 0.59 and time × group P = 0.38. Fixed effects in 
model SREBF1: time P < 0.001, group P = 0.99 and time × group P = 0.09. 
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Common hepatic metabolism 
No differences were found in hepatic mRNA abundance of CS (table 11, figure 27). 
Hepatic mRNA abundance of TNFA showed higher abundance at d 57 pp in mp- compared to MP-
cows (8.31 ± 0.34 and 7.12 ± 0.38 for mp- and MP-cows; P < 0.05). At day of slaughtering mP- 
cows showed lower mRNA levels compared to d 1 pp (7.45 ± 0.24 and 8.55 ± 0.56; P < 0.01). 
Moreover mRNA encoding for IGF1 showed no differences between groups at any time point. In 
mp-cows, mRNA levels at d 57 pp (13.00 ± 0.41) were higher compared to d 1 (11.55 ± 0.38; 
P < 0.01) and d 15 pp (11.88 ± 0.38; P < 0.05). Furthermore, mP-cows had lower hepatic mRNA 
abundance at d 1 (11.87 ± 0.48) compared to d 57 pp (13.32 ± 0.42; P < 0.05). 
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Figure 27: Changes in mRNA abundance of genes related to hepatic metabolism during 155 
days of lactation. 
MP-cows are shown as black boxes, mp-cows as dotted boxes, Mp-cows as grey boxes and 
mP-cows as shaded boxes. Asterisks indicate differences between groups (P < 0.05). 
Differences between time points and between groups can be found in table 11. Fixed effects 
in model CS: time P = 0.32, group P < 0.05 and time × group P = 0.76. Fixed effects in 
model IGF1: time P < 0.01, group P = 0.75 and time × group P = 0.44. Fixed effects in 
model TNFA: time P < 0.001, group P = 0.14 and time × group P < 0.05. 
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Table 11: Hepatic mRNA expression (15-ΔCt) at day of parturition and day 15, 57 and 155 of 
lactation. 
Gene1 MP mp Mp mP 
Lipid metabolism 
ACACA     
d 1 pp 8.11 ± 0.68 9.01 ± 0.69*° 8.38 ± 0.23*# 10.09 ± 0.85° 
d 15 pp 7.81 ± 0.74 8.68 ± 0.69* 8.49 ± 0.73* 9.68 ± 0.77° 
d 57 pp 9.41 ± 0.74 10.48 ± 0.74° 9.90 ± 0.24° 10.48 ± 0.77° 
d 155 pp 7.91 ± 0.82 8.97 ± 0.82*° 6.54 ± 0.61# 7.87 ± 1.85* 
ACADVL     
d 1 pp 13.61 ± 0.19 13.89 ± 0.19* 13.74 ± 0.21*° 13.97 ± 0.24* 
d 15 pp 13.69 ± 0.21a 13.09 ± 0.19b° 13.85 ± 0.16a* 13.85 ± 0.21a* 
d 57 pp 13.55 ± 0.21ab 13.27 ± 0.21ab° 13.59 ± 0.17a*° 13.00 ± 0.21b° 
d 155 pp 13.77 ± 0.21a 13.55 ± 0.24ab*° 13.20 ± 0.24ab° 13.10 ± 0.21b° 
CPT1A     
d 1 pp 13.22 ± 0.25 12.91 ± 0.25 13.06 ± 0.27 13.61 ± 0.32° 
d 15 pp 13.55 ± 0.27a 12.71 ± 0.25b 13.46 ± 0.21a 13.94 ± 0.28a° 
d 57 pp 13.27 ± 0.27 13.27 ± 0.27 13.52 ± 0.22 13.32 ± 0.27° 
d 155 pp 12.82 ± 0.27 12.81 ± 0.32 13.25 ± 0.27 12.56 ± 0.27* 
ECHS1     
d 1 pp 14.77 ± 0.21* 14.51 ± 0.21*# 14.90 ± 0.22*# 14.92 ± 0.25*° 
d 15 pp 15.40 ± 0.23°* 15.12 ± 0.21* 15.47 ± 0.17*° 15.52 ± 0.22° 
d 57 pp 15.42 ± 0.14° 15.51 ± 0.13° 15.65 ± 0.11° 15.51 ± 0.13° 
d 155 pp 15.08 ± 0.22a* 14.44 ± 0.19b# 14.60 ± 0.16ab# 14.93 ± 0.19ab* 
GPAM     
d 1 pp 11.25 ± 0.28* 11.37 ± 0.28* 11.69 ± 0.30*° 12.05 ± 0.36* 
d 15 pp 12.17 ± 0.31° 11.93 ± 0.28°* 12.14 ± 0.24* 11.88 ± 0.32* 
d 57 pp 12.12 ± 0.31° 12.48 ± 0.31° 12.19 ± 0.25* 12.40 ± 0.31* 
d 155 pp 11.66 ± 0.31a*° 11.59 ± 0.35a* 10.93 ± 0.30ab° 10.34 ± 0.31b° 
Protein metabolism 
CTSL     
d 1 pp 14.95 ± 0.23a 15.79 ± 0.23b* 15.29 ± 0.24ab*° 15.44 ± 0.28ab*° 
d 15 pp 15.20 ± 0.25a 15.94 ± 0.22b* 15.41 ± 0.19ab*° 15.57 ± 0.25ab*° 
d 57 pp 15.37 ± 0.25 15.80 ± 0.25* 15.77 ± 0.20* 15.78 ± 0.25* 
d 155 pp 14.92 ± 0.25 14.44 ± 0.28° 14.95 ± 0.24° 14.93 ± 0.25° 
TAT     
d 1 pp 16.00 ± 0.29*° 16.04 ± 0.29 15.36 ± 0.32* 15.66 ± 0.37*° 
d 15 pp 15.47 ± 0.32* 15.28 ± 0.29 15.54 ± 0.24* 15.40 ± 0.32* 
d 57 pp 15.56 ± 0.32*° 15.85 ± 0.32 15.81 ± 0.26*° 15.95 ± 0.32*° 
d 155 pp 16.43 ± 0.32° 16.07 ± 0.37 16.44 ± 0.32° 16.59 ± 0.32° 
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Gene1 MP mp Mp mP 
Carbohydrate metabolism 
PC     
d 1 pp 10.01 ± 0.69a* 11.64 ± 0.69ab* 10.13 ± 0.75ab 12.32 ± 0.87b* 
d 15 pp 9.27 ± 0.76*° 8.60 ± 0.69° 9.86 ± 0.58 10.36 ± 0.77*# 
d 57 pp 7.61 ± 0.76a° 9.59 ± 0.76ab° 9.96 ± 0.63b 8.31 ± 0.77ab° 
d 155 pp 9.46 ± 0.76*° 8.97 ± 0.86° 10.31 ± 0.75 9.67 ± 0.76°# 
PCK1     
d 1 pp 15.16 ± 0.56ab* 14.52 ± 0.56a* 15.99 ± 0.62ab*° 16.47 ± 0.72b*° 
d 15 pp 16.95 ± 0.62°# 15.70 ± 0.62*° 16.48 ± 0.47*° 17.19 ± 0.63* 
d 57 pp 17.40 ± 0.62# 17.17 ± 0.62° 17.12 ± 0.51* 16.87 ± 0.62* 
d 155 pp 15.69 ± 0.62ab*° 17.19 ± 0.72a° 15.15 ± 0.72ab° 15.11 ± 0.62b° 
Glucose transport 
SLC2A2     
d 1 pp 13.58 ± 0.36 13.75 ± 0.36*° 13.31 ± 0.40* 14.36 ± 0.46 
d 15 pp 13.20 ± 0.46 12.90 ± 0.36* 13.30 ± 0.30* 13.85 ± 0.40 
d 57 pp 13.62 ± 0.40 14.21 ± 0.40° 14.02 ± 0.33* 14.05 ± 0.40 
d 155 pp 13.11 ± 0.40ab 13.30 ± 0.46a*° 11.98 ± 0.40b° 13.25 ± 0.40a 
Hormone receptor 
INSR     
d 1 pp 11.33 ± 0.19a 11.81 ± 0.19ab 11.58 ± 0.21a 12.27 ± 0.24b* 
d 15 pp 11.78 ± 0.21 11.75 ± 0.18 11.84 ± 0.16 12.11 ± 0.21* 
d 57 pp 11.67 ± 0.21 12.11 ± 0.21 11.90 ± 0.17 11.68 ± 0.21*° 
d 155 pp 11.88 ± 0.21ab 11.62 ± 0.24ab 12.10 ± 0.21a 11.50 ± 0.21b° 
Ketogenesis 
HMGCS2     
d 1 pp 14.37 ± 0.54* 13.08 ± 0.55* 13.70 ± 0.58* 14.23 ± 0.67 
d 15 pp 16.10 ± 0.59° 15.41 ± 0.60° 15.08 ± 0.46° 15.00 ± 0.60 
d 57 pp 16.16 ± 0.59a° 15.27 ± 0.60ab° 14.40 ± 0.49b*° 15.51 ± 0.60ab 
d 155 pp 14.99 ± 0.59a*° 14.58 ± 0.67ab° 13.21 ± 0.58b* 15.33 ± 0.60a 
Translation 
EIF4B     
d 1 pp 14.51 ± 0.30 14.36 ± 0.30 13.80 ± 0.32* 13.68 ± 0.37* 
d 15 pp 14.70 ± 0.33 14.75 ± 0.30 14.57 ± 0.25° 14.55 ± 0.33°# 
d 57 pp 14.83 ± 0.33 14.27 ± 0.32 14.44 ± 0.27*° 14.16 ± 0.33*° 
d 155 pp 14.23 ± 0.33 14.78 ± 0.36 14.95 ± 0.32° 15.13 ± 0.33# 
Transcription regulation 
HNF4A     
d 1 pp 13.50 ± 0.32*° 12.96 ± 0.32*° 12.93 ± 0.32* 13.64 ± 0.39* 
d 15 pp 13.50 ± 0.34a*° 12.52 ± 0.32b* 13.22 ± 0.27ab* 13.09 ± 0.35ab*° 
d 57 pp 12.99 ± 0.34* 13.28 ± 0.34° 13.30 ± 0.28* 12.71 ± 0.34° 
d 155 pp 13.85 ± 0.34° 13.67 ± 0.37° 14.39 ± 0.33° 13.91 ± 0.34* 
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Gene1 MP mp Mp mP 
PPARA     
d 1 pp 13.60 ± 0.17 13.17 ± 0.17* 13.44 ± 0.19* 13.74 ± 0.23 
d 15 pp 13.46 ± 0.20 13.30 ± 0.17* 13.70 ± 0.15*° 13.72 ± 0.20 
d 57 pp 13.90 ± 0.20 13.90 ± 0.19° 14.05 ± 0.16° 14.04 ± 0.20 
d 155 pp 13.80 ± 0.20 13.91 ± 0.22° 13.56 ± 0.19*° 13.47 ± 0.20 
SREBF1     
d 1 pp 6.63 ± 0.48* 7.13 ± 0.49* 6.52 ± 0.50* 7.50 ± 0.58 
d 15 pp 8.70 ± 0.52°# 7.26 ± 0.53* 8.17 ± 0.41° 8.19 ± 0.53 
d 57 pp 8.09 ± 0.52° 8.95 ± 0.52° 8.45 ± 0.44°# 7.99 ± 0.53 
d 155 pp 9.47 ± 0.51# 8.90 ± 0.58° 9.24 ± 0.50# 8.72 ± 0.52 
Final metabolism 
CS     
d 1 pp 10.75 ± 0.66 10.13 ± 0.72 9.27 ± 0.71 10.70 ± 0.83 
d 15 pp 10.21 ± 0.32 10.79 ± 0.37 9.90 ± 0.29 10.41 ± 0.35 
d 57 pp 10.57 ± 0.36 10.14 ± 0.36 10.39 ± 0.28 10.53 ± 0.34 
d 155 pp 10.12 ± 0.35 9.84 ± 0.36 9.58 ± 0.29 10.07 ± 0.34 
Inflammation 
TNFA     
d 1 pp 7.60 ± 0.46 7.76 ± 0.46 7.27 ± 0.49 8.55 ± 0.56* 
d 15 pp 7.77 ± 0.25 7.68 ± 0.20 7.70 ± 0.20 8.21 ± 0.24*° 
d 57 pp 7.12 ± 0.38a 8.31 ± 0.34b 7.82 ± 0.21ab 7.85 ± 0.27ab*° 
d 155 pp 7.01 ± 0.27 7.26 ± 0.25 7.13 ± 0.20 7.45 ± 0.24° 
Anabolism 
IGF1     
d 1 pp 11.85 ± 0.38 11.55 ± 0.38a* 12.53 ± 0.41 11.87 ± 0.48* 
d 15 pp 12.33 ± 0.42 11.88 ± 0.38* 12.42 ± 0.32 12.51 ± 0.42*° 
d 57 pp 12.65 ± 0.42 13.00 ± 0.41° 12.31 ± 0.34 13.32 ± 0.42° 
d 155 pp 12.38 ± 0.42 11.98 ± 0.47*° 11.72 ± 0.41 12.42 ± 0.42*° 
abcdMeans with alphabetic superscripts indicate differences between groups (P < 0.05). 
*°#+Means with symbolic superscripts indicate differences between time points (P < 0.05). 
1ACACA = acyl-CoA carboxylase α; ACADVL = acyl-CoA dehydrogenase, very long chain; 
CPT1A = carnitine palmitoyltransferase; ECHS1 = enoyl CoA hydratase 1; GPAM = 
glycerol-3-phosphate acyltransferase, mitochondrial; CTSL = cathepsin L; TAT = tyrosine 
aminotransferase; PC = pyruvate carboxylase; PCK1 = phosphoenolpyruvate 
carboxykinase, cytosolic; SLC2A2 = facilitated glucose transporter, member 2; INSR = 
insulin receptor; HMGCS2 = 3-hydroxy-3-methylglutary-coenzyme A synthase 2; EIF4B = 
eukaryotic translation initiation factor 4B; HNF4A = hepatocyte nuclear factor-4A (Loor et 
al., 2005); PPARA = peroxisome proliferator activated receptor-α (Sigl et al., 2010); 
SREBF1 = sterol regulatory element binding transcription factor 1 (Van Dorland et al., 
2009); CS = citrate synthase; TNFA = tumour necrosis factor α; IGF1 = insulin-like growth 
factor 1. 
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3. Feed restrictions 
All 23 animals were subjected to a FR in early lactation (d 26 to 28 pp) and another FR in mid-
lactation (d 141 to 143 pp).  
3.1. DMI intake and energy balance 
Dry matter intake 
During both FRs, DMI was lower at last day during FR (d 28 and 143 pp) compared to last day 
before FR (d 25 and 140 pp) and last day of realimentation (d 31 and 146 pp; P < 0.05 for mp- and 
mP-cows, P < 0.01 for Mp-cows, P < 0.001 for MP-cows; table 12, figure 28). Totally, DMI 
during FR in early lactation was reduced by 34.1 ± 5.5% in MP-, by 33.5 ± 6.7% in mp-, by 
28.1 ± 4.0% in Mp- and by 27.9 ± 3.6% in mP-cows, resulting in 69.1% mean DMI. During FR in 
mid-lactation cows showed 67.9% mean DMI after reduction by 31.1 ± 2.7% in MP-, by 
31.0 ± 2.7% in mp-, by 34.4 ± 2.8% in Mp- and by 31.8 ± 3.5% in mP-cows. 
After three days of restricted feeding (d 29 and 144 pp), DMI increased steeply in all cows 
(P < 0.001). At this time point in early lactation, high yielding cows showed higher DMI 
(22.2 ± 1.1 and 23.4 ± 1.3 kg at d 29 pp in MP- and Mp-cows) than before FR (18.7 ± 0.3 kg and 
18.7 ± 0.9 kg at d 25 pp in MP- and Mp-cows; P < 0.05 for MP- and P < 0.01 for Mp-cows). In 
mid-lactation, low protein cows showed higher DMI after FR (21.6 ± 1.5 and 24.7 ± 1.0 kg at 
d 144 pp in mp- and Mp-cows) than before FR (at d 140 pp in mp-cows 17.8 ± 1.3 kg, P < 0.05; in 
Mp-cows 20.8 ± 1.0 kg, P < 0.01). Nevertheless, DMI at last day after FR (d 31 and 146 pp) was 
comparable to DMI before FR (d 25 and 140 pp) in all cows. 
Furthermore mP-cows showed lower DMI at the day before FR in early lactation (17.8 ± 1.6 kg at 
d 25 pp) compared to the day before FR in mid-lactation (21.4 ± 0.6 kg at d 140 pp; P < 0.05). 
Differences between cows during FR in early lactation could be observed as follows: before FR, 
high yielding cows showed higher mean DMI (18.9 ± 0.3 and 18.3 ± 0.9 kg/d in MP- and Mp-
cows) compared to mp-cows (15.4 ± 0.6 kg/d; P < 0.05). During restricted feeding, DMI was 
comparable amongst all groups. After FR at d 29 pp, MP- (22.16 ± 1.13 kg) and Mp-cows 
(23.36 ± 1.35 kg) showed higher DMI compared to mp- (18.63 ± 1.22 kg; P < 0.05) and mP-cows 
(18.39 ± 1.89 kg; P < 0.05) and at d 31 pp MP-cows (20.2 ± 2.1 kg) showed higher DMI compared 
to mp-cows (15.3 ± 0.7 kg; P < 0.05). 
Before FR in mid-lactation, mp-cows showed lower mean DMI compared to MP- and mP-cows 
(18.4 ± 1.0, 22.0 ± 1.7 and 21.8 ± 0.9 kg/d in mp-, MP- and mP-cows; P < 0.05). During restricted 
feeding, DMI of all cows was comparable. At d 144 pp, DMI was comparable amongst all cows. 
Afterwards, DMI declined in mp-cows, resulting in lower DMI of mp-cows compared to Mp- and 
mP-cows at d 145 pp (17.2 ± 1.5, 20.7 ± 1.6 and 21.1 ± 0.8 kg in mp-, Mp- and mP-cows; 
P < 0.05) and compared to MP-cows at d 146 pp (16.1 ± 1.1 and 20.9 ± 1.0 kg in mp- and MP-
cows; P < 0.05). 
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Figure 28: Dry matter intake (kg) during feed restrictions in early and mid-lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Grey shaded areas show days of restricted 
feeding. Values are presenteds as LSM ± SEM. Fixed effects in model dry matter intake: 
time P < 0.001, group P < 0.001 and time × group P = 0.64. 
 
Energy balance 
All cows showed negative EB before FR in early lactation (table 12, figure 29). Mean EB before 
FR in early lactation was more negative in MP- (-72.4 ± 6.3 MJ NEL/d) compared to mP-cows      
(-46.4 ± 10.8 MJ NEL/d; P < 0.05). During first day of restricted feeding (d 26 pp), EB declined in 
all cows (by 58.8 ± 2.6, 46.7 ± 14.6, 53.0 ± 6.0 and by 37.5 ± 14.3 MJ NEL/d in MP-, mp-, Mp- 
and mP-cows, respectively; P < 0.001), resulting in lower EB of MP-cows (-123.7 ± 6.1 MJ NEL) 
compared to mp- (-93.9 ± 8.5 MJ NEL; P < 0.05) and mP-cows (-79.0 ± 10.9 MJ NEL; P < 0.01) 
and lower EB in Mp- (-116.3 ± 5.3 MJ NEL) compared to mP-cows (P < 0.01). During restricted 
feeding in early lactation, EB increased in Mp-cows from d 26 to 28 pp by 27.1 MJ NEL 
(P < 0.05). Furthermore mP-cows (-77.9 ± 4.2 MJ NEL/d) showed higher mean EB during 
restricted feeding compared to MP- (-111.6 ± 7.6 MJ NEL/d; P < 0.01) and Mp-cows                       
(-102.3 ± 4.9 MJ NEL/d; P < 0.05). During first day after early FR (d 29 pp), EB increased in MP-, 
mp-, Mp- and mP-cows by 52.1 (P < 0.001), 60.6 (P < 0.001), 71.3 (P < 0.001) and 33.0 MJ NEL 
(P < 0.01), respectively. At this time point, MP-cows (-49.3 ± 7.7 MJ NEL) showed lower EB 
compared to Mp-cows (-17.9 ± 10.3 MJ NEL; P < 0.05). After FR in early lactation, MP-cows       
(-55.5 ± 10.2 MJ NEL/d) showed lower mean EB compared to mP-cows (-30.7 ± 8.6 MJ NEL/d; 
P < 0.05). Solely in Mp-cows, EB decreased from d 29 pp (-17.9 ± 10.3 MJ NEL) to d 30 pp          
(-45.6 ± 8.5 MJ NEL; P < 0.01). In mp- and Mp-cows, mean EB showed higher levels after FR           
(-29.9 ± 4.1 and -32.9 ± 6.8 MJ NEL/d) compared to mean EB before FR (-55.7 ± 6.2 MJ NEL/d in 
mp-cows, P < 0.05; -62.6 ± 6.9 MJ NEL/d in Mp-cows, P < 0.01). 
Mean levels of EB before, during and after FR in mid-lactation were higher compared to early 
lactation (P < 0.001 for MP and Mp-cows; P < 0.01 for mp- and mP-cows).  
Before restricted feeding in mid-lactation, mean levels of EB were comparable amongst cows. 
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During first day of restricted feeding in mid-lactation, EB declined by 67.5, 42.7, 62.1 and 
48.7 MJ NEL in MP-, mp-, Mp- and mP-cows (P < 0.001), resulting in more negative EB at 
d 141 pp in Mp- (-73.8 ± 8.4 MJ NEL) compared to mP-cows (-44.2 ± 7.4 MJ NEL; P < 0.05). 
Increase of EB from d 141 to 142 pp was observed in MP- (from -67.2 ± 12.4 to                                     
-26.1 ± 19.6 MJ NEL; P < 0.001) and in Mp-cows (from -73.8 ± 8.4 to -52.1 ± 6.0 MJ NEL; 
P < 0.05), whereas mean EB during restricted feeding was comparable amongst cows. At d 144 pp, 
EB increased by 65.6, 66.8, 74.3 and 63.4 MJ NEL in MP-, mp-, Mp- and mP-cows (P < 0.001). 
No differences between cows were observed in mean EB after FR in mid-lactation.  
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Figure 29: Energy balance (MJ NEL) during feed restrictions in early and mid-lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Grey shaded areas show days of restricted 
feeding. Values are presented as LSM ± SEM. Fixed effects in model energy balance: time 
P < 0.001, group P < 0.05 and time × group P = 0.57. 
 
 
Table 12: Mean feed parameters (LSM ± SE) at last day before, during and after three days 
of feed restriction in early and mid-lactation. 
 MP mp Mp mP 
dry matter intake, kg 
d 25 pp 18.7 ± 0.3* 16.3 ± 1.2* 18.7 ± 0.9* 17.8 ± 1.6*1 
d 28 pp 12.4 ± 1.1° 10.5 ± 0.5° 13.4 ± 0.7° 12.7 ± 0.8° 
d 31 pp 20.2 ± 2.1a* 15.3 ± 0.7b* 18.3 ± 0.3ab* 16.6 ± 1.2ab* 
d 140 pp 22.0 ± 1.5a* 17.8 ± 1.3b* 20.8 ± 1.0ab* 21.4 ± 0.6a* 
d 143 pp 15.1 ± 1.2° 12.3 ± 1.2° 13.7 ± 1.0° 14.6 ± 0.7° 
d 146 pp 20.9 ± 1.0a* 16.1 ± 1.1b* 18.9 ± 1.0ab* 18.4 ± 1.7ab* 
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 MP mp Mp mP 
energy balance, MJ NEL 
d 25 pp -76.5 ± 10.2a*°1 -47.3 ± 9.4b* -63.3 ± 8.5ab*1 -41.5 ± 8.8b*1 
d 28 pp -101.4 ± 9.9*1 -83.7 ± 5.9°1 -89.2 ± 5.1°1 -74.3 ± 3.1°1 
d 31 pp -72.1 ± 15.5°1 -48.4 ± 1.9* -52.7 ± 9.9* -37.3 ± 4.3*1 
d 140 pp 0.3 ± 13.1* -20.0 ± 5.9 -11.7 ± 8.2* 4.6 ± 9.3* 
d 143 pp -34.8 ± 9.6° -43.7 ± 5.8 -48.2 ± 4.3° -34.7 ± 3.9° 
d 146 pp 6.2 ± 6.5* -19.4 ± 8.7 -8.8 ± 7.9* -0.2 ± 11.2* 
abcdAlphabetic superscripts indicate differences between groups (P < 0.05). 
*°#Symbolic superscripts indicate differences between days within a feed restriction 
(P < 0.05). 
1Superscripted 1 indicates difference (P < 0.05) of day in early lactation feed restriction 
(d 25, 28 and 31 pp) compared to day in mid-lactation feed restriction (d 140, 143 and 
146 pp, respectively). 
3.2. Milk composition 
Milk yield 
Before, during and after FR in early lactation, milk yields were higher in all cows compared to FR 
in mid-lactation (table 13, figure 30). 
Before FR in early lactation, milk yield was higher in high yielding cows compared to low 
yielding cows (P < 0.05). In high yielding cows and in mp-cows, milk yield declined during FR by 
5.8, 7.8 and 5.5 kg in MP-, Mp- and mp-cows (P < 0.01). At d 28 pp, Mp-cows (38.9 ± 1.3 kg) 
showed higher milk yield compared to low yielding cows (31.3 ± 1.6 and 30.5 ± 1.4 kg in mp- and 
mP-cows; P < 0.01) and MP-cows (36.0 ± 1.0 kg) showed higher milk yield compared to mP-cows 
(P < 0.05). Solely in MP-cows, milk yield increased from d 28 to 29 pp (by 2.5 kg; P < 0.05), 
resulting in only significant increase after FR in early lactation (P < 0.01). At d 31 pp, high 
yielding cows showed higher milk yields compared to low yielding cows (P < 0.05). 
Before FR in mid-lactation, Mp-cows (37.0 ± 2.4 kg) showed higher milk yield compared to low 
yielding cows (31.2 ± 2.4 and 26.6 ± 2.4 kg in mp- and mP-cows; P < 0.05) and MP-cows 
(32.1 ± 2.2 kg) showed higher milk yield compared to mP-cows (P < 0.05). Milk yield declined 
from d 140 to 143 pp by 4.3, 5.7 and 5.4 kg in MP- (P < 0.05), mp- and Mp-cows (P < 0.01). At 
d 143 pp, Mp-cows (31.6 ± 2.2 kg) showed higher milk yields compared to mp- (25.5 ± 2.5 kg; 
P < 0.05) and mP-cows (23.5 ± 1.7 kg; P < 0.01). After FR in mid-lactation, milk yields of all 
cows stayed on similar levels. 
FCM 
Before, during and after FR in mid-lactation all cows showed lower FCM compared to early FR 
(P < 0.05). Solely mp-cows tended to have similar FCM before FRs (P = 0.07; table 13, figure 30).  
Before FR in early lactation, high yielding cows showed higher FCM compared to low yielding 
cows (53.7 ± 4.1, 49.9 ± 1.9, 39.3 ± 1.7 and 38.7 ± 1.1 kg in MP-, Mp-, mp- and mP-cows; 
P < 0.01). In high yielding cows, FCM declined during FR in early lactation by 7.3 kg in MP-cows 
to 46.4 ± 2.5 kg (P < 0.01) and by 5.5 kg in Mp-cows to 44.4 ± 1.9 kg (P < 0.05). At d 28 pp, high 
yielding cows had still higher FCM compared to low yielding cows (46.4 ± 2.5, 44.4 ± 1.9, 
36.7 ± 1.6 and 37.0 ± 2.2 kg in MP-, Mp-, mp- and mP-cows; P < 0.05). Solely in MP-cows, FCM 
increased after FR in early lactation from d 28 to 29 pp (by 7.5 kg; P < 0.001), leading to only 
significant increase by 5.9 kg to 52.3 ± 2.9 kg (P < 0.05). 
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Before, during and after FR in mid-lactation, FCM was similar amongst all cows and throughout 
days. 
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Figure 30: Milk yield (kg) and FCM (kg) during feed restrictions in early and mid-lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Grey shaded areas show days of restricted 
feeding. Values are presented as LSM ± SEM. Fixed effects in model milk yield: time P < 
0.001, group P < 0.001 and time × group P = 0.92. Fixed effects in model FCM: time P < 
0.001, group P < 0.001 and time × group P = 0.82. 
ECM 
All cows showed lower ECM before, during and after FR in mid-lactation compared to early FR 
(P < 0.05). Solely mp-cows had similar ECM before FRs (P = 0.11; table 13).  
Before FR in early lactation, ECM was higher in high yielding cows compared to low yielding 
cows (P < 0.001) and decreased by 8.2 and 6.4 kg until d 28 pp in MP- (to 47.7 ± 2.5 kg; P < 0.01) 
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and Mp-cows (to 46.0 ± 1.8 kg; P < 0.01). At d 28 pp, high yielding cows showed still higher 
ECM compared to low yielding cows (P < 0.05). After FR, ECM increased in MP-cows until 
d 29 pp by 6.8 kg (P < 0.001), resulting in only significant increase until d 31 pp (to 53.8 ± 2.8 kg; 
P < 0.05). Furthermore, ECM of high yielding cows was still higher after FR compared to low 
yielding cows (P < 0.01). 
Amongst cows, ECM was similar at all days of FR during mid-lactation. Nevertheless, ECM 
decreased in MP-, mp- and Mp-cows from d 140 to 143 pp by 5.9, 6.1 and 5.7 kg (P < 0.05). 
Milk protein concentration 
In high protein cows, milk protein concentration was higher at days of FR in mid-lactation 
compared to FR in early lactation (P < 0.01 and P < 0.001 for MP- and mP-cows; table 13, figure 
31). In low protein cows, protein concentration was higher at d 140 and 146 pp compared to 
respective days of FR in early lactation (P < 0.01 and P < 0.05 for mp- and Mp-cows). 
Before FR in early lactation, milk protein concentration was higher in high protein cows 
(3.28 ± 0.07 and 3.42 ± 0.04% in MP- and mP-cows) compared to low protein cows (2.83 ± 0.06 
and 2.92 ± 0.06 in mp- and Mp-cows; P < 0.01). Afterwards, protein concentration decreased in 
high protein cows (to 3.10 ± 0.08 and 3.22 ± 0.08% in MP- and mP-cows; P < 0.05) and was at 
d 28 pp higher in mP- compared to Mp-cows (2.90 ± 0.06%; P < 0.05). After FR in early lactation, 
protein concentration of high protein cows stayed on previous low levels (3.06 ± 0.07 and 
3.11 ± 0.07% in MP- and mP-cows; P < 0.05) and was higher in mP-cows compared to mp-cows 
(2.79 ± 0.10%; P < 0.05). 
Before FR in mid-lactation (at d 140 pp), milk protein content was higher in high protein cows 
(3.66 ± 0.18 and 3.91 ± 0.14% in MP- and mP-cows) compared to low protein-cows (3.23 ± 0.07 
and 3.18 ± 0.06% in mp- and Mp-cows; P < 0.01). Afterwards, milk protein concentration declined 
only in MP-cows from d 140 pp to d 143 pp (to 3.43 ± 0.20%; P < 0.01). Furthermore, mP-cows 
showed declining protein concentrations from d 141 to 143 pp (3.95 ± 0.16 to 3.80 ± 0.14%; 
P < 0.05). At d 143 pp mP-cows showed overall highest milk protein content (P < 0.05) and MP-
cows (3.43 ± 0.20%) showed higher protein content compared to low protein-cows (3.15 ± 0.08 
and 3.06 ± 0.06% in mp- and Mp-cows; P < 0.05). After FR in mid-lactation, milk protein content 
stayed on similar levels with high protein cows showing higher concentrations compared to low 
protein cows (3.58 ± 0.19, 3.87 ± 0.15, 3.26 ± 0.05 and 3.17 ± 0.05% in MP-, mP-, mp- and Mp-
cows; P < 0.05). 
Milk protein yield 
Compared to respective day of FR in early lactation, high yielding cows showed lower milk 
protein yields during FR in mid-lactation (P < 0.05; table 13, figure 31). 
At d 25 pp, high yielding cows showed higher milk protein yields compared to low yielding cows 
(P < 0.05). Afterwards, declining protein yields were observed in high yielding cows (by 257 and 
238 g in MP- and Mp-cows; P < 0.001) and in mP-cows (by 170 g; P < 0.05). At d 28 pp, mp-cows 
had lower milk protein yields compared to high yielding cows (922 ± 56, 1,116 ± 55 and 
1,127 ± 38 g in mp-, MP- and Mp-cows; P < 0.05) and showed numerically further declining 
protein yields at d 29 pp (850 ±71 g; P = 0.10). Only in MP-cows, milk protein yields increased 
after FR by 140 g until d 146 pp (P < 0.05). After FR in early lactation, high yielding cows showed 
higher milk protein yields compared to low yielding cows (P < 0.05). 
Before FR in mid-lactation, milk protein yields were similar in all cows and declined in all cows 
during FR (by 221, 202, 213 and 143 g in MP-, mp-, Mp- and mP-cows; P < 0.05) to similar levels 
at d 143 (939 ± 27, 810 ± 98, 962 ± 62 and 884 ± 34 g in MP-, mp-, Mp- and mP-cows). After FR, 
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protein yields stayed in all cows on similar levels, resulting in similar protein yields at d 146 pp 
(1,034 ± 44 g, 917 ± 79 g, 1,033 ± 57 g and 916 ± 35 g in MP-, mp-, Mp- and mP-cows). 
Milk fat content 
In all cows, milk fat concentration showed varying amounts with numerically higher levels in high 
protein cows compared to low protein cows and higher levels during the days of FR period in early 
lactation compared to those in mid-lactation (table 13, figure 32). 
Before, during and after FR in early lactation, only MP-cows showed higher milk fat content 
compared to FR in mid-lactation (P < 0.01). Additionally, Mp-cows had higher fat concentration 
in milk after FR in early lactation compared to FR in early lactation (4.93 ± 0.43 and 
13.94 ± 0.15%; P < 0.05). 
At d 25 pp, milk fat content was overall highest in MP-cows (5.93 ± 0.72%; P < 0.05), declined by 
0.52%-points (P = 0.10) and was still higher at d 26 pp compared to low protein cows 
(5.41 ± 0.33%; P < 0.05). Although numerical increases of milk fat concentrations were observed 
in all cows during FR in early lactation, these increases proved not to be significant. At d 28 pp, 
MP-cows showed higher fat content compared to Mp-cows (5.92 ± 0.32 and 4.95 ± 0.3% in MP- 
and Mp-cows; P < 0.05). 
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Figure 31: Milk protein content (%) and protein yield (g) during feed restrictions in early 
and mid-lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Grey shaded areas show days of restricted 
feeding. Values are presented as LSM ± SEM. Fixed effects in model protein content: time 
P < 0.001, group P < 0.001 and time × group P < 0.001. Fixed effects in model protein 
yield: time P < 0.001, group P < 0.001 and time × group P = 0.74. 
 
After FR, fat content increased further until d 29 pp in high protein cows (6.71 ± 0.46 in MP-cows, 
P < 0.05 and 6.39 ± 0.52 in mP-cows, P < 0.01) and numerically in low protein cows (P = 0.07 and 
P = 0.24 for mp- and Mp-cows). Additionally, milk fat concentration decreased until d 30 pp in all 
cows (P < 0.001 for MP-, Mp- and mP-cows, P < 0.1 for mp-cows). At d 31 pp, MP- cows 
(5.80 ± 0.33%) showed higher milk fat content compared to Mp-cows (4.93 ± 0.43%; P < 0.05) 
and tended to be higher compared to mp-cows (4.88 ± 0.46%; P < 0.1). 
Before FR in mid-lactation, mP-cows (5.39 ± 0.62%) showed higher fat content compared to mp- 
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(4.34 ± 0.40%; P < 0.05) and Mp-cows (3.97 ± 0.11%; P < 0.01). Between d 141 and 142 pp, fat 
concentration increased in Mp- and mP-cows (P < 0.05), but overall increase from d 140 or 141 pp 
until d 143 pp proved not to be significant. At d 143 pp, milk fat content was higher in mP- 
(5.38 ± 0.26%) compared to Mp-cows (4.16 ± 0.14%; P < 0.01). after FR in mid-lactation, fat 
content declined from d 144 to 145 pp in all cows (P < 0.05), but overall decrease proved not to be 
significant nevertheless tended to be significant in mP-cows (P < 0.1). 
Milk fat yield 
Before FR in early lactation, high yielding cows had higher milk fat yields compared to FR in mid-
lactation (P < 0.001; table 13, figure 32). Furthermore, milk fat yields were higher in all cows 
during and after FR in early compared to mid-lactation (P < 0.05). 
Regarding FR in early lactation, MP-cows showed highest milk fat yields amongst groups at d 25 
pp (2,466 ± 274 g; P < 0.05) and Mp-cows (2,078 ± 108 g) showed higher milk fat yields 
compared to low yielding cows (1,640 ± 118 and 1,678 ± 61 g in mp- and mP-cows; P < 0.05). 
Only decrease of milk fat yields during restricted feeding was observed in MP-cows (by 331 g, 
P < 0.05). At d 28 pp, milk fat yields were higher in MP-cows (2,135 ± 145 g) compared to mp- 
(1,611 ± 94 g; P < 0.01) and mP-cows (1,654 ± 116 g; P < 0.01). After FR, milk fat yields 
increased in high protein cows from d 28 to 29 pp (by 432 and 266 g in MP- and mP-cows; 
P < 0.05) and declined again to d 30 pp (to 2,271 ± 277 and 1,641 ± 88 g in MP- and mP-cows; 
P < 0.05). Furthermore, Mp-cows showed declining milk fat yields from d 29 to 30 pp by 245 g 
(to 1,792 ± 107 g; P < 0.05) and again inclining fat yields to d 31 pp (by 231 g; P < 0.05). This 
resulted in no significant difference between d 28 and 31 pp. 
During FR in mid-lactation, all cows showed similar milk fat yields at all days. Additionally, no 
differences within groups were observed. 
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Figure 32: Milk fat content (%) and fat yield (g) during feed restrictions in early and mid-
lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Grey shaded areas show days of restricted 
feeding. Values are presented as LSM ± SEM. Fixed effects in model fat content: time 
P < 0.001, group P < 0.001 and time × group P = 0.88. Fixed effects in model fat yield: 
time P < 0.001, group P < 0.001 and time × group P = 0.72. 
Milk lactose concentration 
Milk lactose concentration was similar during days of FR in early and mid-lactation, solely in mP-
cows at d 25 pp (4.94 ± 0.031%), lactose concentration was higher compared to d 140 pp 
(4.72 ± 0.09%; P < 0.05; table 13). 
Before FR in early lactation, no differences of lactose content were observed within cows. In mp-
cows, milk lactose content declined from d 25 to 28 pp by 0.16%-points (P < 0.05), whereas in all 
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other cows, milk lactose content decreased numerically from d 26 to 28 and further to d 29 pp. At 
d 28 pp, mP-cows showed higher lactose content compared to mp-cows (4.60 ± 0.08 and 
4.86 ± 0.06% in mp- and mP-cows; P < 0.01). After FR, milk lactose content increased in all cows 
from d 29 to 30 pp (to 4.88 ± 0.04, 4.80 ± 0.06, 4.83 ± 0.06 and 4.94% in MP-, mp-, Mp- and mP-
cows; P < 0.001 for MP- and mp-cows, P < 0.05 for mP-cows and P < 0.1 for Mp-cows) and 
declined again to d 31 pp (4.77 ± 0.06 and 4.71 ± 0.05% in MP- and mp-cows, P < 0.05; 
4.76 ± 0.07 in Mp-cows, P < 0.01 and 4.88 ± 0.06% in mP-cows, P = 0.17). At all days after FR in 
early lactation, no differences within groups were observed. 
During all days of FR in mid-lactation no differences were proved to be significant within groups 
or days. Also numerically, milk lactose content stayed on similar levels throughout restrictive 
feeding.  
Milk lactose yield 
During both FRs, milk lactose yields showed numerically decreases during restricted feeding and 
higher lactose yields were observed in high yielding cows in FR during early lactation. 
In MP-, Mp- and mP-cows, milk lactose yields were higher at all days during early FR compared 
to respective days of FR in mid-lactation (P < 0.01), whereas milk lactose yields in mp-cows were 
higher solely at d 31 pp compared to d 146 pp (P < 0.05) and tended to be higher at the other days 
(P < 0.1; table 13). 
Regarding FR in early lactation, MP-cows (1,993 ± 82 g) showed lower milk lactose yields at 
d 25 pp compared to Mp- (2,250 ± 89 g; P < 0.05) and higher lactose yields compared to mP-cows 
(1,666 ± 53 g; P < 0.05). Furthermore, Mp-cows showed higher milk lactose yield compared to 
mp- (1,751 ± 42 g; P < 0.001) and mP-cows (P < 0.001). From d 25 to 28 pp, milk lactose yield 
decreased by 305 g in MP-cows (to 1,688 ± 53 g; P < 0.001), by 393 g in Mp-cows 
(to 1,857 ± 68 g; P < 0.001) and by 308 g in mp-cows (to 1,443 ± 91 g; P < 0.01). At d 28 pp, Mp-
cows showed higher milk lactose yield compared to mp- and mP-cows (1,480 ± 62 g; P < 0.01). 
After FR milk lactose yield increased from d 29 to 31 pp in MP-, mp- and Mp-cows (P < 0.05), 
whereas increasing levels from d 28 to 31 pp could be observed solely in MP-cows 
(to 1,965 ± 94 g; P < 0.01). At d 31 pp, high yielding MP- and Mp-cows (1,993 ± 115 g) showed 
higher milk lactose yields compared to low yielding cows (1,632 ± 70 g, P < 0.05 in mp- and 
1,588 ± 47 g, P < 0.01 in mP-cows). 
Before FR in mid-lactation, milk lactose yields at d 140 pp were higher in MP-cows 
(1,512 ± 122 g) compared to mP-cows (1,255 ± 103 g; P < 0.05) and in Mp- (1,783 ± 114 g) 
compared to mp- (1,494 ± 133 g; P < 0.05) and mP-cows (P < 0.001). During FR, milk lactose 
yields declined significantly from d 141 to 142 pp, resulting in significant decreases from d 140 to 
143 pp in MP-, mp-, and Mp-cows (to 1,307 ± 102, 1,214 ± 136 and 1,521 ± 109 g, respectively; 
P < 0.05). At d 143 pp, Mp-cows showed higher milk lactose yields compared to mp- (P < 0.05) 
and mP-cows (1,127 ± 87 g; P < 0.01). Furthermore after FR, milk lactose yields remained low 
and were higher in Mp- compared to mP-cows at d 146 pp (1,549 ± 84 and 1146 ± 100 g in Mp- 
and mP-cows; P < 0.01). 
Milk FPR 
In high yielding cows, FPR was found higher at days of early FR compared to those of FR in mid-
lactation (P < 0.001 in MP- and P < 0.05 in Mp-cows; table 13). 
Before FR in early lactation at d 25 pp, MP-cows (1.81 ± 0.22) showed higher FPR compared to 
Mp- (1.53 ± 0.10; P < 0.05) and mP-cows (1.46 ± 0.06; P < 0.05). During FR in early lactation, 
FPR increased numerically in all cows, but only increases from d 26 to 27 pp in high yielding 
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cows and from d 28 to 29 pp in MP-, mp- and mP-cows were proved to be significant (P < 0.05). 
At d 28 pp, all cows showed similar FPR. After FR, FPR increased further in all cows until 
d 29 pp, resulting in FPR increases of all cows from d 26 to 29 pp (P < 0.05) and decreased 
afterwards to d 30 pp (P < 0.05), showing similar levels to before FR. At d 31 pp, FPR was similar 
amongst cows. 
In FR during mid-lactation, all cows showed similar levels of FPR within days. Slight numerical 
increases were observed in all cows throughout period before, during FR and until d 144 pp. 
Afterwards, FPR decreased in all cows (P < 0.05) to levels similar before FR in mid-lactation. 
Milk SCC 
Milk SCC was similar during all days of FR in early and mid-lactation. Due to two animals with 
constantly elevated SCC and highest SCC at d 31 pp (5,642 and 1,468 × 1,000/mL), mP-cows 
showed overall highest SCC at d 31 pp (1,447.6 ± 1,084.4 × 1,000/mL) compared to d 146 pp 
(598.8 ± 486.7 × 1,000/mL; P < 0.05), d 25 pp (291.2 ± 245.1 × 1,000/mL; P < 0.001) and d 28 pp 
(300.8 ± 212.6 × 1,000/mL; P < 0.001), as well as compared to d 31 pp in MP- 
(40.7 ± 17.1 × 1,000/mL; P < 0.001), mp- (45.6 ± 16.3 × 1,000/mL; P < 0.001) and Mp-cows 
(268.7 ± 240.6 × 1,000/mL; P < 0.001; table 13). 
Additionally, SCC increased in one mp-cow after FR in mid-lactation from d 143 to 146 pp (from 
49 to 3,104 × 1,000/mL) and therefore increased in mp-cows (from 80.2 ± 31.9 to 
679.8 ± 606.3 × 1,000/mL; P < 0.05). 
Milk urea 
Amount of milk urea was lower during early FR in MP-cows at d 28 (154 ± 24 mg/L; P < 0.05) 
and 31 pp (164 ± 19 mg/L; P < 0.05), in mp-cows at d 28 pp (139 ± 19 mg/L; P < 0.05) and in Mp-
cows at d 31 pp (150 ± 17 mg/L; P < 0.01) compared to corresponding days of FR in mid-lactation 
(table 13). 
Milk hydrocortisone 
Although concentrations of milk hydrocortisone seemed to be lower during days of FR in early 
lactation compared to FR in mid-lactation and during days of restricted feeding compared to 
periods before and after those days, differences proved not to be significant (table 13). 
Milk BHBA 
During days of FR in early and mid-lactation, cows showed similar levels of milk BHBA (table 
13). At d 31 pp, mp-cows showed higher milk BHBA (61.3 ± 13.0 mg/L) compared to mP-cows 
(18.9 ± 14.1 mg/L; P < 0.05) and highest value during early FR (P < 0.05). Furthermore, milk 
BHBA in mp-cows was higher at d 31 compared to d 146 pp (27.4 ± 14.6 mg/L; P < 0.001). 
During FR in mid-lactation, milk BHBA in mp-cows declined from d 140 to 143 pp by 25.5 mg/L 
(to 13.8 ± 13.6 mg/L; P < 0.05). 
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Table 13: Mean milk parameters (LSM ± SE) at last day before (d 25 and 140 pp), last day 
during (d 28 and 143 pp) and last day after (d 31 and 146 pp) three days of feed restriction in 
early and mid-lactation. 
 MP mp Mp mP 
milk yield, kg 
d 25 pp 41.7 ± 1.1a*1 36.8 ± 0.6ac*1 46.7 ± 1.7b*1 33.7 ± 1.1c1 
d 28 pp 36.0 ± 1.0ab°1 31.3 ± 1.6ac°1 38.9 ± 1.3b°1 30.5 ± 1.4c1 
d 31 pp 41.1 ± 1.4a*1 34.6 ± 1.4b*°1 41.7 ± 1.9a°1 32.6 ± 1.2b1 
d 140 pp 32.1 ± 2.2ab* 31.2 ± 2.4ac* 37.0 ± 2.4b* 26.6 ± 2.0c 
d 143 pp 27.8 ± 2.0ab° 25.5 ± 2.5a° 31.6 ± 2.2b° 23.5 ± 1.7a 
d 146 pp 29.4 ± 2.4a*° 28.1 ± 2.2ab*° 32.6 ± 1.6a° 23.9 ± 1.8b 
FCM, kg 
d 25 pp 53.7 ± 4.1a*1 39.3 ± 1.7b 49.9 ± 1.9a*1 38.7 ± 1.1b1 
d 28 pp 46.4 ± 2.5a°1 36.7 ± 1.6b1 44.4 ± 1.9a°1 37.0 ± 2.2b1 
d 31 pp 52.3 ± 2.9a*1 39.0 ± 1.9b1 47.0 ± 1.9a*°1 37.9 ± 2.6b1 
d 140 pp 35.0 ± 1.6 33.1 ± 3.6 36.9 ± 2.7 31.7 ± 2.2 
d 143 pp 30.0 ± 2.6 27.7 ± 2.5 32.1 ± 1.6 28.2 ± 1.6 
d 146 pp 30.9 ± 1.7 28.0 ± 2.6 32.2 ± 1.5 25.9 ± 1.6 
ECM, kg 
d 25 pp 55.9 ± 3.6a*1 41.1 ± 1.4b 52.4 ± 1.9a*1 41.4 ± 1.2b1 
d 28 pp 47.7 ± 2.5a°1 38.0 ± 1.8b1 46.0 ± 1.8a°1 38.8 ± 2.3b1 
d 31 pp 53.8 ± 2.8a*1 40.3 ± 1.8b1 48.8 ± 1.6a*°1 39.7 ± 2.6b1 
d 140 pp 38.4 ± 1.6* 35.6 ± 3.6* 40.0 ± 2.8* 34.6 ± 2.0 
d 143 pp 32.5 ± 2.4° 29.5 ± 2.8° 34.3 ± 1.8° 30.5 ± 1.6 
d 146 pp 33.9 ± 1.6*° 30.5 ± 2.8*° 35.0 ± 1.6*° 28.8 ± 1.6 
milk protein content, % 
d 25 pp 3.28 ± 0.07a*1 2.83 ± 0.06b1 2.92 ± 0.06b1 3.42 ± 0.04a*1 
d 28 pp 3.10 ± 0.08ab°1 2.95 ± 0.12ab 2.90 ± 0.06a 3.22 ± 0.08b°1 
d 31 pp 3.06 ± 0.07ab°1 2.79 ± 0.10a1 2.88 ± 0.08ab1 3.11 ± 0.07b°1 
d 140 pp 3.66 ± 0.18a* 3.23 ± 0.07b 3.18 ± 0.06b 3.91 ± 0.14a 
d 143 pp 3.43 ± 0.20a° 3.15 ± 0.08b 3.06 ± 0.06b 3.80 ± 0.14c 
d 146 pp 3.58 ± 0.19a*° 3.26 ± 0.05b 3.17 ± 0.05b 3.87 ± 0.15a 
milk protein yield, g 
d 25 pp 1,373 ± 59a*1 1,043 ± 36b 1,365 ± 50a*1 1,153 ± 42b* 
d 28 pp 1,116 ± 55a°1 922 ± 56b 1,127 ± 38a°1 983 ± 58ab° 
d 31 pp 1,256 ± 57a*1 971 ± 66b 1,196 ± 39a°1 1,014 ± 51b*° 
d 140 pp 1,160 ± 41* 1,012 ± 91* 1,175 ± 79* 1,027 ± 44* 
d 143 pp 939 ± 27° 810 ± 98° 962 ± 62° 884 ± 34° 
d 146 pp 1,034 ± 44*° 917 ± 79*° 1,033 ± 57° 916 ± 35*° 
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 MP mp Mp mP 
milk fat content, % 
d 25 pp 5.93 ± 0.72a1 4.48 ± 0.36b 4.47 ± 0.2 b 4.99 ± 0.22 b 
d 28 pp 5.92 ± 0.32a1 5.18 ± 0.36ab 4.95 ± 0.3b 5.43 ± 0.28ab 
d 31 pp 5.80 ± 0.33a1 4.88 ± 0.46ab 4.93 ± 0.43b1 5.06 ± 0.26ab 
d 140 pp 4.69 ± 0.37ab 4.34 ± 0.40a 3.97 ± 0.11a 5.39 ± 0.62b 
d 143 pp 4.58 ± 0.62ab 4.60 ± 0.24ab 4.16 ± 0.14a 5.38 ± 0.26b 
d 146 pp 4.45 ± 0.38 3.94 ± 0.13 3.94 ± 0.15 4.59 ± 0.14 
milk fat yield, g 
d 25 pp 2,466 ± 274a*1 1,640 ± 118b 2,078 ± 108c1 1,678 ± 61b 
d 28 pp 2,135 ± 145a°1 1,611 ± 94b1 1,920 ± 114ab1 1,654 ± 116b1 
d 31 pp 2,389 ± 168a*°1 1,675 ± 129b1 2,023 ± 117c1 1,659 ± 142b1 
d 140 pp 1,479 ± 74 1,373 ± 186 1,471 ± 117 1,403 ± 134 
d 143 pp 1,259 ± 155 1,164 ± 106 1,295 ± 52 1,252 ± 70 
d 146 pp 1,277 ± 72 1,115 ± 116 1,277 ± 65 1,090 ± 64 
milk lactose content, % 
d 25 pp 4.77 ± 0.08 4.76 ± 0.05* 4.81 ± 0.04 4.94 ± 0.031 
d 28 pp 4.69 ± 0.04ab 4.60 ± 0.08a° 4.77 ± 0.06ab 4.86 ± 0.06b 
d 31 pp 4.77 ± 0.06 4.71 ± 0.05*° 4.76 ± 0.07 4.88 ± 0.06 
d 140 pp 4.70 ± 0.10 4.76 ± 0.07 4.82 ± 0.05 4.72 ± 0.09 
d 143 pp 4.69 ± 0.11 4.73 ± 0.09 4.82 ± 0.04 4.80 ± 0.06 
d 146 pp 4.76 ± 0.08 4.68 ± 0.09 4.75 ± 0.04 4.78 ± 0.08 
milk lactose yield, g 
d 25 pp 1,993 ± 82a*1 1,751 ± 42ac* 2,250 ± 89b*1 1,666 ± 53c1 
d 28 pp 1,688 ± 53ab°1 1,443 ± 91a° 1,857 ± 68b°1 1,480 ± 62a1 
d 31 pp 1,965 ± 94a*1 1,632 ± 70b*°1 1,993 ± 115a°1 1,588 ± 47b1 
d 140 pp 1,512 ± 122ab* 1,494 ± 133ac* 1,783 ± 114b* 1,255 ± 103c 
d 143 pp 1,307 ± 102ab° 1,214 ± 136a° 1,521 ± 109b° 1,127 ± 87a 
d 146 pp 1,403 ± 127ab*° 1,320 ± 123ab*° 1,549 ± 84a° 1,146 ± 100b 
FPR 
d 25 pp 1.81 ± 0.22a1 1.59 ± 0.14ab 1.53 ± 0.10b1 1.46 ± 0.06b 
d 28 pp 1.91 ± 0.081 1.76 ± 0.07 1.71 ± 0.111 1.68 ± 0.06 
d 31 pp 1.90 ± 0.111 1.76 ± 0.201 1.71 ± 0.141 1.63 ± 0.061 
d 140 pp 1.28 ± 0.06 1.35 ± 0.14 1.25 ± 0.03 1.38 ± 0.14 
d 143 pp 1.34 ± 0.16 1.47 ± 0.10 1.36 ± 0.04 1.42 ± 0.06 
d 146 pp 1.24 ± 0.08 1.21 ± 0.05 1.25 ± 0.06 1.19 ± 0.04 
milk SCC,  × 1,000/mL 
d 25 pp 28.5 ± 7.9 37.0 ± 6.7 24.3 ± 3.1 291.2 ± 245.1* 
d 28 pp 45.7 ± 15.4 163.6 ± 122.0 26.6 ± 2.2 300.8 ± 212.6* 
d 31 pp 40.7 ± 17.1a 45.6 ± 16.3a 268.7 ± 240.6a 1,447.6 ± 1,084.4b°1 
d 140 pp 54.8 ± 17.9 94.4 ± 45.2*° 125.1 ± 52.7 362.2 ± 146.8 
d 143 pp 54.2 ± 11.0 80.2 ± 31.9° 67.9 ± 12.4 441.4 ± 257.6 
d 146 pp 68.6 ± 36.7 679.8 ± 606.3* 68.9 ± 24.0 598.8 ± 486.7 
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 MP mp Mp mP 
milk pH 
d 25 pp 6.66 ± 0.05ab 6.60 ± 0.03a 6.68 ± 0.01b* 6.68 ± 0.03ab 
d 28 pp 6.66 ± 0.04a 6.58 ± 0.02b 6.67 ± 0.02a*1 6.67 ± 0.02a 
d 31 pp 6.66 ± 0.03a 6.58 ± 0.03b 6.61 ± 0.03ab° 6.67 ± 0.02a 
d 140 pp 6.61 ± 0.03 6.59 ± 0.03 6.63 ± 0.02 6.61 ± 0.02 
d 143 pp 6.60 ± 0.03ab 6.59 ± 0.01a 6.59 ± 0.03a 6.67 ± 0.02b 
d 146 pp 6.62 ± 0.02 6.61 ± 0.01 6.62 ± 0.02 6.64 ± 0.03 
milk urea, mg/L 
d 25 pp 185 ± 15 163 ± 24 175 ± 16 161 ± 10 
d 28 pp 154 ± 241 139 ± 191 154 ± 19 175 ± 13 
d 31 pp 164 ± 191 159 ± 26 150 ± 171 183 ± 22 
d 140 pp 210 ± 15 190 ± 26 200 ± 22 191 ± 21 
d 143 pp 220 ± 14 206 ± 21 201 ± 8 226 ± 18 
d 146 pp 228 ± 16 179 ± 23 224 ± 23 217 ± 22 
milk hydrocortisone, nmol/L 
d 25 pp 3.34 ± 0.79 2.61 ± 0.49 3.21 ± 0.55 4.01 ± 0.70 
d 28 pp 3.06 ± 0.27 3.49 ± 0.59 2.86 ± 0.29 4.13 ± 0.72 
d 31 pp 3.56 ± 0.70 3.39 ± 0.70 3.09 ± 0.59 3.66 ± 0.48 
d 140 pp 4.29 ± 0.85 3.34 ± 0.40 4.97 ± 0.53 3.20 ± 0.40 
d 143 pp 3.98 ± 0.88 2.99 ± 0.29 3.45 ± 0.52 3.23 ± 0.52 
d 146 pp 5.35 ± 0.77 3.80 ± 0.56 4.20 ± 0.77 4.83 ± 0.79 
milk BHBA, mg/L 
d 25 pp 26.5 ± 12.2 29.6 ± 13.7* 26.9 ± 12.3 13.9 ± 15.4 
d 28 pp 21.9 ± 13.3 21.3 ± 12.9* 29.6 ± 12.2 29.1 ± 14.4 
d 31 pp 27.7 ± 11.8ab 61.3 ± 13.0a°1 36.8 ± 12.4ab 18.9 ± 14.1b 
d 140 pp 41.4 ± 12.2 39.3 ± 12.6* 22.2 ± 11.6 17.1 ± 13.7 
d 143 pp 33.5 ± 13.1 13.8 ± 13.6° 26.3 ± 12.1 14.6 ± 14.8 
d 146 pp 26.4 ± 14.3 27.4 ± 14.6*° 28.1 ± 11.7 19.8 ± 15.1 
abcdAlphabetic superscripts indicate differences between groups (P < 0.05). 
*°#Symbolic superscripts indicate differences between days within a feed restriction 
(P < 0.05). 
1Superscripted 1 indicates difference (P < 0.05) of day in FR during early lactation (d 25, 
28 and 31 pp) compared to day of FR in mid-lactation (d 140, 143 and 146 pp, 
respectively). 
Fixed effects in model milk lactose content: time P < 0.001, group P = 0.22 and 
time × group P = 0.45. Fixed effects in model milk lactose yield: time P < 0.001, group 
P < 0.001 and time × group P = 0.87. Fixed effects in model FPR: time P < 0.001, group 
P = 0.14 and time × group P = 0.96. Fixed effects in model ECM: time P < 0.001, group 
P < 0.001 and time × group P = 0.84. Fixed effects in model SCC: time P = 0.11, group 
P = 0.04 and time × group P = 0.63. Fixed effects in model milk pH: time P < 0.01, group 
P = 0.08 and time × group P = 0.20. Fixed effects in model milk urea: time P < 0.001, 
group P = 0.67 and time × group P = 0.99. Fixed effects in model milk hydrocortisone: 
time P = 0.02, group P = 0.64 and time × group P = 0.96. Fixed effects in model milk 
BHBA: time P = 0.23, group P = 0.83 and time × group P = 0.34. 
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3.3. Blood serum metabolites 
Blood samples were collected in the morning before feeding, meaning that periods before 
restricted feeding are represented by samples at d 26 and 141 pp, days of restricted feeding by d 27 
to 29 and d 142 to 144 pp and periods after restricted feeding by samples at d 32 and 147 pp. 
Glucose 
In MP-cows, lower concentrations of blood serum glucose were observed at all days of FR in early 
lactation compared to mid-lactation (P < 0.05), whereas in mp- and Mp-cows blood serum glucose 
was lower solely at d 29 pp (2.49 ± 0.52 and 2.51 ± 0.18 mmol/L) compared to d 144 pp 
(3.53 ± 0.21 and 3.48 ± 0.09 mmol/L; P < 0.01; table 14, figure 33). 
Levels of blood serum glucose decreased in all cows from d 26 to 29 pp (by 0.7, 0.85, 0.99 and 
0.65 mmol/L in MP-, mp-, Mp- and mP-cows; P < 0.05) and in all cows except of mP-cows below 
critical values of 3.0 mmol/L. At d 29 pp, blood serum glucose was similar in all groups with MP- 
and mp-cows showing levels below value of 3.0 mmol/L. After FR, glucose levels increased until 
d 32 pp significantly in mp-, Mp- and mP-cows (by 1.35 in mp- and by 0.76 nmol/L in Mp- and 
mP-cows; P < 0.05) and increase tended to be significant in MP-cows (by 0.48 mmol/L; P < 0.1). 
At d 32 pp, all cows showed similar blood glucose levels. During days of restricted feeding in 
mid-lactation, glucose levels decreased numerically, but not below critical values and increased 
afterwards. Furthermore at d 147 pp, blood serum glucose levels were higher in MP-cows 
compared to Mp-cows (4.28 ± 0.20 and 3.61 ± 0.11; P < 0.05). 
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Figure 33: Blood serum glucose (mmol/L) during feed restrictions in early and mid-lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Grey shaded areas show days of restricted 
feeding. Values are presented as LSM ± SEM. Fixed effects in model glucose: time 
P < 0.001, group P = 0.24 and time × group P = 0.67. 
NEFA 
All cows showed higher blood serum NEFA levels during FR in early lactation compared to FR in 
mid-lactation (P < 0.05; table 14, figure 34).  
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Blood serum concentrations were similar amongst cows at all days during FR in early lactation. At 
d 26 pp, MP-cows showed levels above critical value of 600 µmol/L. In all cows, NEFA levels 
increased from d 26 to 28 pp above values of 600 µmol/L (to 1,238 ± 141, 1,241 ± 373, 
1,089 ± 143 and 1,064 ± 133 µmol/L in MP-, mp-, Mp- and mP-cows; P < 0.05) and decreased 
until last day of restricted feeding in MP-, mp- and mP-cows by 280, 233 and 322 µmol/L 
(P < 0.05). Only Mp-cows showed increasing blood serum NEFA levels from d 26 
(491 ± 37 µmol/L) to 29 pp (1,091 ± 147 µmol/L; P < 0.001). After days of restricted feeding, 
NEFA levels decreased in Mp- (to 499 ± 60 µmol/L; P < 0.001) and mP-cows (455 ± 57 µmol/L; 
P = 0.05). Levels of NEFA in MP-cows remained still above critical value after FR 
(804 ± 181 µmol/L).  
Concentrations of NEFA increased in all cows during days of restricted feeding in mid-lactation 
and decreased afterwards, but difference proved not to be significant. No increase above critical 
value was measured. 
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Figure 34: Blood serum NEFA (µmol/L) during feed restrictions in early and mid-lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Grey shaded areas show days of restricted 
feeding. Values are presented as LSM ± SEM. Fixed effects in model NEFA: time 
P < 0.001, group P = 0.70 and time × group P = 0.97. 
BHBA 
Compared to respective days of FR in mid-lactation, all cows showed higher levels of blood serum 
BHBA at last day of restricted feeding in early lactation (P < 0.001) and high yielding cows 
showed still higher levels after FR in early lactation (P < 0.05; table 14, figure 35). 
At all days of FR in early lactation, levels of blood serum BHBA were comparable amongst cows. 
From d 26 to 29 pp, concentrations of BHBA increased markedly in all cows above threshold 
values of 1.0 mmol/L (by 1.95, 1.50, 2.17 and 1.78 mmol/L in  MP-, mp-, Mp- and mP-cows; 
P < 0.001). Afterwards, BHBA levels decreased in all cows, but only in mP-cows below threshold 
value of 1.0 mmol/L (P < 0.01). 
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During FR in mid-lactation, no increase of blood serum BHBA levels was measured. 
day relative to parturition
23 25 27 29 31 138 140 142 144 146 148
bl
oo
d 
se
ru
m
 B
H
B
A
 [
m
m
ol
/L
]
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
Figure 35: Blood serum BHBA (mmol/L) during feed restrictions in early and mid-lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Grey shaded areas show days of restricted 
feeding. Values are presented as LSM ± SEM. Fixed effects in model BHBA: time 
P < 0.001, group P = 0.56 and time × group P = 0.99. 
Cholesterol 
Blood serum cholesterol concentrations in high yielding cows were lower during early FR 
compared to second FR (P < 0.05), whereas mp-cows showed lower levels of blood serum 
cholesterol concentrations at d 26 and 29 pp (P < 0.05) and mP-cows at d 26 pp (P < 0.05; 
table 14, figure 36). 
At all days of FR in early lactation, cholesterol levels were similar amongst cows. During 
restricted feeding, levels of blood serum cholesterol increased in MP-cows by 0.40 mmol/L 
(P < 0.05) and remained on similar levels afterwards.  
Regarding FR in mid-lactation, one Mp-cow showed extremely high blood cholesterol 
concentrations at d 141 pp (12.30 mmol/L), resulting in significant higher values of Mp-cows 
(6.49 ± 1.04 mmol/L; P < 0.01). During days of restricted feeding, cholesterol levels remained on 
similar levels and afterwards, Mp-cows showed higher levels at d 144 pp compared to mp- and 
mP-cows (P < 0.05). After days of restricted feeding, blood serum cholesterol concentrations 
decreased in low protein cows (P < 0.05). At d 147 pp, concentrations of blood serum cholesterol 
were higher in Mp-cows compared to mp- and mP-cows (P < 0.05). Additionally MP-cows 
showed higher blood serum cholesterol levels compared to mp-cows (P < 0.05). 
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Figure 36: Blood serum cholesterol (mmol/L) during feed restrictions in early and mid-
lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Grey shaded areas show days of restricted 
feeding. Values are presented as LSM ± SEM. Fixed effects in model cholesterol: time 
P < 0.001, group P < 0.05 and time × group P < 0.05.  
Total bilirubin 
Levels of blood serum tBR showed no distinguishable pattern and no differences between groups 
(table 14). 
 
Table 14: Mean blood parameters (LSM ± SE) before, during and after three days of feed 
restriction in early and mid-lactation. 
 MP mp Mp mP 
blood serum glucose, mmol/L 
d 26 pp 3.63 ± 0.11*1 3.34 ± 0.24* 3.50 ± 0.30* 3.81 ± 0.14* 
d 29 pp 2.93 ± 0.24°1 2.49 ± 0.52°1 2.51 ± 0.18°1 3.16 ± 0.45° 
d 32 pp 3.41 ± 0.26*°1 3.84 ± 0.42* 3.27 ± 0.25* 3.92 ± 0.17* 
d 141 pp 4.28 ± 0.23 3.77 ± 0.16 3.73 ± 0.15 3.81 ± 0.14 
d 144 pp 3.96 ± 0.05 3.53 ± 0.21 3.48 ± 0.09 3.73 ± 0.23 
d 147 pp 4.28 ± 0.20a 3.81 ± 0.16ab 3.61 ± 0.11b 3.97 ± 0.07ab 
blood serum NEFA, µmol/L 
d 26 pp 730 ± 1551 746 ± 2381 491 ± 37*1 491 ± 66*°1 
d 29 pp 958 ± 1991 1,008 ± 4611 1,091 ± 147°1 742 ± 206*1 
d 32 pp 804 ± 1811 591 ± 1961 499 ± 60*1 455 ± 57°1 
d 141 pp 115 ± 13 166 ± 51 93 ± 11 80 ± 9 
d 144 pp 260 ± 28 496 ± 212 322 ± 50 228 ± 66 
d 147 pp 106 ± 25 101 ± 20 128 ± 20 77 ± 5 
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 MP mp Mp mP 
blood serum BHBA, mmol/L 
d 26 pp 0.54 ± 0.06* 1.12 ± 0.42* 0.52 ± 0.03* 0.48 ± 0.05* 
d 29 pp 2.49 ± 0.59°1 2.62 ± 0.74°1 2.69 ± 0.52°1 2.26 ± 0.49°1 
d 32 pp 1.47 ± 0.67#1 1.14 ± 0.42* 1.40 ± 0.66#1 0.62 ± 0.14* 
d 141 pp 0.35 ± 0.02 0.41 ± 0.03 0.44 ± 0.06 0.36 ± 0.03 
d 144 pp 0.39 ± 0.06 0.59 ± 0.04 0.61 ± 0.08 0.51 ± 0.12 
d 147 pp 0.39 ± 0.07 0.52 ± 0.07 0.41 ± 0.04 0.52 ± 0.06 
blood serum cholesterol, mmol/L 
d 26 pp 3.30 ± 0.28*1 3.41 ± 0.131 4.04 ± 0.291 3.38 ± 0.341 
d 29 pp 3.70 ± 0.24°1 3.74 ± 0.131 4.26 ± 0.311 3.58 ± 0.40 
d 32 pp 3.88 ± 0.38°1 3.91 ± 0.27 4.34 ± 0.281 3.89 ± 0.53 
d 141 pp 4.90 ± 0.55a 4.43 ± 0.31a*° 6.49 ± 1.04b* 4.32 ± 0.42a 
d 144 pp 5.51 ± 0.75ab 4.61 ± 0.38a* 6.01 ± 0.53b* 4.63 ± 0.46a 
d 147 pp 5.16 ± 0.72ac 4.28 ± 0.28b° 5.50 ± 0.35c° 4.19 ± 0.51ab 
blood serum total bilirubin, µmol/L 
d 26 pp 5.60 ± 0.98 6.46 ± 1.77 4.97 ± 0.78 3.99 ± 0.48 
d 29 pp 4.18 ± 0.59 7.56 ± 1.97 6.03 ± 0.66 5.73 ± 1.03 
d 32 pp 5.57 ± 0.83 3.20 ± 0.38 4.46 ± 0.63 4.06 ± 0.76 
d 141 pp 2.54 ± 0.29 3.22 ± 0.83 2.10 ± 0.31 3.11 ± 0.32 
d 144 pp 3.49 ± 0.32 5.64 ± 1.42 2.97 ± 0.45 3.57 ± 0.55 
d 147 pp 3.23 ± 0.61 2.39 ± 0.40 2.83 ± 0.39 3.30 ± 0.50 
abcdAlphabetic superscripts indicate differences between groups (P < 0.05). 
*°#Symbolic superscripts indicate differences between days within a feed restriction 
(P < 0.05). 
1Superscripted 1 indicates difference (P < 0.05) of day in early lactation feed restriction 
(d 25, 28 and 31 pp) compared to day in mid-lactation feed restriction (d 140, 143 and 
146 pp, respectively). 
Fixed effects in model bilirubin: time P < 0.05, group P = 0.77 and time × group P = 0.74. 
3.4. Hepatic mRNA profiles 
No differences between FR in early and mid-lactation or between groups within a FR were found 
in mRNA abundance of ACACA, CPT1A, INSR, HMGCS2, EIF4B, PPARA, SREBF1, CS and 
TNFA (table 15). 
Lipid metabolism 
Concerning β-oxidation of fatty acids, hepatic mRNA levels of ACADVL were higher in MP- and 
Mp-cows after early FR (14.13 ± 0.21 and 14.09 ± 0.21 in MP- and Mp-cows) compared to second 
FR (in MP-cows 13.36 ± 0.17, P < 0.05; in Mp-cows 13.57 ± 0.13, P < 0.05). Furthermore, 
transcript abundance increased in mp-cows from d 15 to 29 pp (13.09 ± 0.19 to 13.63 ± 0.15; 
P < 0.05) and decreased from d 29 to 57 pp in Mp- (14.09 ± 0.21 to 13.59 ± 0.17; P < 0.05) and 
mP-cows (14.05 ± 0.23 to 13.00 ± 0.21; P < 0.001). 
Although in β-oxidation no differences were observed for CPT1A transcripts, mp-cows showed 
higher levels in early FR compared to d 15 pp (12.71 ± 0.25 and 13.62 ± 0.16 at d 15 and 29 pp; 
P < 0.05). 
Furthermore Mp-cows showed in β-oxidation higher mRNA abundance of ECHS1 at d 29 pp 
compared to mp-cows (15.93 ± 0.19 and 15.22 ± 0.28 in Mp- and mp-cows; P < 0.05), whereas at 
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d 144 pp MP- (15.74 ± 0.30) and Mp-cows (15.64 ± 0.11) expressed higher hepatic mRNA levels 
compared to mp-cows (14.63 ± 0.56; P < 0.05). Moreover, Mp-cows showed elevated transcript 
abundance after early FR compared to d 15 pp (15.47 ± 0.17; P < 0.05). Second FR led in mp-
cows to increased mRNA levels of ECHS1 compared to d 57 pp (15.51 ± 0.13; P < 0.01). 
Additionally in Mp- and mP-cows, transcript abundance decreased after FR in mid-lactation to day 
of slaughtering (14.60 ± 0.16 and 14.93 ± 0.19 in Mp- and mP-cows; P < 0.05). 
Regarding fatty acid synthesis, transcript abundance of ACACA was lower in MP- (8.68 ± 0.90) 
and mp-cows (8.98 ± 0.31) in early FR compared to d 57 pp (9.41 ± 0.74 and 10.48 ± 0.74 in MP- 
and mp-cows; P < 0.05; table 15). In MP-cows, mRNA levels declined during FR in mid-lactation 
(9.41 ± 0.74 at d 57 pp and 8.77 ± 1.38 at d 144 pp; P < 0.05). Furthermore, Mp-cows showed 
higher transcript levels during second FR compared to day of slaughtering (9.39 ± 0.50 and 
6.54 ± 0.61; P < 0.01). 
Furthermore, mRNA levels of GPAM, encoding for the enzyme of triacylglycerol synthesis’ initial 
step, were higher in early FR in Mp-cows (12.67 ± 0.23) compared to MP- (11.41 ± 0.64; 
P < 0.05) and mp-cows (11.88 ± 0.26; P < 0.05). Furthermore, mRNA levels were higher in Mp- 
and mP-cows in second FR compared to day of slaughtering (10.93 ± 0.30 and 10.34 ± 0.31 at 
d 155 pp in Mp- and mP-cows; P < 0.001) 
Protein metabolism 
Regarding protein catabolism, hepatic transcript abundance of CTSL was lowest at d 144 pp in 
MP-cows (15.01 ± 0.62; P < 0.05; table 15). Furthermore, Mp-cows showed higher mRNA levels 
during early FR compared to d 15 pp (15.41 ± 0.19; P < 0.01) and in all cows except of MP-cows, 
hepatic transcript abundance of CTSL decreased after second FR to 14.44 ± 0.28 in mp- 
(P < 0.001), 14.95 ± 0.24 in Mp- (P < 0.01) and 14.93 ± 0.25 in mP-cows (P < 0.001) at day of 
slaughtering. 
Furthermore hepatic mRNA levels of TAT were higher in Mp-cows compared to mp-cows at 
d 29 pp (16.54 ± 0.23 and 15.68 ± 0.31 in Mp- and mp-cows; P < 0.05) and Mp-cows showed 
higher mRNA abundance after early FR compared to second FR (15.60 ± 0.24; P < 0.05). In Mp-
cows, mRNA encoding for TAT increased from d 15 to 29 pp (by 1.00; P < 0.01) and decreased to 
d 57 pp (15.81 ± 0.26 P < 0.05). Additionally, mP-cows showed lower mRNA levels during FR in 
mid-lactation compared to day of slaughtering (16.59 ± 0.32; P < 0.05). 
Carbohydrate metabolism 
Regarding gluconeogenesis, Mp- and mP-cows expressed higher hepatic mRNA abundance of PC 
at d 29 pp (11.24 ± 0.27 and 10.47 ± 0.80 in Mp- and mP-cows) compared to d 144 pp 
(9.84 ± 0.69 and 8.72 ± 0.85 in Mp- and mP-cows; P < 0.05; table 15). In high yielding and in mP-
cows, mRNA levels of PC were higher in early FR compared to d 57 (7.61 ± 0.76, 9.96 ± 0.63 and 
8.31 ± 0.77 in MP-, Mp- and mP-cows; P < 0.05). 
Moreover transcript abundance of PCK1 at d 144 pp was higher in Mp- (17.19 ± 0.41) compared 
to MP-cows (15.51 ± 0.60; P < 0.05). Furthermore, lower mRNA levels were observed in MP-
cows during early FR compared to d 57 pp (17.40 ± 0.62; P < 0.05) and higher transcript 
abundance occurred in second FR compared to day of slaughtering in Mp- (15.15 ± 0.72) and mP-
cows (15.11 ± 0.62; P < 0.05). 
Glucose metabolism and ketogenesis 
Hepatic transcript abundance of SLC2A2, encoding for glucose transporter, decreased in mp-cows 
from d 57 to 144 pp (from 14.21 ± 0.40 to 12.84 ± 0.57; P < 0.05) and then was higher compared 
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to Mp-cows (13.98 ± 0.16; P < 0.05; table 15). Afterwards, mRNA levels declined in Mp-cows 
and lower levels were observed at day of slaughtering (P < 0.001). 
Hepatic mRNA levels of INSR increased in Mp-cows from d 15 pp to FR in early lactation and 
declined afterwards (11.84 ± 0.16, 12.45 ± 0.33 and 11.90 ± 0.17 at d 15, 29 and 57 pp; P < 0.05). 
Also FR in mid-lactation led to decreasing mRNA levels in mp-cows compared to d 57 pp 
(12.11 ± 0.21; P < 0.05). 
For ketogenesis, mRNA levels of HMGCS2 were measured and showed higher levels in Mp-cows 
during FRs (16.10 ± 0.57 and 15.07 ± 0.75 at d 29 and 144 pp) compared to following sampling 
time points (14.40 ± 0.49 at d 57 pp and 13.21 ± 0.58 at d 155 pp; P < 0.01). 
Translation and transcription factors 
Transcript abundance of translation factor EIF4B showed in MP-cows higher levels at d 144 pp 
(15.14 ± 0.57) compared to d 155 pp (14.23 ± 0.33; P < 0.05; table 15). Furthermore Mp-cows 
showed higher mRNA abundance of transcription factor HNF4A at d 29 pp (14.15 ± 0.37) 
compared to d 144 pp (12.96 ± 0.32; P < 0.05). 
Abundance of mRNA encoding for transcription factor PPARA showed in MP-cows lower levels 
during FR in mid-lactation (12.99 ± 0.65) compared to d 57 (13.90 ± 0.20; P < 0.01) and 155 pp 
(13.80 ± 0.20; P < 0.05). Also hepatic mRNA levels of SREBF1 showed in mP-cows lower 
amounts during FR in early lactation (7.05 ± 0.49) compared to d 15 and 57 pp (8.19 ± 0.53 and 
7.99 ± 0.53; P < 0.05). In mp-cows, transcript abundance was lower during FR in early lactation 
compared to d 57 pp (8.95 ± 0.52; P < 0.01). After FR in mid-lactation, hepatic mRNA abundance 
of SREBF1 increased in Mp- and mP-cows to d 155 pp (to 9.24 ± 0.50 and 8.72 ± 0.52; P < 0.01). 
Common hepatic metabolism 
In mP-cows, hepatic mRNA abundance of CS showed lower levels during FR in mid-lactation 
compared to d 57 and 155 pp (10.53 ± 0.34, 7.90 ± 2.47 and 10.07 ± 0.34 at d 57, 144 and 155 pp; 
P < 0.05; table 15). 
Hepatic levels of mRNA encoding for TNFA showed no differences amongst cows, FRs or days of 
lactation. 
Hepatic mRNA abundance of IGF1 was lower at d 29 compared to 144 pp in low yielding cows 
(10.83 ± 0.25 and 12.45 ± 0.50 in mp-cows, P < 0.05; 11.29 ± 0.90 and 13.12 ± 0.58 in mP-cows, 
P < 0.05). Furthermore, mRNA levels of IGF1 declined in low yielding cows from d 15 to 29 pp 
(by 1.05 and 1.22 to 10.83 ± 0.25 and 11.29 ± 0.90 in mp- and mP-cows; P < 0.05) and increased 
again to d 57 pp (13.00 ± 0.41 and 13.32 ± 0.42 in mp- and mP-cows; P < 0.001). In Mp-cows, 
transcript abundance of IGF1 decreased after FR in mid-lactation to 11.72 ± 0.41 at day of 
slaughtering (P < 0.05). 
 
 
Table 15: mRNA abundance (LSM ± SE of 15-ΔCt) after three days of feed restriction in 
early (d 29 pp) and mid-lactation (d 144 pp). 
 MP mp Mp mP 
Lipid metabolism 
ACACA     
d 29 pp 8.68 ± 0.90 8.98 ± 0.31 9.48 ± 0.46 8.91 ± 0.68 
d 144 pp 8.77 ± 1.38 9.76 ± 0.80 9.39 ± 0.50 9.12 ± 0.24 
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 MP mp Mp mP 
ACADVL     
d 29 pp 14.13 ± 0.21* 13.63 ± 0.15 14.09 ± 0.21* 14.05 ± 0.23 
d 144 pp 13.36 ± 0.17 13.31 ± 0.12 13.57 ± 0.13 13.51 ± 0.19 
CPT1A     
d 29 pp 13.52 ± 0.36 13.62 ± 0.16 14.04 ± 0.18 13.76 ± 0.41 
d 144 pp 12.97 ± 0.65 13.07 ± 0.34 13.53 ± 0.10 12.89 ± 0.28 
ECHS1     
d 29 pp 15.84 ± 0.25ab 15.22 ± 0.28a 15.93 ± 0.19b 15.50 ± 0.22ab 
d 144 pp 15.74 ± 0.30b 14.63 ± 0.56a 15.64 ± 0.11b 15.47 ± 0.14ab 
GPAM     
d 29 pp 11.41 ± 0.64a 11.88 ± 0.26a 12.67 ± 0.23b 12.27 ± 0.22ab 
d 144 pp 11.91 ± 0.15 11.79 ± 0.44 12.29 ± 0.16 12.42 ± 0.33 
Protein metabolism 
CTSL     
d 29 pp 15.40 ± 0.29 16.09 ± 0.24 16.07 ± 0.21 15.73 ± 0.07 
d 144 pp 15.01 ± 0.62a 16.31 ± 0.12b 16.03 ± 0.25b 16.11 ± 0.35b 
TAT     
d 29 pp 15.99 ± 0.69ab 15.68 ± 0.31a 16.54 ± 0.23b* 15.92 ± 0.41ab 
d 144 pp 16.02 ± 0.24 15.16 ± 0.16 15.60 ± 0.24 15.56 ± 0.28 
Carbohydrate metabolism 
PC     
d 29 pp 10.32 ± 0.37 10.35 ± 0.47 11.24 ± 0.27* 10.47 ± 0.80* 
d 144 pp 8.54 ± 0.69 8.83 ± 0.38 9.84 ± 0.69 8.72 ± 0.85 
PCK1     
d 29 pp 16.53 ± 0.59 16.56 ± 0.47 16.58 ± 0.46 16.03 ± 0.29 
d 144 pp 15.51 ± 0.60a 15.98 ± 0.70ab 17.19 ± 0.41b 17.03 ± 0.21ab 
Glucose transport 
SLC2A2     
d 29 pp 13.22 ± 0.42 13.25 ± 0.30 13.70 ± 0.19 13.10 ± 0.63 
d 144 pp 12.85 ± 0.13ab 12.84 ± 0.57a 13.98 ± 0.16b 13.62 ± 0.24ab 
Hormone receptor 
INSR     
d 29 pp 11.71 ± 0.19 11.93 ± 0.13 12.45 ± 0.33 12.10 ± 0.31 
d 144 pp 11.85 ± 0.24 11.45 ± 0.42 11.87 ± 0.13 11.90 ± 0.21 
Ketogenesis 
HMGCS2     
d 29 pp 14.86 ± 1.63 15.57 ± 0.56 16.10 ± 0.57 16.56 ± 1.03 
d 144 pp 14.84 ± 1.20 15.78 ± 0.92 15.07 ± 0.75 14.65 ± 0.64 
Translation 
EIF4B     
d 29 pp 14.75 ± 0.57 14.25 ± 0.21 14.92 ± 0.51 14.58 ± 0.56 
d 144 pp 15.14 ± 0.57 13.76 ± 0.11 14.33 ± 0.14 14.70 ± 0.42 
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 MP mp Mp mP 
Transcription regulation 
HNF4A     
d 29 pp 13.58 ± 0.27 13.26 ± 0.24 14.15 ± 0.37* 13.91 ± 0.70 
d 144 pp 13.46 ± 0.32 12.74 ± 0.07 12.96 ± 0.32 13.04 ± 0.29 
PPARA     
d 29 pp 13.75 ± 0.24 13.58 ± 0.20 13.99 ± 0.28 13.74 ± 0.30 
d 144 pp 12.99 ± 0.65 13.31 ± 0.32 13.71 ± 0.22 13.99 ± 0.11 
SREBF1     
d 29 pp 7.78 ± 0.14 7.10 ± 0.53 8.28 ± 0.29 7.05 ± 0.49 
d 144 pp 8.15 ± 0.14 8.04 ± 0.44 7.64 ± 0.57 7.22 ± 0.33 
Final metabolism 
CS     
d 29 pp 10.32 ± 0.07 9.73 ± 0.65 10.60 ± 0.17 11.08 ± 0.25 
d 144 pp 10.32 ± 0.47 10.02 ± 0.76 9.82 ± 0.86 7.90 ± 2.47 
Inflammation 
TNFA     
d 29 pp 8.35 ± 0.41 7.63 ± 0.16 8.21 ± 0.35 7.80 ± 0.51 
d 144 pp 7.66 ± 0.53 7.45 ± 0.11 7.55 ± 0.18 7.42 ± 0.10 
Anabolism 
IGF1     
d 29 pp 11.59 ± 0.48 10.83 ± 0.25* 11.87 ± 0.30 11.29 ± 0.90* 
d 144 pp 13.35 ± 0.09 12.45 ± 0.50 12.91 ± 0.26 13.12 ± 0.58 
abMeans with alphabetic superscripts indicate differences between groups (P < 0.05). 
*Asterisks indicate differences between FR in early and mid-lactation (P < 0.05). 
Fixed effects in model ACACA: time P = 0.58, group P = 0.61, time × group P = 0.92. 
Fixed effects in model ACADVL: time P < 0.01, group P = 0.27, time × group P = 0.75. 
Fixed effects in model CPT1A: time P < 0.05, group P = 0.19, time × group P = 0.92. Fixed 
effects in model CS: time P = 0.30, group P = 0.89, time × group P = 0.47. Fixed effects in 
model CTSL: time P = 0.84, group P < 0.05, time × group P = 0.67. Fixed effects in model 
ECHS1: time P = 0.24, group P < 0.05, time × group P = 0.79. Fixed effects in model 
EIF4B: time P = 0.58, group P = 0.09, time × group P = 0.96. Fixed effects in model 
GPAM: time P = 0.78, group P = 0.21, time × group P = 0.42. Fixed effects in model 
HMGCS2: time P = 0.18, group P = 0.98, time × group P = 0.30. Fixed effects in model 
HNF4A: time P = 0.03, group P = 0.41, time × group P = 0.58. Fixed effects in model 
IGF1: time P < 0.001, group P = 0.39, time × group P = 0.78. Fixed effects in model INSR: 
time P = 0.16, group P = 0.71, time × group P = 0.79. Fixed effects in model PC: time 
P < 0.01, group P = 0.26, time × group P = 0.98. Fixed effects in model PCK1: time 
P = 0.99, group P = 0.37, time × group P = 0.20. Fixed effects in model PPARA: time 
P = 0.27, group P = 0.22, time × group P = 0.59. Fixed effects in model SLC2A2: time 
P = 0.98, group P = 0.13, time × group P = 0.42. Fixed effects in model SREBF1: time 
P = 0.52, group P = 0.31, time × group P = 0.29. Fixed effects in model TAT: time 
P = 0.07, group P = 0.18, time × group P = 0.50. Fixed effects in model TNFA: time 
P = 0.09, group P = 0.30, time × group P = 0.89.  
4. Intravenous glucose tolerance tests 
Because of technical and biological reasons, cows were subjected to ivGTTs at d 13.8 ± 2.1 ap, 
d 19.7 ± 0.2 and 127.1 ± 0.6 pp (table 16). Furthermore, mP-cows had first ivGTT earlier than 
other cows (d 12.6 ± 1.3, 12.2 ± 1.9, 10.3 ± 1.0 and 20.0 ± 3.0 ap for MP-, mp-, Mp- and mP-
cows; P < 0.01) due to longer gestation length compared to other cows (278.2 ± 1.0, 278.2 ± 2.6, 
277.4 ± 1.6 and 284.8 ± 1.0 days in MP-, mp-, Mp- and mP-cows; P < 0.05). Amounts of infused 
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glucose depended on actual body weight and differed between all time points in MP-cows 
(P < 0.01) and between ivGTT 1 and 2 in mp-, Mp- and mP-cows (P < 0.001), but not between 
groups at the same time point (table 16). Time of glucose infusion averaged 4.4 ± 0.2 minutes. 
 
Table 16: Test day, blood glucose and blood plasma insulin parameters (LSM ± SEM) of 
ivGTTs at wk 2 ap, wk 3 and 19 pp. 
 MP mp Mp mP 
Day of test, pp 
ivGTT 1 -12.6 ± 1.3a* -12.2 ± 1.9a* -10.3 ± 1.0a* -20.0 ± 3.0b* 
ivGTT 2 20.2 ± 0.3° 19.6 ± 0.5° 19.1 ± 0.3° 20.0 ± 0.3° 
ivGTT 3 127.8 ± 1.3# 125.2 ± 2.6# 127.4 ± 0.4# 127.8 ± 1.2# 
Body weight, kg 
ivGTT 1 802.4 ± 30.0* 768.0 ± 52.4* 761.0 ± 23.7* 773.5 ± 46.3* 
ivGTT 2 709.0 ± 20.8° 646.8 ± 33.0° 654.0 ± 24.7° 704.2 ± 24.3° 
ivGTT 3 648.4 ± 10.4# 630.4 ± 46.4° 626.6 ± 20.6° 702.8 ± 26.2° 
Infused glucose, g 
ivGTT 1 150.7 ± 4.2* 145.6 ± 7.5* 144.8 ± 3.4* 146.5 ± 6.6* 
ivGTT 2 137.3 ± 3.0° 128.1 ± 4.9° 129.2 ± 3.7° 136.6 ± 3.5° 
ivGTT 3 128.5 ± 1.5# 125.6 ± 7.0° 125.2 ± 3.1° 136.4 ± 3.8° 
Basal blood glucose, mmol/L 
ivGTT 1 2.81 ± 0.19* 2.57 ± 0.06* 2.57 ± 0.12* 2.73 ± 0.13* 
ivGTT 2 2.29 ± 0.13a° 1.81 ± 0.17b° 1.68 ± 0.11b° 2.38 ± 0.14a° 
ivGTT 3 2.58 ± 0.12*° 2.48 ± 0.12* 2.39 ± 0.08* 2.55 ± 0.10*° 
Maximum blood glucose, mmol/L 
ivGTT 1 11.42 ± 0.61* 10.15 ± 0.42* 10.32 ± 0.49* 10.10 ± 0.62*° 
ivGTT 2 9.98 ± 0.37a° 8.43 ± 0.26b° 8.72 ± 0.22b° 9.10 ± 0.29ab* 
ivGTT 3 9.21 ± 0.25# 9.96 ± 0.47* 9.60 ± 0.29* 9.96 ± 0.39° 
Increase of blood glucose, mmol/L 
ivGTT 1 8.67 ± 0.52* 7.48 ± 0.41*° 7.75 ± 0.42 7.55 ± 0.53 
ivGTT 2 7.94 ± 0.35a* 6.71 ± 0.27b* 7.20 ± 0.23ab 6.92 ± 0.29b 
ivGTT 3 6.79 ± 0.26a° 7.63 ± 0.40ab° 7.22 ± 0.28ab 7.77 ± 0.37b 
Reaching basal glucose level again, minute 
ivGTT 1 99.0 ± 9.7a* 73.2 ± 7.1b 84.4 ± 7.6ab* 73.3 ± 13.6b 
ivGTT 2 59.2 ± 4.9° 59.8 ± 7.5 68.9 ± 6.7° 56.4 ± 2.9 
ivGTT 3 57.4 ± 3.0° 62.8 ± 5.9 56.1 ± 8.1° 53.8 ± 5.7 
Steepest decrease of glucose, mmol/L per minute 
ivGTT 1 1.67 ± 0.76 1.00 ± 0.31* 0.97 ± 0.22 1.81 ± 1.00 
ivGTT 2 0.93 ± 0.16a 3.16 ± 2.37b° 0.73 ± 0.17a 0.87 ± 0.35a 
ivGTT 3 0.59 ± 0.06 0.56 ± 0.06* 0.63 ± 0.08 0.55 ± 0.14 
Time point of steepest glucose level decrease, minute 
ivGTT 1 5.20 ± 1.20 4.00 ± 0.00 4.00 ± 0.00* 5.50 ± 0.96 
ivGTT 2 4.67 ± 0.42ab 5.60 ± 0.98ab 4.00 ± 0.00a* 6.80 ± 1.96b 
ivGTT 3 4.40 ± 0.40a 5.20 ± 0.80ab 6.86 ± 1.06b° 5.60 ± 0.75ab 
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 MP mp Mp mP 
Basal blood plasma insulin, µU/mL 
ivGTT 1 32.29 ± 12.12ab* 29.28 ± 5.66ab* 19.24 ± 3.77a* 39.58 ± 19.97b* 
ivGTT 2 4.40 ± 1.42° 2.65 ± 0.38° 2.58 ± 0.23° 6.03 ± 2.36° 
ivGTT 3 13.55 ± 2.33° 11.32 ± 2.03° 7.47 ± 1.12*° 12.22 ± 3.19° 
Maximum blood plasma insulin, µU/mL 
ivGTT 1 411.7 ± 114.6ab* 443.7 ± 113.3ab* 298.5 ± 99.1a 642.8 ± 388.8b* 
ivGTT 2 121.4 ± 16.8° 111.9 ± 17.3° 87.6 ± 18.9 194.3 ± 38.8° 
ivGTT 3 180.2 ± 54.4*° 147.7 ± 27.8° 97.1 ± 15.4 175.5 ± 38.1° 
Increase of blood plasma insulin, µU/mL 
ivGTT 1 379.4 ± 104.4ab 414.4 ± 111.5ab* 279.2 ± 96.8a 603.2 ± 369.0b* 
ivGTT 2 117.0 ± 15.7 109.2 ± 17.3° 85.0 ± 18.9 188.3 ± 37.4° 
ivGTT 3 166.6 ± 52.2 136.3 ± 29.0° 89.7 ± 14.4 163.3 ± 36.7° 
Reaching basal insulin level again, minute 
ivGTT 1 96.2 ± 6.4* 83.2 ± 7.2 88.0 ± 5.1* 82.0 ± 9.9 
ivGTT 2 87.6 ± 9.7* 78.6 ± 5.3 75.6 ± 8.0*° 80.0 ± 5.7 
ivGTT 3 64.6 ± 5.6° 78.2 ± 6.4 64.0 ± 4.5° 72.2 ± 7.3 
Steepest increase of blood plasma insulin, µU/mL per minute 
ivGTT 1 54.72 ± 17.67ab* 44.69 ± 12.94ab 31.50 ± 15.18a 72.39 ± 36.46b* 
ivGTT 2 21.18 ± 5.00° 17.97 ± 2.90 12.27 ± 3.54 28.14 ± 6.87° 
ivGTT 3 19.60 ± 7.87° 21.21 ± 3.78 15.27 ± 1.81 25.81 ± 6.65° 
Time point of steepest blood plasma insulin level increase, minute 
ivGTT 1 6.0 ± 0.0 6.0 ± 0.0 8.3 ± 1.5* 6.0 ± 0.0 
ivGTT 2 6.8 ± 0.8 6.0 ± 0.0 3.0 ± 3.0° 5.0 ± 1.0 
ivGTT 3 3.6 ± 3.5 6.0 ± 0.0 3.7 ± 2.3*° 6.0 ± 0.0 
Netto AUC of glucose, mmol/L × minute 
ivGTT 1 202.8 ± 17.6* 154.7 ± 27.6* 183.5 ± 24.7* 165.1 ± 26.2* 
ivGTT 2 122.2 ± 15.6° 103.8 ± 17.8° 120.8 ± 12.9° 117.4 ± 3.9*° 
ivGTT 3 102.8 ± 14.9° 129.5 ± 19.8*° 114.0 ± 22.7° 99.2 ± 17.7° 
Netto AUC of insulin, µU/mL × minute 
ivGTT 1 4,160 ± 2,061 4,584 ± 1,765 3,397 ± 1,875 7,081 ± 4,757* 
ivGTT 2 1,109 ± 258 1,432 ± 295 1,058 ± 360 2,009 ± 515° 
ivGTT 3 2,084 ± 1,028 1,730 ± 696 1,028 ± 138 1,440 ± 282° 
Clearance rate of glucose 
ivGTT 1 0.66 ± 0.04* 0.86 ± 0.06* 0.81 ± 0.06* 0.86 ± 0.11* 
ivGTT 2 1.00 ± 0.08° 1.20 ± 0.12° 1.13 ± 0.08° 0.99 ± 0.05*° 
ivGTT 3 1.01 ± 0.07° 0.97 ± 0.10* 1.04 ± 0.06° 1.06 ± 0.06° 
HOMA-IR 
ivGTT 1 4.39 ± 1.92b* 3.33 ± 0.65ab* 2.22 ± 0.48a* 4.85 ± 2.48b* 
ivGTT 2 0.49 ± 0.20° 0.22 ± 0.05° 0.20 ± 0.03° 0.63 ± 0.24° 
ivGTT 3 1.59 ± 0.35° 1.29 ± 0.28*° 0.78 ± 0.11*° 1.40 ± 0.37° 
QUICKI 
ivGTT 1 0.332 ± 0.02* 0.326 ± 0.02* 0.347 ± 0.02* 0.320 ± 0.02* 
ivGTT 2 0.470 ± 0.02a° 0.526 ± 0.02b° 0.536 ± 0.02b° 0.444 ± 0.02a° 
ivGTT 3 0.360 ± 0.02* 0.374 ± 0.02* 0.406 ± 0.02# 0.374 ± 0.02* 
abAlphabetic superscripts indicate differences between groups within ivGTT (P < 0.05). 
*°#Symbolic superscripts indicate differences between ivGTTs within group (P < 0.05). 
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4.1. Blood glucose and plasma insulin 
Time course of blood glucose and blood plasma insulin of the four groups can be found in figures 
37 (ivGTT 1), 38 (ivGTT 2) and 39 (ivGTT 3). 
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Figure 37: Course of blood glucose (mmol/L) and blood plasma insulin (µU/mL) during 
ivGTT 1. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Values are presented as LSM ± SEM. Glucose 
infusion started immediately after blood sampling time point 0, lasted 4.6 ± 0.5 minutes and 
next sampling was done after end of infusion (2 minutes for glucose and 6 minutes for 
insulin measurements). 
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Figure 38: Course of blood glucose (mmol/L) and blood plasma insulin (µU/mL) during 
ivGTT 2. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Values are presented as LSM ± SEM. Glucose 
infusion started immediately after blood sampling time point 0, lasted 4.7 ± 0.7 minutes and 
next sampling was done after end of infusion (2 minutes for glucose and 6 minutes for 
insulin measurements). 
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Figure 39: Course of blood glucose (mmol/L) and blood plasma insulin (µU/mL) during 
ivGTT 3. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. Values are presented as LSM ± SEM. Glucose 
infusion started immediately after blood sampling time point 0, lasted 4.1 ± 0.1 minutes and 
next sampling was done after end of infusion (2 minutes for glucose and 6 minutes for 
insulin measurements). 
 
Basal blood glucose 
Basal blood glucose was higher at first ivGTT (2.81 ± 0.19, 2.57 ± 0.06, 2.57 ± 0.12 and 
2.73 ± 0.13 mmol/L in MP-, mp-, Mp- and mP-cows) compared to second ivGTT in all cows 
(P < 0.05; table 16, figure 40). In mp- and Mp-cows, basal blood glucose was lowest at second 
ivGTT (1.81 ± 0.17 and 1.68 ± 0.11 mmol/L in mp- and Mp-cows; P < 0.001). Moreover mp- and 
Mp-cows showed lower basal blood glucose levels during second ivGTT compared to MP- 
(2.29 ± 0.13 mmol/L) and mP-cows (2.38 ± 0.14; P < 0.01). 
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Figure 40: Basal blood glucose (mmol/L) during ivGTT at d 14 ap (ivGTT 1), d 20 (ivGTT 2) 
and 127 pp (ivGTT 3). 
MP-cows are shown as black boxes, mp-cows as dotted boxes, Mp-cows as grey boxes and 
mP-cows as shaded boxes.  
*#Symbolic superscripts indicate differences between groups at the same time point 
(P < 0.05).  
abAlphabetic superscripts indicate differences between time points within a group 
(P < 0.05).  
Fixed effects in model: time P < 0.05, group P < 0.001 and time × group P < 0.1. 
 
Maximum and increase of blood glucose 
Blood glucose levels increased after infusion of glucose, reached higher maximum levels in ivGTT 
1 compared to ivGTT 2 in MP-, mp- and Mp-cows (P < 0.05) and difference tended to be 
significant in mP-cows (P < 0.1; table 16). In mp-, Mp- and mP-cows, blood glucose peaked 
higher during ivGTT 2 compared to ivGTT 3 (P < 0.05). Only in MP-cows, maximum blood 
glucose was higher during ivGTT 2 compared to ivGTT 3 (P < 0.05). Additionally, MP-cows 
showed higher maximum blood glucose during second ivGTT compared to low yielding cows 
(9.98 ± 0.37, 8.43 ± 0.26 and 8.72 ± 0.22 mmol/L in MP-, mp- and mP-cows; P < 0.01). 
Consequently, increase of blood glucose during ivGTT 3 was lower in MP-cows compared to 
ivGTT 1 and 2 (P < 0.01) and higher in mp-cows compared to ivGTT 2 (P < 0.05; table 16, figure 
41). Furthermore, MP-cows showed higher increase of blood glucose during second ivGTT 
compared to low yielding cows (7.94 ± 0.35, 6.71 ± 0.27 and 6.92 ± 0.29 mmol/L in MP-, mp- and 
mP-cows; P < 0.05). During ivGTT 3, increase of blood glucose was higher in mP-cows compared 
to MP-cows (6.79 ± 0.26 and 7.77 ± 0.37 in MP- and mP-cows; P < 0.05). 
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Figure 41: Increase of blood glucose (mmol/L) during ivGTT at d 14 ap (ivGTT 1), d 20 
(ivGTT 2) and 127 pp (ivGTT 3). 
MP-cows are shown as black boxes, mp-cows as dotted boxes, Mp-cows as grey boxes and 
mP-cows as shaded boxes.  
*#Symbolic superscripts indicate differences between groups at the same time point 
(P < 0.05).  
abAlphabetic superscripts indicate differences between time points within a group 
(P < 0.05).  
Fixed effects in model: time P = 0.71, group P = 0.22 and time × group P = 0.39. 
 
Time course of blood glucose 
During ivGTT at d 14 ap, MP-cows needed more time compared to mp- and mP-cows (73.2 ± 7.1 
and 73.3 ± 13.6 minutes; P < 0.05) until they reached basal blood glucose level again (table 16). 
Furthermore, high yielding cows took during ivGTT 1 longest to reach basal blood glucose levels 
again (99.0 ± 9.7 minutes in MP-cows, P < 0.001 and 84.4 ± 7.6 minutes in Mp-cows, P < 0.05). 
Steepest decrease of glucose during ivGTT 2 was observed in mp-cows at 5.60 ± 0.98 minutes 
(3.16 ± 2.37 mmol/L per minute; P < 0.05; table 16). Furthermore, mp-cows showed lower 
decreases during ivGTT 1 and 3 (1.00 ± 0.31 and 0.56 ± 0.06 mmol/L per minute) compared to 
ivGTT 2 (P < 0.05). 
Steepest decrease of glucose in second ivGTT was observed earlier in Mp-cows 
(minute 4.00 ± 0.00) compared to mP-cows (minute 6.80 ± 1.96; P < 0.05) and during ivGTT 3 
earlier in MP- (4.40 ± 0.40) compared to Mp-cows (6.86 ± 1.06; P < 0.05; table 16). Furthermore, 
Mp-cows showed steepest decrease of glucose in ivGTT 3 later compared to earlier ivGTTs 
(P < 0.01). 
Basal, maximum and increase of blood plasma insulin 
Basal levels of blood plasma insulin during ivGTT 1 were higher in mP-cows 
(39.58 ± 19.97 µU/mL) compared to Mp-cows (19.24 ± 3.77 µU/mL; P < 0.05; table 16). 
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Furthermore basal blood plasma insulin levels were highest in MP-, mp- and mP-cows during 
ivGTT 1 (32.29 ± 12.12, 29.28 ± 5.66 and 39.58 ± 19.97 µU/mL, respectively; P < 0.05). Basal 
levels of blood plasma insulin in Mp-cows were higher during ivGTT 1 (19.24 ± 3.77 µU/mL) 
compared only to ivGTT 2 (2.58 ± 0.23 µU/mL; P < 0.05). 
Levels of blood plasma insulin peaked higher during ivGTT 1 in mP- compared to Mp-cows 
(298.5 ± 99.1 and 642.8 ± 388.8 µU/mL in Mp- and mP-cows; P < 0.05; table 16). In mp- 
(443.7 ± 113.3 µU/mL) and mP-cows, blood plasma insulin showed highest peaks during ivGTT 1 
(P < 0.05), whereas maximum of blood plasma insulin in MP-cows was reached during ivGTT 1 
(411.7 ± 114.6 µU/mL) compared to ivGTT 2 (121.4 ± 16.8 µU/mL; P < 0.05). 
Consequently, increase of blood plasma insulin during ivGTT 1 was higher in mP- compared to 
Mp-cows (603.2 ± 369.0 and 279.2 ± 96.8 µU/mL; P < 0.05; table 16). In low yielding cows, 
increase of blood plasma insulin was highest during ivGTT 1 (in mp-cows 414.4 ± 111.5 µU/mL, 
P < 0.05 and in mP-cows P < 0.01). 
Time course of blood plasma insulin 
Basal level of blood plasma insulin was reached fastest in MP-cows during ivGTT 3 
(64.6 ± 5.6 minutes; P < 0.05) and faster in Mp-cows during ivGTT 3 (64.0 ± 4.5 minutes) 
compared to ivGTT 1 (88.0 ± 5.1, P < 0.01; table 16). 
Increase of blood plasma insulin levels during ivGTT 1 was strongest in MP- and mP-cows 
(54.72 ± 17.67 and 72.39 ± 36.46 µU/mL per minute; P < 0.05; table 16). Moreover during ivGTT 
1, mP-cows showed steeper increase of blood plasma insulin levels compared to Mp-cows 
(31.50 ± 15.18 µU/mL per minute; P < 0.05). Additionally time point of steepest blood plasma 
insulin increase solely was higher in Mp-cows during ivGTT 1 (minute 8.3 ± 1.5) compared to 
ivGTT 3 (minute 3.0 ± 3.0; P < 0.05). 
4.2. AUC of blood glucose and insulin 
In high yielding cows, netto area under the curve of glucose (nAUCG) was highest during ivGTT 1 
(202.8 ± 17.6 and 183.5 ± 24.7 mmol/L × minute in MP- and Mp-cows; P < 0.01), whereas in mp-
cows nAUCG was only higher in ivGTT 1 (154.7 ± 27.6 mmol/L × minute) compared to ivGTT 2 
(103.8 ± 17.8 mmol/L × minute; P < 0.05; table 16, figure 42). Furthermore in mP-cows nAUCG 
was higher in ivGTT 1 (165.1 ± 26.2 mmol/L × minute) compared to ivGTT 3 
(99.2 ± 17.7 mmol/L × minute; P < 0.05). 
IV. Results   97 
ivGTT 1 ivGTT 2 ivGTT 3
ne
tto
 A
U
C
 g
lu
co
se
 [
m
m
ol
/L
 x
 m
in
ut
e]
0
50
100
150
200
250
a
a
a
a
b
bb
b b
b
ab
ab
Figure 42: Netto AUC of blood glucose (mmol/L × minute) during ivGTT at d 14 ap 
(ivGTT 1), d 20 (ivGTT 2) and 127 pp (ivGTT 3). 
MP-cows are shown as black boxes, mp-cows as dotted boxes, Mp-cows as grey boxes and 
mP-cows as shaded boxes.  
*#Symbolic superscripts indicate differences between groups at the same time point 
(P < 0.05).  
abAlphabetic superscripts indicate differences between time points within a group 
(P < 0.05).  
Fixed effects in model: time P = 0.90, group P < 0.001 and time × group P = 0.59. 
 
Differences in nAUC of blood plasma insulin (nAUCI) could only be observed in mP-cows, where 
nAUCI was highest during ivGTT 1 (7,081 ± 4,757 µU/mL × minute; P < 0.05; table 16, figure 
43) due to one animal in this group (maximum blood plasma insulin 8,901 µU/mL, nAUCI 
34,899 µU/mL × minute). 
IV. Results   98 
ivGTT 1 ivGTT 2 ivGTT 3
ne
tto
 A
U
C
 in
su
lin
 [
µ
U
/m
l x
 m
in
ut
e]
0
2000
4000
6000
8000
10000
12000
a
b
b
Figure 43: Netto AUC of blood plasma insulin (µU/mL × minute) during ivGTT at d 14 ap 
(ivGTT 1), d 20 (ivGTT 2) and 127 pp (ivGTT 3). 
MP-cows are shown as black boxes, mp-cows as dotted boxes, Mp-cows as grey boxes and 
mP-cows as shaded boxes.  
*#Symbolic superscripts indicate differences between groups at the same time point 
(P < 0.05).  
abAlphabetic superscripts indicate differences between time points within a group 
(P < 0.05).  
Fixed effects in model: time P = 0.68, group P < 0.01 and time × group P = 0.92. 
 
4.3. Clearance rate of blood glucose 
Clearance rate of glucose (CR) was lowest in high yielding cows during ivGTT 1 (0.66 ± 0.04 and 
0.81 ± 0.06 in MP- and Mp-cows; P < 0.01), whereas mp-cows showed highest CR during 
ivGTT 2 (1.20 ± 0.12; P < 0.05; table 16, figure 44). Furthermore mP-cows showed higher glucose 
CR during ivGTT 3 (1.06 ± 0.06) compared to ivGTT 1 (0.86 ± 0.11; P < 0.05). 
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Figure 44: Clearance rate of glucose during ivGTT at d 14 ap (ivGTT 1), d 20 (ivGTT 2) and 
127 pp (ivGTT 3). 
MP-cows are shown as black boxes, mp-cows as dotted boxes, Mp-cows as grey boxes and 
mP-cows as shaded boxes.  
*#Symbolic superscripts indicate differences between groups at the same time point 
(P < 0.05). 
abAlphabetic superscripts indicate differences between time points within a group 
(P < 0.05).  
Fixed effects in model: time P = 0.64, group P < 0.001 and time × group P = 0.22. 
 
4.4. Model estimations 
HOMA-IR 
In high protein cows highest HOMA-IR was observed during ivGTT 1 (4.39 ± 1.92 and 
4.85 ± 2.48 in MP- and mP-cows; P < 0.05), whereas in low protein cows HOMA-IR was higher 
during ivGTT 1 (3.33 ± 0.65 and 2.22 ± 0.48 in mp- and Mp-cows) compared to ivGTT 2 
(0.22 ± 0.05 and 0.20 ± 0.03 in mp- and Mp-cows; P < 0.05; table 16, figure 45). Furthermore Mp-
cows showed lowest HOMA-IR during ivGTT 1 compared to MP- (P < 0.05) and mP-cows 
(P < 0.05). 
QUICKI 
The calculated insulin sensitivity index QUICKI was lower in all cows before parturition 
compared to ivGTT 2 (P < 0.001). Furthermore, differences in QUICKI of Mp-cows proved to be 
significant at all three time points (0.347 ± 0.02, 0.536 ± 0.02 and 0.406 ± 0.02 during ivGTT 1, 2 
and 3; P < 0.05). During ivGTT 2, high protein cows showed lower QUICKI compared to low 
protein cows (0.470 ± 0.02, 0.444 ± 0.02, 0.526 ± 0.02 and 0.536 ± 0.02 in MP-, mP-, mp- and 
Mp-cows; P < 0.05). 
IV. Results   100 
QUICKI
ivGTT 1 ivGTT 2 ivGTT 3
0.0
0.3
0.4
0.5
0.6
a
b
*
*
##
a
a a
b
b
a a
a
b
c
HOMA-IR
ivGTT 1 ivGTT 2 ivGTT 3
0
2
4
6
8
*
#
#
a
b
a
b
a
ab
b
a
ab
b
b
b
#*
Figure 45: HOMA-IR and QUICKI during ivGTT at d 14 ap (ivGTT 1), d 20 (ivGTT 2) and 
127 pp (ivGTT 3). 
MP-cows are shown as black boxes, mp-cows as dotted boxes, Mp-cows as grey boxes and 
mP-cows as shaded boxes.  
*#Symbolic superscripts indicate differences between groups at the same time point 
(P < 0.05).  
abAlphabetic superscripts indicate differences between time points within a group 
(P < 0.05).  
Fixed effects in model HOMA-IR: time P = 0.32, group P < 0.001 and time × group 
P = 0.72. Fixed effects in model QUICKI: time P < 0.001, group P < 0.05 and time × group 
P = 0.13.  
 
4.5. Milk parameters 
Mean milk parameters and differences between days and cows during ivGTT 2 and ivGTT 3 can 
be observed in table 17. 
 
Table 17: Mean milk parameters (LSM ± SEM) at days of ivGTT at wk 3 and 19 pp. 
 MP mp Mp mP 
milk yield, kg 
ivGTT 2 37.55 ± 1.29a* 34.54 ± 2.46ab 40.83 ± 1.68a* 30.70 ± 1.36b 
ivGTT 3 29.65 ± 2.45 30.64 ± 2.19 34.35 ± 2.95 27.39 ± 2.67 
FCM, kg 
ivGTT 2 49.57 ± 3.35a* 43.45 ± 4.60ab* 51.20 ± 2.83a* 39.54 ± 1.19b 
ivGTT 3 34.12 ± 2.97 32.82 ± 3.41 35.65 ± 2.56 32.19 ± 4.11 
ECM, kg 
ivGTT 2 51.11 ± 3.16a* 44.38 ± 4.37ab* 52.45 ± 2.58a* 41.52 ± 1.41b 
ivGTT 3 36.51 ± 2.89 35.32 ± 3.50 38.08 ± 2.74 35.36 ± 4.20 
milk protein content, % 
ivGTT 2 3.20 ± 0.10ac* 2.90 ± 0.06b* 2.95 ± 0.03bc 3.44 ± 0.08a* 
ivGTT 3 3.46 ± 0.18a 3.27 ± 0.06ab 3.08 ± 0.07b 3.94 ± 0.19c 
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 MP mp Mp mP 
milk protein yield, g 
ivGTT 2 1204 ± 70 1003 ± 73 1203 ± 47 1060 ± 63 
ivGTT 3 1011 ± 60 1004 ± 82 1054 ± 88 1071 ± 94 
milk fat content, % 
ivGTT 2 6.12 ± 0.44* 5.68 ± 0.47* 5.72 ± 0.46* 5.95 ± 0.20 
ivGTT 3 5.02 ± 0.24 4.41 ± 0.31 4.37 ± 0.36 5.15 ± 0.55 
milk fat yield, g 
ivGTT 2 2,303 ± 200ab* 1,976 ± 251ab* 2,325 ± 174a* 1,818 ± 49b 
ivGTT 3 1,484 ± 140 1,371 ± 171 1,461 ± 115 1,416 ± 221 
milk lactose content, % 
ivGTT 2 4.77 ± 0.04ab 4.67 ± 0.06a 4.73 ± 0.06ab 4.86 ± 0.02b 
ivGTT 3 4.76 ± 0.09 4.73 ± 0.07 4.80 ± 0.05 4.79 ± 0.08 
milk lactose yield, g 
ivGTT 2 1,794 ± 70ab* 1,617 ± 137ab 1,932 ± 89a* 1,491 ± 64b 
ivGTT 3 1,416 ± 130 1,453 ± 121 1,654 ± 149 1,310 ± 126 
FPR 
ivGTT 2 1.93 ± 0.18* 1.96 ± 0.17* 1.94 ± 0.16* 1.74 ± 0.10* 
ivGTT 3 1.46 ± 0.09 1.35 ± 0.08 1.42 ± 0.11 1.30 ± 0.09 
SCC,  × 1,000/mL 
ivGTT 2 40.0 ± 11.8 65.6 ± 19.0 35.0 ± 6.0 931.8 ± 791.5 
ivGTT 3 73.4 ± 33.8a 87.4 ± 29.3ab 69.6 ± 18.4a 388.5 ± 217.1b 
milk urea, mg/L 
ivGTT 2 240.3 ± 30.1 191.8 ± 24.0 245.0 ± 26.8 239.0 ± 37.2 
ivGTT 3 237.8 ± 13.4 248.8 ± 23.3 263.1 ± 16.0 238.5 ± 35.8 
milk hydrocortisone, nmol/L 
ivGTT 2 2.82 ± 0.39* 3.82 ± 0.67 3.21 ± 0.46 3.00 ± 0.81 
ivGTT 3 4.12 ± 0.57 3.36 ± 0.22 3.12 ± 0.47 3.24 ± 0.70 
abcAlphabetic superscripts indicate differences between groups within ivGTT (P < 0.05). 
*Asterisks indicate differences between ivGTTs within group (P < 0.05). 
5. Milk protein fractions 
Altogether, 457 skim milk samples were measured, thereof 325 during lactation and 132 at days of 
FR. Intra- and inter-assay CVs were 1.7 and 6.5% (α-LA), 4.3 and 6.1% (β-LG), 1.4 and 5.8% (α-
CN), 0.0 and 8.0% (β-CN) and 0.0 and 10.8% (κ-CN).  
5.1. Composition of milk protein during 22 weeks of lactation 
Measurement of protein fractions was performed after all samples were taken. After freezing and 
thawing, 37 milk samples were unfortunately clotted. Of finally 288 milk samples were 56, 61, 58, 
42, 59 and 12 samples from period 1, 2, 3, 4, 5 and 6, respectively. 
α-lactalbumin 
Content of α-LA was similar amongst groups, except during period 6, when mP-cows showed 
overall highest concentrations (2.53 ± 0.19%; P < 0.05; table 18, figure 46). During lactation, all 
cows showed similar contents of α-LA with slightly declining amounts after period 3 and 
increasing concentrations of α-LA in mP-cows from period 5 to 6 (P < 0.001). 
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Figure 46: Concentration of α-lactalbumin (% of total protein) in skim milk during first 22 
weeks of lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model: 
time P < 0.001, group P = 0.83 and time × group P = 0.24. Differences between periods 
and between groups can be found in table 18. 
 
β-lactoglobulin 
Mean concentration of β-LG was higher in Mp-cows during period 1 compared to period 2 
(10.34 ± 0.74 and 9.37 ± 0.74%; P < 0.05) and increased in low yielding cows from period 5 to 6 
(9.00 ± 0.88 and 10.44 ± 0.94% in mp-cows, P < 0.05; 9.74 ± 0.88 and 12.42 ± 0.94%, P < 0.001; 
table 18, figure 47). Furthermore, concentrations of β-LG were higher at d 36 compared to d 43 pp 
in high yielding and mP-cows (8.24 ± 0.89, 8.88 ± 0.82 and 10.10 ± 0.98% in MP-, Mp- and mP-
cows; P < 0.05). In mP-cows, β-LG concentration increased from d 64 to 78 pp by 1.40%-points 
(P < 0.01). Afterwards, β-LG contents decreased in Mp-cows by 1.23%-points (P < 0.1) and in 
mP-cows by 1.98%-points (P < 0.01) from d 78 to 92 pp. At d 106 pp, β-LG concentrations were 
higher in mP-cows compared to d 113 pp (9.08 ± 0.98%; P < 0.05). During period 6, mP-cows 
showed higher concentrations of β-LG compared to high yielding cows (9.42 ± 0.88, 9.79 ± 0.84 
and 12.42 ± 0.94% in MP-, Mp- and mP-cows; P < 0.05). 
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Figure 47: Concentration of β-lactoglobulin (% of total protein) in skim milk during first 22 
weeks of lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model: 
time P < 0.001, group P = 0.41 and time × group P = 0.87. Differences between periods 
and between groups can be found in table 18. 
α-casein 
Mean concentration of α-casein was in higher in Mp-cows compared to mP-cows in period 1, 
compared to low yielding cows in period 2, 3, 4 and 5 and compared to high protein cows in 
period 6 (P < 0.05; table 18, figure 48). Furthermore, MP-cows showed higher mean amounts of α-
CN during period 5 compared to period 6 (33.9 ± 0.8 and 32.0 ± 1.0%; P < 0.05). From d 8 to 
15 pp and from d 57 to 64 pp, concentrations of α-CN decreased in mp- cows by 3.92 and 3.24%-
points (P < 0.05). At the end of experiment, α-CN concentrations in mp-cows increased to 
33.9 ± 1.33% (P < 0.05). 
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Figure 48: Concentration of α-casein (% of total protein) in skim milk during first 22 weeks 
of lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model: 
time P < 0.01, group P < 0.05 and time × group P = 0.71. Differences between periods and 
between groups can be found in table 18. 
 
β-casein 
All cows showed increasing mean concentrations of β-CN from period 1 to 2 (P < 0.05), resulting 
in higher levels of Mp-cows compared to mP-cows (34.9 ± 0.8 and 31.2 ± 1.0%; P < 0.01; 
table 18, figure 49). From period 3 to 4, Mp- and mP-cows showed decreasing mean contents of β-
CN (P < 0.05). During period 4, overall lowest mean concentration of β-CN was observed in mP-
cows (28.9 ± 1.0%; P < 0.05). Afterwards, mean amounts of β-CN increased in Mp-cows to 
period 5 (34.2 ± 0.8%; P < 0.05) and mP-cows showed still overall lowest concentration 
(29.6 ± 1.0%; P < 0.01). In Mp- and mp-cows, mean concentration of β-CN decreased to period 6 
(29.1 ± 1.2 and 30.7 ± 1.1% in Mp- and mp-cows; P < 0.001). During period 6, MP-cows showed 
higher mean β-CN content compared to mP-cows (P < 0.05). Furthermore, all cows showed higher 
concentrations of β-CN at d 43, 57 and 113 pp compared to days before and after (d 36, 50, 64, 
106 and 120 pp; P < 0.05). 
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Figure 49: Concentration of β-casein (% of total protein) in skim milk during first 22 weeks 
of lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model: 
time P < 0.001, group P < 0.1 and time × group P = 0.27. Differences between periods and 
between groups can be found in table 18. 
 
κ-casein 
Mean concentration of κ-CN declined from period 1 to 2 in Mp-cows (13.6 ± 1.3 and 11.5 ± 1.3%; 
P < 0.01) and was then lower compared to low yielding cows (16.6 ± 1.6 and 16.4 ± 1.6% in mp- 
and mP-cows; P < 0.05; table 18, figure 50). In period 3, Mp-cows showed lower mean content of 
κ-CN compared to mp-cows (12.1 ± 1.4 and 17.1 ± 1.6% in Mp- and mp-cows; P < 0.05) and 
amounts increased to period 4 in mp-, Mp- and mP-cows (P < 0.05). During period 4, Mp-cows 
still showed lower mean content of κ-CN compared to mp-cows (13.7 ± 1.4 and 19.3 ± 1.6% in 
Mp- and mp-cows; P < 0.05) and in period 5 compared to low yielding cows (18.3 ± 1.6, 
12.6 ± 1.3 and 18.6 ± 1.6% in mp-, Mp- and mP-cows; P < 0.01). In mP-cows, mean concentration 
of    κ-CN decreased to period 6 (to 14.9 ± 1.7%; P < 0.001). Furthermore, Mp-cows showed lower 
mean κ-CN concentration compared to mp-cows (19.0 ± 1.7 and 13.9 ± 1.5% in mp- and Mp-
cows; P < 0.05). 
In MP-cows, concentration of κ-CN was lower at d 43 compared to d 50 pp (13.9 ± 1.5 and 
16.2 ± 1.6% at d 43 and 50 pp; P < 0.05) and at d 113 compared to d 106 and 120 pp (17.7 ± 1.6, 
15.4 ± 1.5 and 17.7 ± 1.6% at d 106, 113 and 120 pp; P < 0.05). Concentration of κ-CN was lower 
in mp-cows at d 43 compared to d 36 and 50 pp (18.1 ± 1.7, 13.7 ± 1.7 and 18.7 ± 1.7% at d 36, 43 
and 50 pp; P < 0.001), at d 57 compared to d 50 and 64 (14.0 ± 1.7 and 19.7 ± 1.7% at d 57 and 
64 pp; P < 0.001) and at d 113 compared to d 106 and 120 pp (19.2 ± 1.7, 16.2 ± 1.7 and 
20.0 ± 1.7% at d 106, 113 and 120 pp; P < 0.01). In Mp-cows, κ-CN concentration was lower at 
d 57 and 113 pp compared to following measurements (10.2 ± 1.5, 13.3 ± 1.5, 11.9 ± 1.4 and 
14.0 ± 1.4% at d 57, 64, 113 and 120 pp; P < 0.05). 
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Figure 50: Concentration of κ-casein (% of total protein) in skim milk during first 22 weeks 
of lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model: 
time P < 0.001, group P < 0.1 and time × group P < 0.05. Differences between periods and 
between groups can be found in table 18. 
 
Unidentified proteins 
During period 1, all cows showed similar mean concentrations of unidentified proteins. In mp-
cows, mean content decreased to period 2 (from 5.82 ± 0.79 to 4.30 ± 0.75%; P < 0.05) and stayed 
on similar levels throughout period 3 (table 18, figure 51). From period 3 to 4, content of 
unidentified proteins increased in mP-cows (5.33 ± 0.75 to 7.67 ± 0.75%; P < 0.001) and was 
higher in mP-cows compared to mp-cows (5.28 ± 0.75%; P < 0.05). In period 5, mP-cows still 
showed higher levels of unidentified proteins compared to mp-cows (7.12 ± 0.75 and 4.99 ± 0.75% 
in mP- and mp-cows; P < 0.05). Afterwards, concentration of unidentified proteins increased in 
mP- (to 9.89 ± 0.84; P < 0.001) and Mp-cows (from 6.60 ± 0.64 to 8.64 ± 0.77% in period 6; 
P < 0.01). In period 6, mP-cows showed higher levels of unidentified proteins compared to MP- 
(7.44 ± 0.80%; P < 0.05) and mp-cows (5.55 ± 0.84%; P < 0.001) and Mp-cows showed higher 
levels compared to mp-cows (P < 0.01). 
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Figure 51: Concentration of unidentified proteins (% of total protein) in skim milk during 
first 22 weeks of lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model: 
time P < 0.001, group P = 0.19 and time × group P = 0.14. Differences between periods 
and between groups can be found in table 18. 
 
Table 18: Mean composition of milk protein (content of major milk proteins in skim milk 
LSM ± SE) in 6 time periods during 155 days of lactation and mean values of the 6 time 
periods. 
 MP mp Mp mP 
α-lactalbumin, % of total protein 
period 1 2.21 ± 0.16 2.25 ± 0.17 2.35 ± 0.14 2.25 ± 0.16 
period 2 2.19 ± 0.15 2.07 ± 0.16 2.14 ± 0.14 2.06 ± 0.16 
period 3 2.25 ± 0.15 1.97 ± 0.16 2.10 ± 0.15 2.13 ± 0.16 
period 4 2.06 ± 0.16 1.83 ± 0.16 2.02 ± 0.14 2.02 ± 0.16 
period 5 1.88 ± 0.15 1.78 ± 0.16 2.00 ± 0.14 1.84 ± 0.16 
period 6 1.84 ± 0.18a 1.97 ± 0.19a 1.96 ± 0.18a 2.53 ± 0.19b* 
mean 2.11 ± 0.12 2.00 ± 0.13 2.12 ± 0.11 2.10 ± 0.13 
β-lactoglobulin, % of total protein 
period 1 9.40 ± 0.82 9.81 ± 0.90 10.34 ± 0.74 11.20 ± 0.88 
period 2 8.83 ± 0.80 9.68 ± 0.88 9.37 ± 0.74* 10.55 ± 0.88 
period 3 9.02 ± 0.80 9.45 ± 0.88 9.26 ± 0.77 10.84 ± 0.88 
period 4 8.73 ± 0.82 9.19 ± 0.88 9.14 ± 0.75 10.29 ± 0.88 
period 5 8.56 ± 0.80 9.00 ± 0.88 8.77 ± 0.74 9.74 ± 0.88 
period 6 9.42 ± 0.88a 10.44 ± 0.94ab* 9.79 ± 0.84a 12.42 ± 0.94b* 
mean 9.03 ± 0.78 9.53 ± 0.85 9.50 ± 0.72 10.75 ± 0.85 
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 MP mp Mp mP 
α-casein, % of total protein 
period 1 35.4 ± 0.8ab 34.5 ± 0.9ab 36.7 ± 0.7a 33.9 ± 0.8b 
period 2 34.5 ± 0.8ab 33.9 ± 0.9a 36.7 ± 0.7b 33.4 ± 0.9a 
period 3 34.9 ± 0.8ab 33.3 ± 0.9a 36.9 ± 0.8b 34.0 ± 0.9a 
period 4 34.2 ± 0.8ab 32.7 ± 0.9a 35.9 ± 0.8b 33.3 ± 0.9a 
period 5 33.9 ± 0.8ab 32.7 ± 0.9a 35.3 ± 0.7b 32.7 ± 0.9a 
period 6 32.0 ± 1.0a* 34.3 ± 1.0ab 35.4 ± 1.0b 32.4 ± 1.0a 
mean 34.4 ± 0.7ab 33.1 ± 0.8a 36.4 ± 0.7b 33.5 ± 0.8a 
β-casein, % of total protein 
period 1 30.8 ± 1.0 31.3 ± 1.1 30.9 ± 0.8 29.2 ± 1.0 
period 2 33.8 ± 0.9ab* 33.8 ± 1.0ab* 34.9 ± 0.8a* 31.2 ± 1.0b* 
period 3 33.2 ± 0.9 33.2 ± 1.0 34.2 ± 0.9 31.8 ± 1.0 
period 4 32.0 ± 1.0a 32.2 ± 1.0a 32.3 ± 0.9a* 28.9 ± 1.0b* 
period 5 33.3 ± 0.9a 33.7 ± 1.0a 34.2 ± 0.8a* 29.6 ± 1.0b 
period 6 32.3 ± 1.1a 29.1 ± 1.2ab* 30.7 ± 1.1ab* 28.2 ± 1.2b 
mean 32.1 ± 0.7a 32.5 ± 0.7a 32.8 ± 0.6a 30.1 ± 0.7b 
κ-casein, % of total protein 
period 1 15.9 ± 1.5 16.6 ± 1.6 13.6 ± 1.3 16.3 ± 1.6 
period 2 15.1 ± 1.5ab 16.6 ± 1.6a 11.5 ± 1.3b* 16.4 ± 1.6a 
period 3 15.2 ± 1.5ab 17.1 ± 1.6a 12.1 ± 1.4b 15.9 ± 1.6ab 
period 4 16.4 ± 1.5ab 19.3 ± 1.6a* 13.7 ± 1.4b* 17.7 ± 1.6ab* 
period 5 16.0 ± 1.5ab 18.3 ± 1.6a 12.6 ± 1.3b 18.6 ± 1.6a 
period 6 16.9 ± 1.6ab 19.0 ± 1.7a 13.9 ± 1.5b 14.9 ± 1.7ab* 
mean 16.0 ± 1.4ab 17.7 ± 1.5a 12.9 ± 1.3b 16.8 ± 1.5ab 
Unidentified proteins, % of total protein 
period 1 6.47 ± 0.71 5.82 ± 0.79 6.28 ± 0.64 6.96 ± 0.75 
period 2 5.58 ± 0.69 4.30 ± 0.75* 5.71 ± 0.64 6.05 ± 0.75 
period 3 5.64 ± 0.69 4.87 ± 0.75 5.64 ± 0.68 5.33 ± 0.75 
period 4 6.57 ± 0.71ab 5.28 ± 0.75a 6.64 ± 0.66ab 7.67 ± 0.75b* 
period 5 6.33 ± 0.69ab 4.99 ± 0.75a 6.60 ± 0.64ab 7.12 ± 0.75b 
period 6 7.44 ± 0.80ab 5.55 ± 0.84a 8.64 ± 0.77bc* 9.89 ± 0.84c* 
mean 6.33 ± 0.62 5.21 ± 0.66 6.35 ± 0.57 6.75 ± 0.66 
abcAlphabetic superscripts indicate differences between groups within time period 
(P < 0.05). 
*Asterisks indicate differences to previous time periods within group (P < 0.05). 
5.2. Influence of three days feed restriction on milk protein composition 
Out of 132 milk samples taken at days of FRs, 17 were clotted after freezing and thawing. Of the 
remaining 115 milk samples, 19 were each from d 25 and 28, 21 samples from d 31, 140 and 
143 pp and 14 samples from d 146 pp. 
α-lactalbumin 
In MP-cows content of α-LA was higher during all days of early FR (P < 0.05) compared to FR in 
mid-lactation, whereas in low protein cows higher α-LA content was observed at d 25 pp 
(2.23 ± 0.19 and 2.49 ± 0.16% in mp- and Mp-cows) compared to d 140 pp (1.67 ± 0.18 and 
2.06 ± 0.16% in mp- and Mp-cows; P < 0.01; table 19, figure 52). During early FR, mP-cows 
showed higher concentration of α-LA at d 31 pp (2.31 ± 0.18%) compared to d 146 pp 
(1.88 ± 0.21%; P < 0.05). Moreover during second FR, α-LA content was lowest in mp-cows at 
d 140 pp (1.67 ± 0.18%; P < 0.05). Differences between groups were not observed. 
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Figure 52: Concentration of α-lactalbumin (% of total protein) in skim milk at last day 
before (d 25 and 140 pp), last day during (d 28 and 143 pp) and last day after (d 31 and 
146 pp) three days of feed restriction in early and mid-lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model 
α-lactalbumin: time P < 0.001, group P = 0.74 and time × group P = 0.36. Differences 
between days and between groups can be found in table 19. 
 
β-lactoglobulin 
After both periods of restricted feeding, concentration of β-LG seemed to increase in low protein 
cows and to decrease in high protein cows. In low yielding cows, content of β-LG was higher at 
d 25 (10.19 ± 0.90 and 11.18 ± 0.90% in mp- and mP-cows) compared to 140 pp (8.82 ± 0.87 and 
9.81 ± 0.87% in mp- and mP-cows; P < 0.05; table 19, figure 53). Furthermore during second FR, 
mp-cows showed lower concentration of β-LG at d 140 (8.82 ± 0.87%) compared to d 146 pp 
(10.43 ± 1.03%; P < 0.05). No differences between groups were observed. 
IV. Results   110 
day relative to parturition
23 25 27 29 31 138 140 142 144 146
co
nt
en
t o
f 
β-
la
ct
og
lo
bu
lin
 [
%
]
0.0
8.0
8.5
9.0
9.5
10.0
10.5
11.0
11.5
12.0
12.5
 
Figure 53: Concentration of β-lactoglobulin (% of total protein) in skim milk at last day 
before (d 25 and 140 pp), last day during (d 28 and 143 pp) and last day after (d 31 and 
146 pp) three days of feed restriction in early and mid-lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model 
β-lactoglobulin: time P < 0.01, group P = 0.77 and time × group P = 0.68. Differences 
between days and between groups can be found in table 19. 
 
α-casein 
During FR in early lactation, mp-cows showed lower α-CN contents at d 25 pp compared to Mp-
cows (32.9 ± 1.2 and 37.0 ± 1.0% in mp- and Mp-cows; P < 0.05) and at d 28 pp compared to Mp- 
and mP-cows (31.2 ± 1.1, 35.6 ± 1.1 and 34.8 ± 1.2% in mp-, Mp- and mP-cows; P < 0.05; table 
19, figure 54). At d 31 pp, Mp-cows showed overall highest content of α-CN (37.5 ± 1.0%; 
P < 0.05). Furthermore, α-CN concentration in mp-cows was lower at d 28 compared to d 143 pp 
(P < 0.01).  
During FR in mid-lactation, α-CN content increased in mp-cows from d 140 to 143 pp (32.1 ± 1.1 
and 35.2 ± 1.1% at d 140 and 143 pp; P < 0.05). Furthermore, Mp-cows showed higher content of 
α-CN at d 140 pp compared to mp-cows (35.7 ± 1.0% in Mp-cows; P < 0.05) and at d 143 pp 
compared to MP- and mP-cows (37.7 ± 1.0, 33.8 ± 1.2 and 32.3 ± 1.1% in Mp-, MP- and mP-
cows; P < 0.05).  
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Figure 54: Concentration of α-casein (% of total protein) in skim milk at last day before 
(d 25 and 140 pp), last day during (d 28 and 143 pp) and last day after (d 31 and 146 pp) 
three days of feed restriction in early and mid-lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model 
α-casein: time P = 0.63, group P < 0.01 and time × group P = 0.31. Differences between 
days and between groups can be found in table 19. 
 
β-casein 
After the period of restricted feeding in early lactation, concentration of β-CN seemed to decrease 
in low protein cows and to increase in high protein cows, whereas after period of restricted feeding 
in mid-lactation, β-CN content seemed to increase in all cows.  
During FR in early lactation, no differences between groups or days were observed. However 
content of β-CN was higher in mP-cows at d 25 compared to d 140 pp (31.3 ± 1.1 and 
27.6 ± 1.0%; P < 0.05; table 19, figure 55). 
Moreover, mP-cows showed lower concentrations of β-CN compared to low protein cows at 
d 140 pp (31.6 ± 1.0 and 31.3 ± 0.9% in mp- and Mp-cows; P < 0.01) and d 143 pp (32.4 ± 1.0, 
32.1 ± 0.8 and 29.2 ± 1.0% in mp-, Mp- and mP-cows; P < 0.05).  
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Figure 55: Concentration of β-casein (% of total protein) in skim milk at last day before 
(d 25 and 140 pp), last day during (d 28 and 143 pp) and last day after (d 31 and 146 pp) 
three days of feed restriction in early and mid-lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model 
β-casein: time P < 0.01, group P < 0.01 and time × group P = 0.97. Differences between 
days and between groups can be found in table 19. 
 
κ-casein 
Concentration of κ-CN was higher in mp- compared to Mp-cows at d 31 pp (18.0 ± 1.7 and 
12.8 ± 1.5% in mp- and Mp-cows; P < 0.05; table 19, figure 56). Compared to FR in mid-lactation, 
lower κ-CN contents were observed in mp-cows before (16.8 ± 1.7 and 21.0 ± 1.7 at d 25 and 
140 pp; P < 0.01) and in mP-cows before and after periods of restricted feeding in early lactation 
(15.9 ± 1.7, 14.2 ± 1.7, 19.8 ± 1.7 and 19.0 ± 1.7% at d 25, 28, 140 and 143 pp; P < 0.05). 
During FR in mid-lactation, κ-CN concentration declined in mp-cows from d 140 to 143 pp 
(21.0 ± 1.7 to 15.4 ± 1.7%; P < 0.001). Moreover, content of κ-CN was lower in Mp-cows at 
d 140 pp compared to low yielding cows (21.0 ± 1.7, 14.8 ± 1.5 and 19.8 ± 1.7% in mp-, Mp- and 
mP-cows; P < 0.05) and at d 143 pp compared to high protein cows (17.5 ± 1.7, 13.0 ± 1.4 and 
19.0 ± 1.7% in MP-, Mp- and mP-cows; P < 0.05). 
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Figure 56: Concentration of κ-casein (% of total protein) in skim milk at last day before 
(d 25 and 140 pp), last day during (d 28 and 143 pp) and last day after (d 31 and 146 pp) 
three days of feed restriction in early and mid-lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model 
κ-casein: time P < 0.001, group P = 0.11 and time × group P = 0.19. Differences between 
days and between groups can be found in table 19. 
 
Unidentified proteins 
During FR in early lactation, high protein cows seemed to have higher concentrations of 
unidentified proteins compared to low protein cows. 
Differences between days and between groups during FR in early and in mid-lactation proved not 
to be significant (table 19, figure 57). However, Mp-cows showed lower levels of unidentified 
proteins at d 31 compared to d 146 pp (5.21 ± 0.88 and 7.35 ± 0.88%; P < 0.05). 
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Figure 57: Concentration of unidentified proteins (% of total protein) in skim milk at last 
day before (d 25 and 140 pp), last day during (d 28 and 143 pp) and last day after (d 31 and 
146 pp) three days of feed restrfiction in early and mid-lactation. 
MP-cows are shown as filled squares ■, mp-cows as empty circles ○, Mp-cows as empty 
squares □ and mP-cows as filled circles ●. White and grey areas show period 1 to 6. Shaded 
areas show feed restrictions. Values are presented as LSM ± SEM. Fixed effects in model 
unidentified proteins: time P = 0.05, group P = 0.40 and time × group P = 0.87. Differences 
between days and between groups can be found in table 19. 
 
 
Table 19: Composition of milk protein (content of major milk proteins in skim milk 
LSM ± SE) at last day before (d 25 and 140 pp), last day during (d 28 and 143 pp) and last 
day after (d 31 and 146 pp) three days of feed restriction in early and mid-lactation. 
 MP mp Mp mP mean 
α-lactalbumin, % of total protein 
d 25 pp 2.28 ± 0.181 2.23 ± 0.191 2.49 ± 0.161 2.13 ± 0.19 2.28 ± 0.091 
d 28 pp 2.26 ± 0.181 2.27 ± 0.18 2.18 ± 0.17 2.02 ± 0.19 2.19 ± 0.091 
d 31 pp 2.46 ± 0.181 2.14 ± 0.18 2.35 ± 0.16 2.31 ± 0.181 2.31 ± 0.091 
d 140 pp 1.84 ± 0.18 1.67 ± 0.18* 2.06 ± 0.16 1.79 ± 0.18 1.84 ± 0.09 
d 143 pp 1.84 ± 0.19 2.04 ± 0.18° 2.10 ± 0.15 1.80 ± 0.18 1.95 ± 0.09 
d 146 pp 1.74 ± 0.21 2.21 ± 0.24° 2.06 ± 0.16 1.88 ± 0.21 1.97 ± 0.10 
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 MP mp Mp mP mean 
β-lactoglobulin, % of total protein 
d 25 pp 10.17 ± 0.87 10.19 ± 0.901 9.75 ± 0.76 11.18 ± 0.901 10.32 ± 0.431 
d 28 pp 9.27 ± 0.87 10.43 ± 0.87 9.94 ± 0.78 10.58 ± 0.90 10.06 ± 0.431 
d 31 pp 9.29 ± 0.87 9.86 ± 0.87 9.35 ± 0.76 11.23 ± 0.87 9.93 ± 0.42 
d 140 pp 9.21 ± 0.87 8.82 ± 0.87* 9.06 ± 0.75 9.81 ± 0.87 9.22 ± 0.42° 
d 143 pp 8.86 ± 0.90 9.32 ± 0.87*° 9.46 ± 0.74 9.52 ± 0.87 9.29 ± 0.42° 
d 146 pp 9.36 ± 0.95 10.43 ± 1.03° 10.07 ± 0.76 10.60 ± 0.95 10.12 ± 0.46* 
α-casein, % of total protein 
d 25 pp 35.2 ± 1.1ab 32.9 ± 1.2a 37.0 ± 1.0b 33.8 ± 1.3ab 34.7 ± 0.6 
d 28 pp 34.0 ± 1.1ab 31.2 ± 1.1a1 35.6 ± 1.1b 34.8 ± 1.2b 33.9 ± 0.6 
d 31 pp 34.3 ± 1.1a 32.3 ± 1.1a 37.5 ± 1.0b 32.8 ± 1.1a 34.2 ± 0.5 
d 140 pp 34.7 ± 1.1ab 32.1 ± 1.1a* 35.7 ± 1.0b 32.7 ± 1.1ab 33.8 ± 0.5 
d 143 pp 33.8 ± 1.2a 35.2 ± 1.1ab° 37.7 ± 1.0b 32.3 ± 1.1a 34.8 ± 0.6 
d 146 pp 32.6 ± 1.4 33.4 ± 1.7*° 35.6 ± 1.0 34.0 ± 1.4 33.9 ± 0.7 
β-casein, % of total protein 
d 25 pp 31.4 ± 1.0 34.0 ± 1.1 32.5 ± 0.9 31.3 ± 1.11 32.3 ± 0.51 
d 28 pp 32.8 ± 1.0 33.5 ± 1.0 31.7 ± 1.0 31.7 ± 1.1 32.4 ± 0.51 
d 31 pp 31.6 ± 1.0 33.1 ± 1.0 32.3 ± 0.9 31.2 ± 1.0 32.1 ± 0.5 
d 140 pp 30.1 ± 1.0ab 31.6 ± 1.0a 31.3 ± 0.9a 27.6 ± 1.0b 30.1 ± 0.5 
d 143 pp 30.4 ± 1.1ab 32.4 ± 1.0a 32.1 ± 0.8a 29.2 ± 1.0b 31.0 ± 0.5 
d 146 pp 30.0 ± 1.2 31.9 ± 1.5 30.9 ± 0.9 29.2 ± 1.3 30.5 ± 0.6 
κ-casein, % of total protein 
d 25 pp 15.2 ± 1.7 16.8 ± 1.71 12.4 ± 1.5 15.9 ± 1.71 15.1 ± 0.81 
d 28 pp 15.3 ± 1.7 17.5 ± 1.7 14.0 ± 1.5 14.2 ± 1.71 15.2 ± 0.8 
d 31 pp 16.1 ± 1.7ab 18.0 ± 1.7a 12.8 ± 1.5b 16.3 ± 1.7ab 15.8 ± 0.8 
d 140 pp 17.6 ± 1.7ab 21.0 ± 1.7a* 14.8 ± 1.5b 19.8 ± 1.7a 18.3 ± 0.8° 
d 143 pp 17.5 ± 1.7a 15.4 ± 1.7ab° 13.0 ± 1.4b 19.0 ± 1.7a 16.2 ± 0.8* 
d 146 pp 18.0 ± 1.9 18.5 ± 2.1*° 14.1 ± 1.5 17.8 ± 1.9 17.1 ± 0.9°* 
Unidentified proteins, % of total protein 
d 25 pp 6.20 ± 0.99 5.10 ± 1.06 5.37 ± 0.88 6.00 ± 1.07 5.67 ± 0.501 
d 28 pp 6.46 ± 0.99 4.65 ± 0.99 6.56 ± 0.94 6.33 ± 1.07 6.00 ± 0.50 
d 31 pp 6.49 ± 0.99 4.73 ± 0.99 5.21 ± 0.881 6.22 ± 0.99 5.66 ± 0.48 
d 140 pp 6.84 ± 0.99 5.93 ± 0.99 7.05 ± 0.88 8.03 ± 0.99 6.96 ± 0.48 
d 143 pp 7.10 ± 1.06 5.74 ± 0.99 6.12 ± 0.84 8.18 ± 0.99 6.79 ± 0.49 
d 146 pp 6.81 ± 1.18 4.47 ± 1.37 7.35 ± 0.88 6.17 ± 0.18 6.20 ± 0.58 
abAlphabetic superscripts indicate differences between groups within time point (P < 0.05). 
*°#Symbolic superscripts indicate differences between time points within a feed restriction 
and within groups (P < 0.05). 
1Superscripted 1 indicates difference (P < 0.05) of day in FR during early lactation (d 25, 
28 and 31 pp) compared to day in FR during mid-lactation (d 140, 143 and 146 pp, 
respectively). 
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V.  DISCUSSION 
1. Experimental animals 
Grouping according to FCM and milk protein content during d 23 to 25 pp of the 23 cows resulted 
in groups differing in those parameters, even if single animals seemed not to fit in their respective 
group (e.g. 14030 03870 with 40.97 kg/d in MP-cows). However after omitting these animals, 
groups and significant results did not change, so they were further included in the study. 
Mean milk and blood parameters 
As intended, mean milk yield, FCM and ECM values during 4th week of lactation in high yielding 
cows surpassed those in low yielding cows as did protein concentration in high protein cows 
compared to low protein cows. 
Over the course of the whole experimental period of 155 d most differences or non-differences 
between respective groups remained throughout times of improved metabolic and energetic status. 
This could be explained by the genetic influence on milk yield and milk protein concentration. 
However, milk yield and milk protein content of some individual animals after 155 d of lactation 
deviated from respective means of early selected groups. One reason could be found in differences 
in the metabolic reaction to a negative energy balance during early lactation with concomitant 
influence on milk yield and milk protein content. Particularly, MP- and mP-cows differed in 
average milk protein concentration. This agrees with previous findings which show that high milk 
yield is associated with lower concentrations of constituents (Teepker and Swalve, 1988). 
However, milk fat concentration was highest in MP-cows resulting in highest FPR and they 
showed numerically highest blood serum NEFA throughout first 22 weeks of lactation. It can be 
concluded that those cows produced the highest amount of milk energy during that time period. 
Nevertheless, they mobilised only 32% of their back-fat throughout experimental period. Previous 
studies showed that not only excessive mobilisation of body fat, but rather individual factors 
contribute to degree of metabolic imbalance (Ingvartsen et al., 2003; Hammon et al., 2009). Most 
excessive fat mobilisation was observed in mP-cows  (-63%). However this did not lead to 
increased blood serum NEFA levels neither in mean values nor in values during early lactation as 
reviewed by Drackley (1999), but milk fat concentration was higher compared to low protein 
cows. Nevertheless mP-cows seemed not to be impaired in metabolism, showing low FPR and 
numerically lowest blood serum NEFA and BHBA values. 
Yields of milk protein (0.92), fat (0.77) and lactose (0.96) are positively correlated to milk yield 
(Teepker and Swalve, 1988; Shahbazkia et al., 2010) and therefore highest in high yielding cows. 
Overall highest SCC could be observed in the 5 mP-cows. This is due to the single cow with the 
only clinical case of mastitis during wk 5 pp and the three cows showing elevated SCC during two 
consecutive weeks in the study. 
Course of milk parameters 
Throughout the experiment, all cows showed typical lactation curves with steep increases of milk 
yield, FCM and ECM after calving. Protein concentration reached a nadir in wk 6 pp and increased 
constantly afterwards. 
In low yielding cows, FCM and ECM did not increase after wk 2 pp although milk yield did. This 
is explained by the slightly sharper decrease in milk constituents compared with high yielding 
cows during that time period. As a result of high milk yield, economic valuable milk protein yield 
was highest in Mp- and MP-cows during the first 3 weeks of lactation and throughout 
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experimental period. In Mp-cows highest values were observed during the first week of lactation 
and values decreased thereafter. This is due to the sharp decrease in milk protein concentration 
which could be a result of ruminal microbial energy shortage (Brun-Lafleur et al., 2010). Contrary 
to intended similarity of protein yield between Mp- and mP-cows, values were still different at the 
end of the experimental period due to the persistent influence of milk yield on this parameter. 
However, milk protein concentration of mP-cows after 22 weeks was at a very high level (4.07%) 
as compared to Mp-cows (3.19%). A further increase in milk protein concentration of mP-cows 
could be expected towards the end of lactation which might blur the differences.  
In Mp-cows during wk 9 pp, one cow showed exceptional low protein concentration (2.22%) and 
in wk 10 pp another cow high concentration (4.05%), resulting in lower and higher mean milk 
protein concentration compared to previous and following week (figure 10). Milk fat concentration 
shows high fluctuation throughout lactation and from milking to milking (Quist et al., 2008). 
Furthermore milk fat concentration decreases with increasing amount of feeding rapidly fermented 
carbohydrates due to diminished synthesis of short chain fatty acids (leading to rumen acidosis) 
and is increased by enhanced body fat mobilisation due to insufficient energy intake or decreased 
energy output (e.g. lactation, gravidity; van Knegsel et al., 2005). 
Milk hydrocortisone could be used as a diagnostic marker of chronic stress in animals. In wk 2 pp 
one mP-cow showed a highly increased hydrocortisone level (18.7 nmol/L). This cow was over-
conditioned (BCS 4.5) before parturition. Furthermore lameness and inflammation of interdigital 
space were diagnosed one week pp. Moreover during wk 19 pp, one MP-cow showed unusual high 
milk hydrocortisone levels due to an inflammation of subcutaneous tissue following muscle biopsy 
three days earlier. Fisher et al. (2002) showed elevated basal blood levels of hydrocortisone in 
lying deprivated cows. In contrast to van der Kolk (1990) and consistent with Patel et al. (1996), in 
our study milk hydrocortisone did not decrease during first 22 weeks of lactation. 
Course of blood serum parameters 
Remarkable high blood serum glucose levels in mp-cows at day of parturition were observed. 
Sampling took place within 24 hours after calving and mp-cows showed unintentionally lowest 
average sampling time (6 h pp). Therefore, results of blood sampling could be influenced by the 
physiological high blood glucose level during calving (Silva-del-Río et al., 2010). 
Massive metabolic transformation processes for preparation of parturition and lactation already 
take place during prepartal transition period. This is reflected among others by enhanced 
gluconeogenesis and fat mobilisation (Loor et al., 2005; Ingvartsen, 2006; van Dorland et al., 
2009). In the present study, only Mp-cows showed numerically higher blood serum NEFA levels 
prior to parturition which had been associated recently with higher risks of postpartum diseases 
(Piechotta et al., 2012). However, most of cows reached critical (1,000 µmol/l; Chapinal et al., 
2011) and maximum levels in wk 2 pp and NEFA values declined constantly thereafter (Grummer 
et al., 2004). 
Consequently, blood serum BHBA increased in all cows after parturition above 0.5 mmol/L and 
reached maximum levels at d 8 pp. In two mp-cows highly increased blood serum BHBA levels 
were observed from d 15 to 22 pp and one cow showed BHBA levels over 1.5 mmol/L at d 8, 15 
and 22 pp. However, no concurrent excessive body fat mobilisation or weight loss nor enhanced 
ketogenesis as described by Grummer (1993) and Hegardt (1999) could be found in these cows. 
Graber et al. (2010) also described elevated blood BHBA levels without enhanced ketogenesis due 
to elevated abundance of HMGCS2 mRNA. As all cows received the same feed ration, elevation 
due to uptake of ketogenic substances, e.g. fermentation product butyric acid in wet silages or 
supplementation with butanediol (Mills et al., 1986) can nearly be excluded.  
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In accordance with Herdt and Smith (1996), blood serum cholesterol levels of cows in the present 
study were lowest at day of parturition and increased afterwards. Furthermore high yielding cows 
showed higher blood serum cholesterol levels from wk 6 pp on. Previous studies showed that 
blood cholesterol levels are positively correlated to milk yield, but not to milk fat yield or 
concentration. This is due to the simultaneous transport of triacylglycerols and cholesterol in 
lipoproteins, which supply mammary gland with fat precursors (Palmquist and Mattos, 1978; 
Mazur et al., 1992). Moreover low levels of blood cholesterol at the beginning of lactation indicate 
higher risk of fatty liver disease, due to impairment of hepatic lipoprotein synthesis (Rayssiguier et 
al., 1988; Mazur et al., 1989). 
Blood serum bilirubin is elevated in early lactation due to its diminished hepatic uptake in favour 
of NEFA uptake (Reid et al., 1977). In the study of Steen (2001) diseased liver was obvious, if 
total bilirubin exceeded 6.0 µmol/L and one of the liver-specific enzymes aspartate 
aminotransferase, glutamate dehydrogenase or gamma-glutamyl transferase was elevated. In the 
present study, all cows exceeded critical values of blood serum tBR up to d 22 pp. 
Body condition parameters 
Cows showed typical course of body condition parameters with declining weights, BCS and BFT 
throughout early lactation (Drackley, 1999; Ingvartsen and Andersen, 2000; Grummer et al., 
2004). Nevertheless, mP-cows gained more weight from wk 6 pp on and BCS increased from 
wk 12 pp on. The reason could be that mP-cows reached positive energy balance after parturition 
faster due to lower energy outputs in milk (ECM) compared with high yielding cows. 
Cyclicity and health status 
Three cows were excluded from statistical analysis of cyclicity because of ovarial cysts. One mp-
cow suffered inflammation of uterus (retained placenta) and the other two Mp-cows showed 
during first six weeks overall highest FCM yield (48.5 ± 0.41 kg/d) and second highest ECM yield 
(52.2 ± 1.24 kg/d). According to Walsh et al. (2011) are the two main reasons leading to decreased 
fertility infectious diseases of genital tract and risk of metabolic imbalances over the course of 
peri-parturient period due to high milk yields. Dairy cows in good nutritional state ovulate around 
d 15 pp (Crowe, 2008). In the present study cows ovulated at d 23 ± 2 pp but within the 
physiological timeframe up to approximately 30 days pp. However, only 40% of Mp-cows 
ovulated before d 30 pp (average d 31 ± 4 pp) indicating higher fertility problems in those animals.  
Incidence of lameness and retained placenta was highest in high yielding dairy cows, whereas mp-
cows showed lowest incidence of clinical diseases. Previous studies confirmed that high yielding 
dairy cows are more susceptible to diseases (Mallard et al., 1998; LeBlanc, 2010), whereas 
Ingvartsen et al. (2003) found only positive correlation between milk yield and infectious risk of 
mammary gland and associate degree of increasing milk yield until peak yield with higher 
incidence of diseases.  
100 day performance 
For previous lactation, 100 day performance of milk yield, milk protein and fat concentration was 
calculated according to procedure of Arbeitsgemeinschaft Deutscher Rinderzuechter e.V. (Bonn), 
which uses milk performance test data of every four weeks. In contrast, 100 day performance of 
milk yield during experimental lactation was calculated by summing up daily milk yields and 
weekly means of milk fat and milk protein yield were multiplied by 7 and then summed. Therefore 
100 day performance of previous lactation is based on the first three milk performance 
measurements, whereas performance in current lactation based on 91 measurements for milk yield 
and 27 measurements of milk fat and protein yield, consequently aggravating comparison. 
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In Mp-cows 85% of cows were in second lactation during the study and showed higher milk yield, 
milk fat and protein yield compared to previous lactation. Fleischer et al. (2001) and Sejrsen 
(1994) showed that development of mammary gland is not completed with onset of first lactation 
and milk output increases further in second lactation. Yet, due to the high proportion of heifers in 
the original herd (49%), intended selection of solely multiparous cows fitting to all groups was not 
feasible. 
Recapitulation 
Based on milk, blood serum and body condition parameters, high yielding cows seemed to be in 
severest metabolic stress during early lactation. However mP-cows mobilised more body fat 
reserves compared to other groups but restored those early in mid-lactation. Furthermore mp-cows 
showed in part unclear individual metabolic adaptations. Fertility of Mp-cows seemed to be 
diminished in this study. Considering the fact that MP-cows did not show signs of abnormal 
fertility further detailed studies with more animals could shed light on reproductive problems of 
high yielding dairy cows with different milk protein concentration. 
2. Hepatic mRNA expression during lactation 
Lipid metabolism 
Elevated NEFA and BHBA levels in blood due to reduced DMI in peri-parturient period increase 
expression rates of hepatic transcription regulation factors HNF4A and PPARA. Therefore they 
promote β-oxidation of fatty acids and enhance expression of ACADVL, CPT1A and ECHS1 
mRNA (Mandard et al., 2004; Odom et al., 2004; Loor et al., 2005). 
Abundances of mRNA involved in β-oxidation of fatty acids and their transcription regulation 
factors were diminished in mp-cows at d 15 pp which is reflected by the lowest blood serum 
BHBA at that time point. This suggests lower body fat mobilisation in these cows during the first 
two weeks of lactation or delayed enhancement of hepatic fatty acid oxidation until d 57 pp, when 
mRNA levels were similar amongst cows. Solely mRNA of translation factor EIF4B, triggered by 
decreasing DMI and EB stayed on higher levels in mp-cows, similar to others. Furthermore, Mp-
cows showed higher levels of ACADVL mRNA at d 57 pp and MP-cows at d 155 pp, both 
compared to mP-cows. Also, MP-cows had higher levels of ECHS1 mRNA compared to mp-cows 
at d 155 pp. This could indicate enhanced fatty acid oxidation in these cows even during mid-
lactation. 
Hepatic fatty acid synthesis is also positively influenced by elevated NEFA levels in blood through 
enhanced expression of SREBF1 mRNA. This is a transcription regulation factor for GPAM 
mRNA, encoding the enzyme of initial step in triacylglycerol synthesis. Furthermore, elevated 
levels of PPARA mRNA diminish SREBF1 expression (Loor et al., 2005; 2006). 
In all cows, SREBF1 mRNA levels increased until end of study as did ACACA and GPAM until 
d 57 pp. These results go in line with Loor et al. (2005), who found increasing transcript 
abundances for SREBF1 and GPAM throughout early lactation. Kim et al. (2004) and Romics et al. 
(2004) reported that up-regulation of SREBF1 in mice was followed by up-regulation of GPAM. 
These modifications were important for adaptation to the greater influx of NEFA into liver. 
Additionally, Ueki et al. (2004) described increased expression of SREBF1 leading to fatty liver in 
mice. 
Carbohydrate metabolism 
Transcription regulation factors HNF4A and PPARA are also involved in regulation of hepatic 
gluconeogenesis, HNF4A promotes PCK1 expression and PPARA expression of PC (Loor et al., 
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2005; 2006). 
All cows except of Mp-cows showed highest PC mRNA levels at d 1 pp. With onset of lactation, 
increase in milk yield and demand for lactose is associated with up-regulation of PC mRNA levels 
(Greenfield et al., 2000).  
Hepatic levels of PCK1 mRNA increased steeply in mp-cows from d 1 to 57 pp, whereas Mp- and 
mP-cows showed only slow increases. In MP-cows, PCK1 abundance was elevated within two 
weeks after parturition. Comparable results were reported by Greenfield et al. (2000). Up-
regulation of PCK1 during early lactation in the current study is associated with the large demand 
of glucose for milk synthesis and a result of increased gluconeogenesis. Nevertheless, high 
yielding Mp-cows seemed to have diminished gluconeogenesis potential due to slower increasing 
mRNA abundance of PCK1 mRNA and lower PC mRNA in early lactation.  
Protein metabolism 
Hepatic mRNA TAT and CTSL encode for proteinases associated with amino acid catabolism 
which is diminished during peri-parturient period (Loor et al., 2005). The present data revealed a 
down-regulation of CTSL and up-regulation of TAT in all cows on d 155 pp compared to time 
points in early lactation. Moreover MP-cows showed lower mRNA levels of CTSL at d 1 and 
15 pp compared to mp-cows. Enhanced activities of TAT and CTSL are associated with increased 
amino acid fragments, partly used for gluconeogenesis or ketogenesis. Regarding diminished fatty 
acid oxidation and regular gluconeogenesis in mp-cows, these animals probably met enhanced 
requirements in early lactation from amino acids. 
Glucose metabolism 
In mp-cows, abundance of insulin independent glucose transporter SLC2A2 mRNA was lower at 
d 15 compared to 57 pp. This glucose transporter is mainly involved in release of hepatic glucose 
and regulation of insulin secretion from β-cells (Zhao and Keating, 2007). Therefore, mp-cows 
seemed to show lower hepatic glucose output two weeks after parturition. Furthermore Mp-cows 
showed lowest SLC2A2 mRNA abundance at day of slaughtering compared to earlier time points 
and compared to low yielding cows. However in contrast to Rencurel et al. (1996), Mp-cows 
showed not significantly lower blood glucose levels at this time. 
At day of parturition, hepatic INSR mRNA abundance was highest in mP-cows compared to high 
yielding cows. According to Liu et al. (2010), high yielding cows seemed therefore to show higher 
risk for fatty liver. Moreover, high levels of insulin lead to a decrease in INSR mRNA expression 
in calf hepatocytes (Zhang et al., 2011). This could be an explanation for mP-cows showing lower 
INSR abundance at day of slaughter compared to Mp-cows and also supporting the fact that basal 
insulin levels during ivGTT (d 127 pp) were lowest in Mp-cows.  
Moreover, hepatic ketogenesis occurs commonly during peri-parturient period reflected in mRNA 
changes of control enzyme 3-hydroxy-3-methylglutaryl-CoA synthase 2 (Voet and Voet, 2004; 
Loor et al., 2005). In contrast, van Dorland et al. (2009) and Graber et al. (2010) found no different 
HMGCS2 expression during early lactation. In the current study, hepatic ketogenesis seemed to be 
diminished at day of parturition in all cows except of mP-cows and increased to maximum at d 15 
pp. Afterwards, Mp-cows showed lower levels of HMGCS2 mRNA at d 57 pp compared to MP-
cows and at day of slaughter compared to high protein cows. Despite of high milk yield in Mp-
cows, these cows either seemed to achieve their energy demands by reaching of maximum feed 
intake fastest or ketogenesis was diminished due to hepatic dysfunction. 
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Common metabolism 
Hepatic levels of CS mRNA were similar amongst all cows and time points, indicating no 
impairment of hepatic citric acid cycle. 
Abundance of hepatic TNFA mRNA was higher in mP-cows at day of parturition compared to 
d 155 pp and similar results were observed by Loor et al. (2005). Diminished levels of TNFA 
mRNA in MP-cows could be related to decreased body fat mobilisation (Loor et al., 2005), 
however blood serum NEFA levels and body condition parameters did not reflect diminished 
lipolysis. 
Abundance of IGF1 mRNA was higher in mp-cows at d 57 pp compared to earlier time points and 
in mP-cows compared to day of parturition. According to Fenwick et al. (2008), these results 
indicated enhanced negative EB in mP-cows at parturition and in mp-cows during first two weeks 
of lactation. They also found elevated IGF-1 blood levels whereas Graber et al. (2010) observed 
highest plasma levels at wk 3 ap and decreasing levels until wk 4 pp. 
Recapitulation 
Hepatic mRNA abundances of key enzymes in lipid, protein and carbohydrate metabolism were 
similar in cows observed here compared to previous studies. 
Furthermore, mp-cows seemed to differ in metabolism during early lactation due to enhanced 
protein catabolism instead of lipolysis. Nonetheless, high yielding cows and especially Mp-cows 
showed higher risk for fatty liver development and seemed to have diminished gluconeogenesis 
potential. 
3. Feed restrictions 
In immediate postpartum period, negative EB leads to a marked decrease in milk protein 
concentration and therefore to an undesirable loss in average 305-d milk protein yield (Depeters 
and Cant, 1992; Murphy and Omara, 1993; Walker et al., 2004). However, the base level of the 
nadir in milk protein concentration during early lactation varies between animals according to 
individual metabolic and endocrine adaptation capacities to nutritional shortage and to genetic 
background of cows (Kessel et al., 2008). It was possible in the current experimental trial to 
evaluate those physiological adaptive responses in cows with significantly different milk protein 
concentrations during early lactation and concomitant significantly varying FCM yield under same 
housing and feeding conditions.  
DMI intake and energy balance 
For individual measurement of feed intake cows were brought to a tie stall with separated feed 
troughs and with eye contact to the herd. Although cows were accustomed to cubicle housing 
system, no effects on behaviour such as excessive mooing or restlessness were detected during 
tied-stall housing. Average DMI of all animals was 17.9 ± 0.59 kg at d 25 pp and 20.5 ± 0.61 kg at 
d 140 pp, therefore slightly higher compared to previously reported DMI for multiparous cows in 
wk 4 and 20 pp (approx. 16 and 18 kg; Ingvartsen and Andersen, 2000). 
As expected, mp-cows showed lowest ad libitum DMI. This could either be associated to 
endocrine feed intake regulation due to low energy demand for milk production or to individual 
low feed intake which results in a low milk production (Baile and McLaughlin, 1987). The short-
term FR intended to decrease DMI to 70% of average DMI of d 23 to 25 pp and d 138 to 143 pp, 
which was only roughly met. During FR in early lactation MP-cows showed 65.9, mp-cows 66.5, 
Mp-cows 71.9 and mP-cows 72.1% of previous DMI, whereas during FR in mid lactation, DMI 
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was even lower (68.9, 69.0, 65.6 and 68.2% in MP-, mp-, Mp- and mP-cows). Particularly during 
mid-lactation, cows adopted slowly to straw-supplemented RD. Moreover, hyperketonaemia could 
have decreased feed intake in early lactation. Nonetheless, this metabolic challenge had to be faced 
by all animals during FRs. These results are supported by the well-known fact that during early 
lactation energy intake regularly lags behind milk-production related energy demands leading to a 
NEB (Bell, 1995; Drackley, 1999).  
All ad libitum fed cows, regardless of group membership, experienced negative EB at d 25 pp 
(average -57.1 ± 4.84 MJ NEL), but negative EB during early lactation was even lower compared 
to Kessel et al. (2008; approx. -35 MJ NEL). Energy balance of low protein cows was also negative 
at d 140 pp (average -15.9 ± 9.48 MJ NEL). 
On the first day of FRs, severe decline of EB was found in all cows. High yielding cows showed 
most negative values, whereas mP-cows in early and mp-cows in mid-lactation showed only slight 
decreases. Subsequently, on the second day of FR, EB increased slightly in high yielding cows 
during early lactation and in all cows during mid-lactation. These findings reflect the fast 
metabolic adaptation of high yielding animals to increased negative EB in early lactation and the 
greater potential to cope with metabolic challenges in mid-lactation. 
Milk parameters  
As expected, milk yield declined during restricted feeding but decrease was not significant in mP-
cows. Furthermore, FCM yield decreased only in high yielding cows and only during FR in early 
lactation, showing disturbance of milk production due to restricted feeding in those cows. 
In agreement with Nielsen et al. (2003) and Agenäs et al. (2003), milk protein concentration of low 
protein cows was unaffected by both FRs, whereas in high protein cows during early lactation and 
in MP-cows also during mid-lactation protein content of milk decreased. Agenäs et al. (2003) 
illustrated a distinct decline in milk protein concentration during subsequent first two days of 
realimentation. In the present study, milk protein concentration also declined to a nadir two days 
after FR in early lactation, but not during FR in mid-lactation. As expected due to the decreased 
milk yield and milk protein concentration, milk protein yield also declined over the course of FRs.  
Moreover in all cows, milk fat concentration did not vary during FRs and milk fat yield decreased 
only in MP-cows during FR in early lactation due to decreased milk yield. These results are 
supported by Guinard-Flament et al. (2007) and Carlson et al. (2006), but differ from other studies 
with longer FR periods, where FR led to decreasing milk fat yields (Velez and Donkin, 2005). 
Throughout the experiment, milk lactose concentration was constant in all cows except of mp-
cows in FR during early lactation. Constant milk lactose content can be explained by the osmotic 
role of lactose and the fact that milk volume is mainly depending on lactose synthesis (Linzell and 
Peaker, 1971).  
As shown before, lowest level of protein content was reached on the second day of refeeding in 
early lactation, while milk fat and lactose content were not responsive to the reduced feeding level 
and no influence of FR was observed during mid-lactation. The subsequent minimum of protein 
content in FR during early lactation is not unusual, as fat and lactose synthesis have top priority 
due to breeding preferences over the last decades. Also, fat mobilisation is the prior feedback on 
unsatisfying energy supply in dairy cows. Beside this, if the deficiency lasts, changes in protein 
metabolism towards catabolism will occur. 
Cows displaying FPR more than 1.5 during early lactation are at risk for ketosis or are already 
affected with it (Heuer et al., 1999). All cows showed higher FPR values during FR in early 
lactation as well as in mid-lactation reflecting the increase in blood serum BHBA values during 
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those time periods. Prior to FRs, FPR was elevated only in early lactation. 
Although no signs of clinical mastitis could be observed, SCC increased steeply in two mP-cows 
during FR in early lactation and in one mp-cow after FR in mid-lactation. On the one hand this is 
certainly due to individual variations in resistance to mammary infections, on the other hand due to 
higher incidence of mammary gland infections in tie stalls (Valde et al., 1997). 
Regarding milk hydrocortisone content, it is well known that high milk yield and concurrently 
large energy deficit as well as ketosis are correlated to lower hydrocortisone levels (Torres et al., 
1997; Beerda et al., 2004; Forslund et al., 2010). Fisher et al. (2002) observed no effects of 
moderate feed restriction on hydrocortisone levels. As expected, milk BHBA-levels increase 
during FR, but differences proved to be significant only in mp-cows. 
Blood serum parameters  
As previously shown, blood serum glucose levels decreased during FR in early lactation in all 
groups and reached the initial level during subsequent ad libitum feeding (Nielsen et al., 2003; 
Loor et al., 2007). Nonetheless in mid-lactation, differences proved not to be significant due to 
diminished milk output, higher feed intake and less severe negative energy balance. 
Insufficient energy supply results in lipolysis of adipose tissue and circulating NEFAs in blood are 
supplied to β-oxidation in hepatocytes (Mashek and Grummer, 2003). In agreement with previous 
results, blood serum NEFA concentrations increased in all groups until second day of FR in early 
lactation and reached initial levels during subsequent ad libitum feeding (Nielsen et al., 2003; Loor 
et al., 2007). Furthermore, average blood serum NEFA levels rose in all groups above threshold 
levels of 1,000 µmol/L during restricted feeding, whereas during FR in mid-lactation no 
significant increases could be observed and levels stayed well below the threshold level. Lower 
serum NEFA levels in mid-lactation suggested a more stable metabolic status together with a 
sustained physiological serum glucose concentration.  
Due to deficiency of glucose, the product of β-oxidation Acetyl-CoA is not metabolized in citrate-
cycle and induces ketogenesis during negative EB (Zammit, 1983). Blood serum BHBA levels 
increased in all groups drastically up to the third day of FR in early lactation above threshold 
values for subclinical ketosis of 1.2 - 1.4 mmol/L (LeBlanc, 2010), whereas during mid-lactation, 
no increases were observed.  
Blood serum cholesterol showed only slight increase in MP-cows during FR in early lactation, 
whereas during mid-lactation levels were lower after refeeding in low protein cows. Drackley et al. 
(1992) showed that during first week of FR in early lactation and during realimentation, blood 
cholesterol concentrations increased slightly. Moreover, Gerloff et al. (1986) reported negative 
correlation of serum cholesterol with hepatic triglyceride content. Therefore, Mp-cows seemed to 
show higher susceptibility to hepatic steatosis even in mid-lactation. 
In contrast to Reid et al. (1977), who found increasing serum bilirubin concentrations during 
fasting, the present study revealed no distinguishable patterns. Differences proved to be significant 
only during FR in early lactation in Mp-cows showing declining levels from first to second day of 
FR and in mp-cows, showing increasing levels during first day of FR and afterwards declining 
until refeeding. 
However, results show large animal-to-animal variation in all measured blood metabolites 
regardless of group membership. Earlier, Baird et al. (1972) showed that starvation induced 
different compensatory modifications in individual cows. 
 
V. Discussion   124 
Hepatic mRNA profile 
Throughout both FRs, several significant changes of hepatic mRNA abundances occurred.  
In all cows, abundance of mRNA encoding for enzymes of fatty acid oxidation was enhanced by 
FR in early lactation, whereas FR in mid-lactation resulted only in mild and variable increases. 
Moreover, high yielding cows showed higher levels of mRNA compared to mp-cows during both 
FRs. Patterns of elevation in translation and transcription regulating factors with influence on fatty 
acid oxidation could be observed similarly in all cows for EIF4B influence on ECHS1 during both 
FRs as well as during FR in early lactation for EIF4B and HNF4A on ACADVL and CPT1A and 
for PPARA on ACADVL (Drackley, 1999; Loor et al., 2005; 2006). The only translation or 
transcription regulating factor differing between FRs was HNF4A with higher levels in Mp-cows 
during early lactation, suggesting enhanced gluconeogenesis and fatty acid oxidation (Loor et al., 
2005).  
In contrast to Loor et al. (2007), who reported down-regulation of ACACA associated with FR in 
high yielding cows, ACACA and also GPAM mRNA levels were decreased in all cows except of 
Mp-cows by FR in early lactation. During FR in mid-lactation, MP-cows showed decreased and 
Mp-cows increased mRNA levels. Levels of transcription regulation factor SREBF1 decreased at 
least numerically during FR in early lactation in all cows, except of Mp-cows (Loor et al., 2005; 
2006). In Mp-cows, higher levels of hepatic mRNA encoding for enzymes of fatty acid synthesis 
might suggest a higher risk of hepatic steatosis (Romics et al., 2004; Ueki et al., 2004). 
Hepatic proteinases TAT and CTSL showed higher mRNA levels in all cows after FR in early 
lactation and CTSL mRNA was higher after FR in mid-lactation in all cows except of MP-cows. 
Therefore FR in early lactation resulted in enhanced amino acid catabolism, whereas during FR in 
mid-lactation only CTSL was induced, producing precursors for gluconeogenesis or ketogenesis. 
Although PPARA and HNF4A regulate transcription of PC and PCK1 mRNA (Loor et al., 2005; 
2006), their expression patterns were not similar to those of PC and PCK1. Unlike FR in mid-
lactation, FR in early lactation increased PC mRNA abundance. In contrast, PCK1 abundance was 
elevated during FR in mid-lactation and highest in Mp- and mP-cows. Therefore, hepatic 
gluconeogenesis was enhanced by both FRs and Mp-cows showed highest PC levels in early 
lactation and highest PCK1 levels in mid-lactation. 
Transcript abundance of SLC2A2 was not influenced by FR in early lactation, whereas during mid-
lactation, Mp-cows showed higher and mp-cows lower abundances. Due to increased 
gluconeogenesis in Mp-cows during FR in mid-lactation, hepatic output and therefore expression 
of SLC2A2 mRNA seemed to increase according to Zhao et al. (1993). 
Both FRs altered mRNA abundance of INSR: during early lactation, Mp-cows showed higher 
levels and during mid-lactation, mp-cows showed reduced levels. Selection for milk yield results 
in low circulating insulin concentrations (Bonczek et al., 1988) and thus in higher hepatic INSR 
mRNA (Zhang et al., 2011). The opposite could happen during FR in mid-lactation in mp-cows. If 
they showed high insulin concentrations, which is supportable due to less milk output and 
restoring of body reserves, hepatic INSR abundance would have decreased. 
Elevated levels of HMGCS2 mRNA in Mp-cows during both FRs show clearly that also during 
mid-lactation, metabolic impairment can be simulated in high yielding cows. Also Hegardt et al. 
(1999) observed increased activity of HMGCS2 in fasting rats, whereas van Dorland et al. (2009) 
and Graber et al. (2010) found no changes in HMGCS2 expression in cows during early lactation. 
Baird et al. (1972) found slight decreases of citrate synthase activity after starvation and Heitzman 
et al. (1972) found significant correlation between concentration and activity of citrate synthase. 
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Therefore, reduced CS mRNA levels in mP-cows after FR in mid-lactation might contribute to 
lower enzyme activity. Reasons for this phenomenon remain to be elucidated.  
As previously shown, blood levels of IGF1 declined during FR (McGuire et al., 1992; Thissen et 
al., 1994). In the present study, similar results were observed after FR in early lactation: abundance 
of hepatic IGF1 mRNA decreased numerically in all cows and differences proved to be significant 
in low yielding cows, whereas no effect of FR in mid-lactation could be observed. 
Recapitulation 
Feed restriction during early lactation exacerbated metabolic imbalance, especially in high 
yielding cows. Physiological adaptation seemed to be in part diminished in cows with high milk 
yield and low milk protein concentration (Mp-cows). Although FR during mid-lactation provoked 
only lighter changes in metabolic adaptation, also Mp-cows seemed to be more susceptible. 
4. Intravenous glucose tolerance tests 
Due to technical reasons, cows were only subjected to ivGTTs, although HECs are considered to 
be the gold standard (Holtenius et al., 2000). Nevertheless, previous studies showed that ivGTTs 
are suited to characterise insulin response and glucose metabolism in lactating cows (Cummins 
and Sartin, 1987; Stangassinger, 2006; Chagas et al., 2009; Grünberg et al., 2011). Body weight 
and therefore amount of infused glucose decreased in all cows from ivGTT before parturition to 
ivGTT 2 and in MP-cows also to ivGTT 3, reflecting firstly a loss of total weight due to 
parturition, but secondly also mobilisation of body reserves to maintain lactation (Grummer et al., 
2004; Schröder and Staufenbiel, 2006). 
Blood glucose and blood plasma insulin 
Basal blood glucose was lower during ivGTT 2 (2.04 ± 0.06 mmol/L) in all cows due to glucose 
distribution to mammary gland and milk synthesis (Bell and Bauman, 1997). Basal blood glucose 
showed higher levels during ivGTT 2 in high protein cows (table 16), but milk yield in MP-cows 
was higher compared to mP-cows. This suggests better gluconeogenesis capacity in MP-cows, 
compared also to Mp-cows with similar milk yield but lower basal blood glucose at this day 
(Aschenbach et al., 2010; Loor, 2010). After infusion of glucose, all cows showed lower 
maximum blood glucose levels in ivGTT 2 compared to ivGTT 1 due to previously mentioned 
redirection of glucose to mammary gland. In ivGTT 2 compared to ivGTT 3, solely MP-cows 
showed higher maximum levels of blood glucose and also higher compared to low protein cows. 
This might lead to the conclusion that glucose withdrawal by mammary gland was lower 
compared to that of other cows due to lower expression of GLUT1. Also hepatic gluconeogenesis 
could exceed needs for milk production and therefore amounts of infused glucose elevated blood 
glucose more compared to other cows (Zhao and Keating, 2007; Graber et al., 2010). The latter is 
supported by the patterns of blood glucose increase: MP-cows showed higher increase of blood 
glucose and Mp-cows numerically higher increase during ivGTT 2 compared to low yielding 
cows. 
Basal glucose levels were reached again earlier in low yielding cows during ivGTT 1 compared to 
other cows and later in high yielding cows compared to other time points. This suggests reduced 
insulin responsiveness to glucose or reduced insulin sensitivity in high yielding cows before 
parturition. Sano et al. (1993) reported that insulin responsiveness to glucose is higher in dry cows 
compared to lactating cows, whereas tissue responsiveness to insulin (insulin sensitivity) remains 
unchanged. Furthermore, steepest decrease of blood glucose was found in mp-cows during ivGTT 
2, probably due to exceeding renal glucose threshold (Gould and Holman, 1993). 
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According to Blum et al. (1973) and Stangassinger (2011), basal blood plasma insulin levels were 
higher before parturition compared to levels during early and mid-lactation. Furthermore, insulin 
levels increase with energy balance of cows (Hart et al., 1979; Vasilatos and Wangsness, 1981), 
suggesting higher energy balance in mP-cows before parturition and in early lactation. Maximum 
as well as increase of blood plasma insulin (insulin response) were higher during ivGTT 1 in low 
yielding cows compared to ivGTT 2 and 3, similar to results of Sano et al. (1993), which also 
supports faster glucose clearance during ivGTT 1 in those cows at this time point. In contrast, 
insulin response proved not to be different between experimental days in high yielding cows. 
Moreover before parturition, insulin response in mP-cows was twice higher compared to Mp-cows 
due to one animal with exceptional high values (insulin increased by 1,709.7 µU/mL). 
Furthermore increase of blood plasma insulin was steeper, providing support that high yielding 
dairy cows experience considerable metabolic changes and also diminished tissue responsiveness 
to insulin prior to parturition (Prior and Christenson, 1978; Petterson et al., 1994; Drackley, 1999; 
Hayirli, 2006).  
It is well known that AUC of insulin and glucose, representing bioavailability of respective 
metabolites, declines from before parturition to early lactation (Subiyatno et al., 1996; 
Stangassinger, 2006; Grünberg et al., 2011). Low and high yielding cows show similar AUC of 
insulin and glucose during early lactation (Chagas et al., 2009) and also in the present study. As 
observed before (Bell, 1995; Subiyatno et al., 1996), CR of glucose was higher during lactation 
due to high secretion of glucose as milk lactose, but differences between cows proved not to be 
significant. 
Indices 
Regarding the IR estimation models HOMA-IR and QUICKI, one has to keep in mind that they 
are derived from human analyses. The denominator in calculation of HOMA-IR derives from basal 
levels of blood glucose and plasma insulin in humans. In the current study the product would be 
80.7 (2.68 mmol/L and 30.11 µU/mL, mean of all cows during ivGTT 1). According to 
Muniyappa et al. (2008) in healthy humans, HOMA-IR equals 1 and correlates positively to IR. 
With a denominator being 3.6 fold higher in cows at d 14 ap compared to healthy humans, 
HOMA-IR of 3.6 shows physiological IR in wk 2 ap and the other time points are compared to this 
time point. However MP- and mP-cows showed enhanced IR before parturition compared to low 
protein cows. In all cows, HOMA-IR decreased to ivGTT 2 and showed similar levels during 
ivGTT 3 in high protein cows. Nevertheless, in humans with severely impaired or absent 
pancreatic β-cell function, HOMA-IR provides no appropriate results (Muniyappa et al., 2008). 
However regarding QUICKI, similar patterns were observed: QUICKI was overall highest during 
ivGTT 2, suggesting decreased IR (Holtenius and Holtenius, 2007; Muniyappa et al., 2008). 
Moreover, high protein cows showed lower QUICKI during ivGTT 2 compared to other cows. 
These results go in line with Hayirli (2006), Baird (1981), Sano et al. (1993) and others showing 
that reduced tissue sensitivity to insulin is a complex regulated physiological process to ensure 
nutrition of the offspring. It starts in late pregnancy due to insulin independent glucose distribution 
to uterus and foetus and leads further in early lactation to insulin independent mammary glucose 
uptake and lactose synthesis. Therefore it was expected that high yielding cows showed also 
highest IR (Chagas et al., 2009), whereas in the actual study highest IR was observed in high 
protein cows during ivGTT 1 and 2.  
Recapitulation 
The present study supports the well known facts of metabolism in dry and lactating cows. 
Furthermore, differences in cows grouped for milk yield and milk protein content can be observed: 
high yielding cows seemed to show gluconeogenesis activity meeting demands of milk synthesis 
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in early lactation and MP-cows seemed even to exceed the needs of mammary gland. Insulin 
sensitivity was reduced in high yielding dairy cows prior to parturition and mP-cows seemed to be 
in better energetic situation compared to other cows. Furthermore, no differences in bioavailability 
of glucose or insulin and glucose CR in early lactation were found amongst the cows. 
During ivGTT before parturition and in early lactation, high protein cows showed highest IR, 
distributing most of glucose to foetus or mammary gland. Therefore during early lactation, cows 
with lower milk yield (mP-cows) show higher body tissue utilisation of glucose, which is 
according to Rose et al. (1997) mainly insulin-independent. 
5. Milk protein fractions 
For the first time, high reproducible and high throughput capillary electrophoresis was used to 
determine composition of milk protein during course of lactation. 
Composition of milk protein during 22 weeks of lactation 
Regarding the concentrations of individual milk proteins, the present study showed higher values 
of α- (34.3 compared to 19.6%) and β-CN (31.9 compared to 28.2%) compared to Bobe et al. 
(2007). This resulted in lower total concentrations of whey proteins (17.7%) and higher 
concentrations of total caseins (82.3%) compared to Mackle et al. (20.8 and 79.2%; 1999), 
whereas Bobe et al. (2009) observed lower whey protein concentrations (14.2%) and higher casein 
concentrations (85.8%). Partly these differences are due to the different determination methods 
(HPLC and PAGE) as seen for other proteins by Goetz et al. (2004). 
Throughout the study, α-CN was higher in Mp-cows compared to low yielding cows. As was 
shown previously, high yielding dairy cows produce milk with higher concentrations of αS1-CN 
(Bobe et al., 2007), which represents about 75% of α-CN (De Marchi et al., 2009; Demeter et al., 
2010).  
Concentrations of β-CN were lowest in mP-cows from wk 14 pp on. It is well known that cows 
with β-LG genotype BB show higher relative amounts of all caseins (Ng-Kwai-Hang et al., 1987; 
Heck et al., 2009). Nevertheless, composite β-LG genotype AB was found in all low yielding 
cows, whereas in 66% of MP-cows genotype AB and 34% genotype AA was determined. In 57% 
of Mp-cows genotype AA, in 29% genotype BB and in 14% genotype AB was observed. 
Therefore it was expected that high yielding cows had lower casein concentrations compared to 
low yielding cows. Regarding concentrations of κ-CN, this could be confirmed comparing 
concentrations of Mp- with those of mp-cows. Moreover all Mp-cows expressed κ-CN genotype 
AA, whereas in mp-cows 20% genotype BB and 20% genotype AB were observed. Additionally, 
κ-CN genotype BB is associated with higher concentrations of α- and κ-CN, resulting in higher 
curd yield and firmness (Ng-Kwai-Hang et al., 1987; Heck et al., 2009). 
Further it has to be taken into account that concentrations of whey proteins increase during 
inflammations of mammary gland due to increased permeability of blood mammary barrier 
(Hogarth et al., 2004) and milk SCC is positive correlated to concentrations of α-LA, β-LG and α-
CN (Ng-Kwai-Hang et al., 1987). This could explain that concentrations of α-LA and β-LG and 
also SCC were higher in mP-cows during period 6. 
Concentrations of unidentified proteins reflect all proteins detectable in capillary electrophoresis 
except of above mentioned major proteins (e.g. BSA, IgG; Anema and Lloyd, 1999), but also 
proteolysis products developed by endogenous proteases like plasmin (Eigel et al., 1979; 
Reimerdes, 1983) or by microbial proteolytic activity (Haddadi et al., 2005). Furthermore, elevated 
SCC is associated with higher proteolysis in milk (Wedholm et al., 2008). Due to higher levels of 
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unidentified proteins in mP-cows during wk 14 pp and lower levels of β-LG and β-CN, these cows 
seemed to show higher proteolytic activity of β-LG and β-CN in milk. Similar results can be 
observed during wk 22 pp regarding concentrations of κ-CN and unidentified proteins in mP-cows.  
At time points of biopsies (muscle biopsy d 43 and 113 pp, liver biopsy d 57 pp), concentrations of 
whey proteins and κ-CN declined, whereas β-CN content increased and α-CN stayed on similar 
levels. Although tissue of cows was anesthetised, the biopsy procedure seemed to be a stressor for 
cows. Acute stress situations lead to increased values of adrenaline and noradrenalin and those 
diminish milk yield and alter nutritive blood flow to the mammary gland (Linzell, 1960; Prosser et 
al., 1996). 
Influence of FR on milk protein composition 
Although Auldist et al. (2000) found significant changes of all individual milk proteins during 
restricted pasture allowance in dairy cows having both β-LG genotype AA and BB. Bobe et al. 
(2009) found slightly decreased whey protein concentrations with declining α-LA and increasing 
β-LG and constant casein concentrations with slightly increased αS1-CN and decreased αS2-, β- and 
κ-CN concentrations. In the present study, no obvious differences amongst cows were observed in 
concentrations of individual proteins during both FRs. During FR in mid-lactation, whey proteins 
increased in mp-cows, probably due to elevated SCC at d 146 pp in those cows. Furthermore 
levels of α-CN were higher and levels of κ-CN lower in Mp-cows compared to low yielding cows, 
as seen during lactation. 
Regarding mean concentrations of individual milk proteins (table 19), levels of whey proteins and 
β-CN were higher and those of κ-CN were lower in FR during early lactation. Interestingly, 
restricted feeding influenced solely economically valuable κ-CN during mid-lactation, resulting in 
a decrease which was compensated after the three days of realimentation. 
Recapitulation 
Over the first 22 weeks of lactation, differences in concentrations of individual milk proteins could 
be observed in an expected manner. Furthermore the cows showed no obvious pattern of changed 
protein concentrations after a short term FR, neither during early lactation nor during mid-
lactation. Solely after FR in mid-lactation, mean concentration of κ-CN decreased. Therefore 
composition of major milk proteins seems to be influenced mainly by individual factors like 
genotype and health and is rather stable. 
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VI. CONCLUSION 
For the first time, two easy conductible and reproducible analytical methods were used: an EIA for 
hydrocortisone in skim milk and determination of milk protein composition during the course of 
lactation by capillary electrophoresis on a chip. Furthermore, cows grouped for FCM and milk 
protein concentration were characterised in metabolic and productive parameters. 
Regarding the presented results, it can be concluded that high yielding cows were in severest 
metabolic stress during early lactation, showed higher risk for fatty liver development and seemed 
to have diminished gluconeogenesis potential. In Mp-cows, these impairments were most obvious. 
Also an enhancement of the metabolic imbalance in early lactation by feed restrictions affected the 
high yielding cows and especially those with low milk protein concentration in the severest 
manner. Fertility of MP-cows seemed to be diminished. These results indicate that MP-cows are 
less susceptible to metabolic imbalances compared to those with low milk protein content (Mp-
cows). 
Furthermore mP-cows showed higher insulin resistance prior to parturition compared to MP-cows. 
Therefore mP-cows showed higher utilisation of glucose in body tissues during early lactation. 
Moreover, these cows lost more body fat reserves compared to other cows and solely these cows 
gained body weight and back-fat-thickness in mid-lactation. Regarding percentage amount of milk 
constituents in total energy output during experimental period, MP-cows showed highest values 
accounting for milk fat (57.9 ± 0.7%) and mP-cows highest amounts accounting for milk protein 
yields (19.4 ± 0.3%; table 20). Even though protein yield of mP-cows tended to be lower 
compared to MP-cows (P = 0.06), this shift in nutrient distribution results in higher nutrient 
density of protein in mP-cows (10.8 ± 0.2 g/MJ). 
In summary, it can be said that a possible way to reduce metabolic stress of high yielding dairy 
cows in early lactation, besides optimised feeding regime, could be selection of cows and bulls 
inheriting higher milk protein concentration and lower milk yield. This results in similar yields of 
milk protein, which is the most rewarded output of dairy cows, and concurrently improves health 
status of dairy cows in early lactation, a common aim of farmers and veterinarians. 
Table 20: Nutrient density of milk constituents during experimental period. 
  MP mp Mp mP 
milk constituent kJ/g total yield, kg 
protein 18.0 167.2 ± 6.2ac 143.9 ± 10.2bc 170.9 ± 3.9a 148.5 ± 4.9c 
fat 39.7 248.3 ± 9.6a 192.2 ± 14.1b 232.2 ± 6.9a 193.1 ± 8.8b 
carbohydrates 17.6 236.7 ± 9.9a 215.7 ± 13.4b 264.0 ± 7.9a 195.7 ± 6.8b 
  total energy output, GJ 
protein  3.0 ± 0.1ac 2.6 ± 0.2bc 3.1 ± 0.1a 2.7 ± 0.1c 
fat  9.9 ± 0.4a 7.6 ± 0.6b 9.2 ± 0.3a 7.7 ± 0.3b 
carbohydrates  4.2 ± 0.2a 3.8 ± 0.2ac 4.6 ± 0.1b 3.4 ± 0.1c 
  total energy output, % 
protein  17.7 ± 0.5a 18.5 ± 0.2ab 18.2 ± 0.3a 19.4 ± 0.3b 
fat  57.9 ± 0.7a 54.4 ± 0.6b 54.4 ± 1.0b 55.6 ± 0.9ab 
carbohydrates  24.4 ± 0.4a 27.1 ± 0.4b 27.4 ± 0.6b 25.0 ± 0.8a 
  nutrient density, g/MJ 
protein  9.8 ± 0.3a 10.3 ± 0.1ab 10.1 ± 0.2a 10.8 ± 0.2b 
fat  14.6 ± 0.2a 13.7 ± 0.1b 13.7 ± 0.2b 14.0 ± 0.2ab 
carbohydrates  13.9 ± 0.2a 15.4 ± 0.2b 15.6 ± 0.4b 14.2 ± 0.4a 
abcAlphabetic superscripts indicate differences between groups (P < 0.05). 
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VII. SUMMARY 
Metabolic and productive characterisation of multiparous cows grouped for fat-corrected milk 
yield and milk protein concentration 
Objective of this study was to determine health and productivity of cows grouped for fat corrected 
milk yield and protein concentration. Therefore 23 cows (6 cows with high FCM and high protein 
content, 5 with low FCM and low protein, 7 with high FCM and low protein and 5 cows with low 
FCM and high protein concentration) were examined from two weeks before parturition 
throughout the first 22 weeks of lactation. Regularly, milk and blood samples were collected and 
body condition observed. Cows were subjected to 30% feed restriction in early (d 26 to 28 pp) and 
mid-lactation (d 141 to 143 pp) to evaluate metabolic reaction. Three intravenous glucose 
tolerance tests (ivGTT; d -14, 20 and 127 pp) were conducted to assess differences in insulin 
response. Furthermore hepatic gene expression profiles were examined at day of parturition, d 15, 
57 and 155 pp as well as at the last day of both feed restriction periods. Measured target genes (20) 
play key roles in glucose transport, lipid, protein and carbohydrate metabolism as well as in 
ketogenesis. 
Milk, blood serum and body condition parameters revealed highest risk for metabolic imbalances 
of high yielding dairy cows during early lactation. Gene expression profiles indicated that high 
yielding and especially cows with high FCM and low protein concentration had higher risk for 
fatty liver development and diminished gluconeogenesis potential. Also, during feed restriction in 
early lactation, these cows seemed to have reduced physiological adaptation capacities to the 
exacerbated energetic imbalance. Nevertheless, results of ivGTTs suggest that high yielding cows 
show gluconeogenesis activity meeting demands of milk synthesis in early lactation and cows with 
high FCM and protein concentration even seemed to exceed the needs of mammary gland. Insulin 
sensitivity was reduced in high yielding dairy cows prior to parturition. 
Furthermore only cows with low FCM and high protein content were able to restore body reserves 
in mid-lactation. Regarding results of hepatic mRNA abundance and ivGTTs, those cows seemed 
to be in an improved energetic situation compared to other cows. Moreover, high protein cows 
showed highest insulin resistance in early lactation. Property of cows with low FCM and low 
protein concentration was a difference in metabolism due to seemingly enhanced protein 
catabolism instead of lipolysis. 
Additionally, protein composition of milk was analysed throughout experimental period with 
capillary electrophoresis on a chip (Agilent Protein 80 Chip for Bioanalyzer). Cows grouped for 
FCM yield and protein concentration showed differences in concentrations of major milk proteins 
α-lactalbumin, β-lactoglobulin, α-, β- and κ-casein, which could be explained by their different 
genotypes of β-LG and κ-CN: high yielding cows showed lower casein concentrations compared 
to low yielding cows. Furthermore, low yielding cows had lower contents of α-CN. 
Composition of milk protein was almost not altered by restricted feeding. Solely restricted feeding 
in mid-lactation resulted in decreased mean contents of κ-CN and therefore potentially diminished 
processing quality of milk for cheese making. 
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VIII. ZUSAMMENFASSUNG 
Metabolische und produktive Charakterisierung von mehrkalbigen Kühen gruppiert anhand 
fettkorrigierter Milchmenge und Milchproteinkonzentration 
Ziel dieser Studie war die Beschreibung von metabolischer Anpassungsfähigkeit und Produktivität 
von Kühen, die nach fettkorrigierter Milchmenge und Proteingehalt der Milch eingeteilt wurden. 
Darum wurden 23 Kühe (sechs davon mit hohem FCM und hohem Milchproteingehalt, fünf mit 
niedrigem FCM und niedrigem Proteingehalt, sieben mit hohem FCM und niedrigem Proteingehalt 
und fünf Tiere mit niedrigen FCM und hohem Proteingehalt der Milch) im Zeitraum von zwei 
Wochen vor der Abkalbung bis zur 22. Woche der Laktation untersucht. Regelmäßig wurden Blut- 
und Milchproben gesammelt und die Körperkondition überwacht. Die Kühe wurden einer 
30%igen Futterrestriktion in der frühen (Tag 26 bis 28 der Laktation) und der mittleren Laktation 
(Tag 141 bis 143 der Laktation) unterzogen, um die metabolische Reaktion zu untersuchen. Drei 
intravenöse Glukose Toleranz Tests (ivGTT, Tag -14, 20 und 127 der Laktation) wurden 
durchgeführt, um Unterschiede in der Insulinantwort zu beleuchten. Des Weiteren wurden 
Genexpressionsprofile der Leber erstellt am Tag der Kalbung, Tag 15, 57 und 155 der Laktation 
sowie am letzten Tag beider Futterrestriktionen. Die untersuchten Zielgene (20) spielen 
Schlüsselrollen im Glukosetransport, Fett-, Protein- und Kohlenhydratstoffwechsel sowie in der 
Ketogenese. 
Milch, Blutserum und Körperkonditionsparameter der hochleistenden Tiere deuteten auf ein 
erhöhtes Risiko an metabolischer Imbalance während der frühen Laktation hin. 
Genexpressionsprofile zeigten, dass hochleistende und vor allem die Kühe mit hohem FCM und 
niedrigem Proteingehalt ein höheres Risiko hatten, an Fettleber zu erkranken, und ein verringertes 
Glukoneogenese Potential aufwiesen. Während der Futterrestriktion in der Frühlaktation schienen 
diese Kühe reduzierte physiologische Anpassungsfähigkeiten an die gesteigerte energetische 
Belastung zu zeigen. Nichtsdestotrotz lassen die Ergebnisse der ivGTTs darauf schließen, dass 
hochleistende Kühe Glukoneogenese Aktivität zeigen, welche den Anforderungen an die 
Milchsynthese in der Frühlaktation genügt. Bei Kühen mit hohem FCM und hohem 
Milchproteingehalt schien die Glukoneogenese Kapazität diese Ansprüche sogar zu übertreffen. 
Insulin Sensitivität war in hochleistenden Kühen vor der Kalbung reduziert. 
Des Weiteren waren nur Kühe mit niedrigem FCM und hohem Proteingehalt in der Lage, 
Körperreserven in der mittleren Laktation wieder aufzubauen. Verglichen mit den anderen Kühen 
schienen sich diese Tiere auch hinsichtlich der Genexpressionsprofile und der ivGTTs in einer 
besseren energetischen Situation zu befinden. Ferner zeigten die hoch-Protein-Kühe die höchste 
Insulinresistenz in der frühen Laktation. Eigenheit der Tiere mit niedrigem FCM und Proteingehalt 
war ein Unterschied im Stoffwechsel aufgrund des scheinbar verstärkten Proteinabbaus anstatt der 
Lipolyse. 
Zusätzlich wurde die Proteinzusammensetzung der Milch während des Versuchs mithilfe der 
Kapillarelektrophorese auf einem Chip gemessen (Agilent Protein 80 Chip für den Bioanalyzer). 
Nach FCM und Proteingehalt gruppierte Kühe zeigten Unterschiede in den 
Hauptmilchproteinfraktionen α-Laktalbumin, β-Laktoglobulin, α-, β- und κ-Casein. Diese können 
mit den verschiedenen Genotypen der Tiere hinsichtlich β-LG und κ-CN erklärt werden. 
Hochleistende Kühe zeigten geringere Konzentrationen an Caseinen verglichen mit den 
niedrigleistenden Kühen. Des Weiteren hatten niedrigleistende Tiere niedrigere Konzentrationen 
von α-CN. 
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Die Zusammensetzung des Milchproteins änderte sich fast nicht durch die restriktive Fütterung. 
Nur die Futterrestriktion in der Mitte der Laktation resultierte in gesunkenen κ-CN 
Konzentrationen, die wiederum zu verringerter Prozesssierungsqualität im Käsereiprozess führen 
kann. 
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